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ABSTRACT 
Background:  Obsessive-compulsive disorder (OCD) is a neuropsychiatric condition 
characterized by significant heterogeneity.  It has been suggested that classification of OCD 
into more homogeneous subtypes, and identification of their associations with etiological 
factors (e.g. genetic variants, or psychological trauma), and outcome (e.g. disability and 
treatment response), may be useful.  The identified subtypes are not definitive yet and 
continue to be subject to revision.  The overall objective of this dissertation was to assess 
comprehensively a sample of OCD patients, and to use cluster analytic methods to delineate 
valid OCD subtypes.   
Methods:  Patients meeting DSM-IV criteria for a primary diagnosis of OCD (N=261) on the 
Structured Clinical Interview for Axis I Disorders - Patient Version (SCID-I/P), with ages 
ranging from 16 to 71, took part in the study.  The newly developed Structured Clinical 
Interview for the Diagnosis of putative Obsessive-Compulsive Spectrum Disorders (SCID-
OCSD) was administered to assess OCD-related conditions not covered by the SCID-I/P.  
OCD subtyping, based on OCD symptomatology (assessed with the Yale-Brown Obsessive-
Compulsive Symptom Checklist [YBOCS-CL]), and based on comorbidity with the OCD 
spectrum of disorders (assessed with the SCID-OCSD), proceeded along the following lines: 
Firstly, latent class cluster analysis (LCA), a categorical analogue to traditional factor 
analysis (FA), and with many advantages compared to FA, was implemented with the (nine) 
most frequently endorsed OC symptoms.  Secondly, in an attempt to remedy some of the 
limitations of the LCA (e.g. increased potential for computational instability when additional 
indicators / symptoms were included), cluster analyses (Ward’s method) were performed on 
all of the items of the YBOCS-CL and SCID-OCSD, respectively, for all OCD patients.  The 
associations of cluster scores with demographic variables (age, gender), clinical variables 
(age of onset, obsessive-compulsive symptom severity and dimensions, level of insight, 
temperament, childhood trauma, treatment response) and genotypes were then examined, 
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using Spearman correlation coefficients, one-way analysis of variance (ANOVA), and Mann-
Whitney U-tests, where appropriate.   
Results:  The findings suggested that increased presentation of symptoms characteristic of 
each of the clusters of cases was associated with specific demographic and clinical 
characteristics, which substantiated the presence of distinct clinical subtypes of OCD.  
Cluster analysis of the 45 selected items of the YBOCS-CL in this sample of OCD patients 
identified 6 separate clusters; these clusters were labelled “Contamination fears / washing”, 
“Hoarding / collecting”, “Symmetry / ordering / counting / arranging / repeating”, “Sexual”, 
“Somatic, religious and diverse” and “Harm-related”.  Increased presentation of symptoms 
characteristic of each of the clusters was associated with specific demographic, clinical and, 
in some cases, genetic characteristics.  Of note, the findings indicated the L/L (met/met) 
genotype of COMT Val158Met polymorphism plays a major role in the increased 
manifestation of sexual, somatic, religious and diverse, and harm-related symptoms of OCD, 
as such contributing to the relatively limited data on OC symptom subtypes and genetics.  
However, the fact that the associated features did not clearly and uniquely differentiate 
clusters and that clusters were significantly correlated with one another suggested that the 
delineation of the OCD complex into OC symptom clusters is not the only way to approach 
the heterogeneity characteristic of OCD.  Nevertheless, the significant comorbidity with 
OCSD’s in the identified clusters (e.g. tics associated with sexual obsessions / compulsions) 
highlighted the significant relationship of OCD with the OCSD’s.  This again raised the 
question about the way in which the OCSD’s “fit” with the standard OC symptomatology 
outlined in the YBOCS-CL.  A cluster analysis of OCSD’s in OCD patients identified a 
Tourette’s syndrome / tics subtype of OCD (part of the so-called “reward deficiency” cluster), 
as well as an impulsivity subtype, and a somatic subtype – each associated with specific 
clinical and demographic variables.  Here, a significant relationship between the identified 
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clusters and the investigated dopaminergic and serotonergic polymorphisms was not found, 
suggesting that variants in other genes in these systems should also be explored.   
Conclusion:  The main finding was that OCD is indeed a heterogeneous disorder that may 
be subtyped into different symptom dimensions.  The identified OCD subtypes with their 
associated features were to a large extent consistent with previously published data.  
However, in contrast to factor analysis, LCA provided a novel, appropriate and 
advantageous statistical analysis strategy for the data.  Furthermore, to our knowledge, the 
attempt to classifiy OCD according to comorbid OCSD’s was the first cluster analysis based 
on a prospective comprehensive interview investigating a range of OCSD’s.  As such, 
although the dimensional structure of OCD is still not entirely understood, the categorization 
of our OCD patients into different groups and the investigation of their respective features 
have gone beyond the literature and thus add another dimension to the increasing efforts to 
fully delineate OCD subtypes.   
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ABSTRAK 
Agtergrond:  Obsessief-kompulsiewe steuring (OKS) is ‘n neuropsigiatriese toestand wat 
deur beduidende heterogeniteit gekenmerk word.  Daar is voorheen voorgestel dat die 
klassifikasie van OKS in meer homogene endofenotipes of subtipes, en die identifisering 
van beduidende assosiasies daarvan met by voorbeeld spesifieke oorsaaklike faktore (bv. 
genetiese variante, of sielkundige trauma) en uitkomste (insluitend inperking en 
behandelingsrespons), nuttig kan wees.  Die geïdentifiseerde subtipes is nog nie finaal 
bevestig nie en word daar met die hersiening van bevindinge hieroor volgehou.  Die primêre 
doelstelling van hierdie verhandeling was om ‘n groep pasiënte met OKS deeglik te 
assesseer, en om tros-analise te gebruik om geldige OKS-subtipes te identifiseer.   
Metodes:  Pasiënte wat voldoen het aan DSM-IV criteria vir ‘n primêre diagnose van OKS 
(N=261) volgens die “Structured Clinical Interview for Axis I Disorders – Patient Version” 
(SCID-I/P), met ouderdomme strekkend vanaf 16 tot 71 jaar, het aan die studie 
deelgeneem.  Die nuut-ontwikkelde “Structured Clinical Interview for the Diagnosis of 
Putative Obsessive-Compulsive Spectrum Disorders” (SCID-OCSD) is toegepas ten einde 
OKS-verwante toestande wat nie by die SCID-I/P ingesluit is nie, te assesseer.  Subtipering 
van OKS gebaseer op OKS simptomatologie (soos vasgestel met die Yale-Brown 
Obsessive-Compulsive Symptom Checklist [YBOCS-CL]), en op komorbiditeit met die OKS 
spektrum van toestande (soos vasgestel met die SCID-OCSD), het op die volgende wyses 
geskied:  Eerstens, latente klas tros-analise (LKA), ‘n kategoriese analoog vir tradisionele 
faktor analise (FA), en met baie voordele in vergelyking met FA, is geïmplementeer op die 
(nege) obsessief-kompulsiewe simptome wat die meeste gerapporteer is.  Tweedens, ten 
einde sommige van die beperkinge van LKA aan te spreek (bv. die verhoogde moontlikheid 
vir onstabiliteit in die rekenaar-bewerkings wanneer addisioneleindikatore / simptome 
ingesluit word), is nog ‘n tros-analise (Ward se metode) op al die items van die YBOCS-CL 
en die SCID-OCSD onderskeidelik, vir alle OKS-pasiënte toegepas.  Die assosiasies van die 
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tros-tellings met demografiese veranderlikes (ouderdom, geslag), kliniese veranderlikes 
(aanvangsouderdom van OKS, ernstigheidsgraad van obsessiewe-kompulsiewe simptome 
en dimensies, mate van insig, temperament, trauma in die kindertyd, behandelingsrespons) 
en genotipes is daarna ondersoek deur gebruik te maak van Spearman korrelasie-
koëffisiënte, een-rigting analises van variansie (ANOVA), en Mann-Whitney U-toetse, soos 
toepaslik. 
Resultate:  Die bevindinge suggereer dat verhoogde rapportering van simptome 
kenmerkend van elkeen van die trosse van gevalle met spesifieke demografiese, kliniese 
en, in sommige gevalle, genetiese eienskappe geassosieërd was, wat die teenwoordigheid 
van unieke kliniese subtipes van OKS verder ondersteun.  Tros-analise van die 45 
geselekteerde items van die YBOCS-CL in hierdie groep OKS-pasiente het 6 afsonderlike 
trosse geïdentifiseer.  Hierdie trosse is genoem “Besmettingsvrese / skoonmaak”, “Opgaar / 
bymekaarmaak”, “Simmetrie / orden / tel / organiseer / sekermaak / herhaal”, “Seksueel”, 
“Somaties, godsdienstig en divers” en “Skade-verwant”.  Verhoogde rapportering van die 
simptome van elk van die trosse was met spesifieke demografiese, kliniese, en in sommige 
gevalle, genetiese kenmerke, geassosieërd.  Die bevindinge het daarop gedui dat die L/L 
(met/met) genotipe van die COMT Val158Met polimorfisme ‘n belangrike rol in die 
manifestasie van seksuele, somatiese, religieuse en diverse, en skade-verwante simptome 
van OKS kan speel.  Hierdie bevinding dra by tot die relatief beperkte beskikbare literatuur 
oor OK simptoom subtipes en genetika.  Aan die ander kant, die feit dat die geassosieërde 
kenmerke nie die trosse duidelik en uniek van mekaar onderskei het nie en dat die trosse op 
beduidende wyse met mekaar gekorreleerd was, suggereer dat die kategorisering van die 
OKS-kompleks in OK simptoom-trosse nie die enigste manier is om die heterogeneïteit van 
OKS te benader nie.  Nietemin, die beduidende komorbiditeit met OKS-verwante toestande 
in die geïdentifiseerde trosse (bv. die assosiasie tussen tics en seksuele obsessies / 
kompulsies), het die betekenisvolle verhouding tussen OKS en die OKS-verwante toestande 
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beklemtoon.  Dit het weer aanleiding gegee tot ‘n vraag na die wyse waarop die OKS-
verwante toestande “inpas” by die standaard OK simptomatologie, soos uiteengesit in die 
YBOCS-CL.  ‘n Tros-analise van die OKS-verwante toestande in OKS-pasiënte het ‘n 
Tourette Sindroom / tics subtipe van OKS (deel van die sogenaamde “beloningstekort”-tros), 
sowel as ‘n impulsiwiteitsubtipe, en ‘n somatiese subtipe geïdentifiseer – wat elkeen met 
spesifieke kliniese en demografiese veranderlikes geassosieërd was.  Hier is nie ‘n 
beduidende verhouding tussen die geïdentifiseerde trosse en die dopaminergiese en 
serotonergiese polimorfismes wat ondersoek is, gevind nie, wat moontlik daarop dui dat 
variante van ander gene in hierdie sisteme ook ondersoek behoort te word.  
Gevolgtrekking:  Die hoofbevinding was dat OKS is inderdaad ‘n heterogene toestand wat 
subtipeer kan word in ‘n aantal verskillende simptoom-dimensies.  Die geïdentifiseerde 
OKS-subtipes met hulle geassosieërde kenmerke was in ‘n groot mate ooreenstemmend 
met voorheen gepubliseerde data.  In teenstelling met FA, het die LKA ‘n nuwe, toepaslike 
en voordelige statistiese analise strategie vir die data gebied.  Verder, sover ons weet, was 
die poging om OKS te klassifiseer volgens die komorbiditeit met OKS-verwante toestande 
die eerste tros-analise wat gebaseer was op ‘n prospektiewe volledige onderhoud wat die 
reeks van OKS-verwante toestande ondersoek.  Alhoewel die dimensionele struktuur van 
OKS dus nog steeds nie volkome verstaan word nie, strek hierdie kategorisering van OKS-
pasiënte in verskillende groepe en die ondersoek na hulle onderskeidelike kenmerke verder 
as die bestaande literatuur, en voeg dus nog ‘n dimensie tot die toenemende pogings om 
die OKS-subtipes af te baken.     
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  1
INTRODUCTION 
 
 
Obsessive-compulsive disorder (OCD) is now recognized as one of the most common 
psychiatric disorders, associated with substantial morbidity and impaired quality of life.  In 
the clinic, the diagnosis of OCD is made with increasing frequency, and in the research 
setting, the empirical investigation of OCD has increased.  Major advances have recently 
been made in characterizing the phenomenology and psychobiology of OCD.   It has 
become clear that OCD is not simply a uniform or homogeneous disorder, but rather a 
disorder characterized by significant heterogeneity that obscures the findings of clinical, 
natural history and treatment response studies and complicates the search for vulnerability 
genes.     
 
This dissertation focussed on the classification of OCD into more homogeneous subtypes or 
symptom dimensions, arguing that subtyping is a useful means of integrating the 
heterogeneous data on symptomatology, psychobiology, genetics and treatment response.  
In particular, with the existing literature as background (Chapter 1), the overall objective of 
this study was to assemble, analyze and interpret original data in order to better previous 
efforts delineating valid OCD subtypes or dimensions and their associated features, with 
appropriate data classification and association study methods, in a large sample of South 
African OCD patients.  Chapter 2 includes a general overview of the methodological 
procedures (including patient recruitment, data collection methods and data analyses) that 
were implemented in this investigation.  Subsequent chapters include a methods section 
with a detailed description of specific objectives and the procedures followed to achieve 
these aims.  Chapter 3 provides a description of findings obtained with the YBOCS-CL as 
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an important introduction to subsequent analyses (Chapters 4 and 5), with a 
comprehensive description and rationale for the use of the YBOCS-CL and the provision of 
a profile of the present OCD sample based on their YBOCS-CL responses.  This section 
also includes comments on the content and comprehensiveness of the YBOCS-CL as an 
assessment tool of OC symptomatology.  Subtyping based on OCD symptomatology as well 
as comorbidity (especially with OCD-spectrum conditions) as classifying variables have 
been two of the most common strategies for identifying OCD subtypes, and has been 
receiving increasing attention in recent years.  The subtyping efforts proceeded along these 
lines, i.e. firstly based on OCD symptomatology assessed with the YBOCS-CL (Chapters 4 
and 5), and secondly, given the significant comorbidity of the identified subtypes with the 
OCD spectrum of disorders, subtyping proceeded based on comorbidity with the OCSD’s 
(assessed with the Structured Clinical Interview for the Diagnosis of putative Obsessive-
Compulsive Spectrum Disorders [SCID-OCSD]) (Chapter 6).  More specifically, Chapter 4 
includes a Latent Class Analysis (LCA), which basically entails different statistical 
techniques to classify OCD cases based on their OC symptomatology as determined by the 
YBOCS-CL.  Chapter 5, on the other hand, implements a different statistical technique 
namely cluster analysis (Ward’s Method), and entails the classification of OC symptoms (as 
variables).  These were the initial steps in the classification of OCD into more homogeneous 
subtypes or dimensions.  Subsequently, recognizing the importance of comorbidity in 
subtyping of heterogeneous disorders such as OCD and the significant relationship of OCD 
with the OCSD’s, Chapter 6 also attempts classification of variables, i.e. the cluster analysis 
(Ward’s method) of comorbid OCSD’s in patients with OCD as determined by the SCID-
OCSD.  The associations of the identified clusters or dimensions with other relevant 
variables including demographic variables (age, gender), clinical variables (age of onset, 
obsessive-compulsive symptom severity and dimensions, level of insight, 
temperament/character, treatment response) and genotypes are described.  In order to 
  3
reduce the chance of type I error, the number of comparisons have been minimalized as far 
as possible, with priority given to those variables shown to have significant association with 
the symptom subtypes in previous studies, i.e. childhood interpersonal trauma history and 
specific genetic variables.  Chapter 7 includes a general discussion of the main findings, 
with suggestions for clinical practice as well as future research directions.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Footnote: Tables that were not of immediate importance given the thesis objectives were 
excluded but may be obtained from the candidate.) 
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CHAPTER 1 
BACKGROUND 
 
 
The central aim of Chapter 1 is to review the existing literature on the heterogeneity of 
obsessive-compulsive disorder (OCD), providing an introduction to and motivation for 
subsequent chapters on the delineation of OCD into different subtypes, each with distinct 
associated features.  It will be argued that subtyping OCD is a useful means of integrating 
the heterogeneous data on its symptomatology, psychobiology, genetics and treatment 
response. 
 
1.1 Obsessive-compulsive disorder in context 
 
Epidemiological data from World Health Organisation (WHO) studies indicate that 5 of the 
10 most disabling disorders are neuropsychiatric conditions (Murray and Lopez, 1996).  In 
particular, OCD is one of the most common mental disorders; for example, in the 
Epidemiological Catchment Area study in the USA, it was the fourth most common condition 
with a life-time prevalence of 2.5% (Karno et al., 1988).  OCD is estimated to affect nearly 5 
million US citizens (Karno et al., 1988), with a resultant annual impact on the US economy of 
approximately $ 8.4 billion (DuPont et al., 1995), making it a public health issue of national 
scope.  Moreover, these findings have been confirmed by further surveys conducted 
internationally (Weissman et al., 1994).  The significant negative social and economic impact 
of OCD on society is also recognized in developing countries such as South Africa (Stein et 
al., 1996).  
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1.2 A short history of OCD 
 
The first time a clinical case of OCD was described in psychiatric literature, was during the 
first half of the 19th century.  The rest of the 19th century saw a steady progress in the way 
OCD was conceptualised, with clinicians like Falret, Morel, Krafft-Ebing and Westphahl 
offering Psychiatry numerous and varying descriptions of OCD.  Interestingly, in as early as 
the 1870’s, heritability was recognized as one of the most prominent etiologic factors in 
OCD. 
 
In the following years, other diagnostically related categories, e.g. “neurasthenia”, and 
“psychasthenia” were proposed.  These categories apparently showed some significant 
overlap with one another, but also lead to confusion about, and consequently endangering 
the existence and the conceptualisation of OCD.  Nevertheless, the first two to three 
decades of the 20th century saw Janet and Freud’s significant clinical and theoretical 
contributions to the concept of OCD.  After numerous speculations about the concept, Freud 
finally ended his psychoanalytically - based investigation on OCD in 1926, with the following 
statement:  “Obsessional neurosis is certainly the most interesting and grateful subject of 
analytic research, but as problem still not solved.” (Translated) (Freud, 1926).  By the 
second half of the 20th century, OCD was recognized as a neuropsychiatric condition 
thought to be caused by early traumatic experiences or environmental factors, warranting 
treatment.  In addition, the last two to three decades saw an increased attention to the 
influence of genetic factors in the manifestation of this disorder; i.e. a definitive move 
towards an approach to OCD as a biochemical and neurobiological condition. 
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1.3 OCD: DSM-IV diagnostic criteria 
 
Today, in the clinic the diagnosis of OCD is made with increasing frequency (Stoll et al., 
1992), and in the research setting the empirical investigation of OCD has increased much 
(Lochner and Stein, 2003a).  Despite it still being relatively under-recognized and under-
treated, there is growing recognition that OCD is a frequently occurring and disabling 
neuropsychiatric disorder, associated with substantial morbidity (e.g. unemployment, marital 
separation or divorce, and lower socio-economic status), and thus significantly impaired 
quality of life (Karno et al., 1988).  
 
According to the Diagnostic and Statistical Manual of Mental Disorders (4th edition) (APA, 
1994), OCD is characterized by recurrent obsessions and/or compulsions that cause 
marked distress, are time-consuming (i. e. requiring more than 1 hour a day), and 
significantly interfere with the individual's social, academic, or occupational functioning.  
Obsessions are defined as persistent, intrusive ideas, thoughts, images, or impulses, such 
as fears of contamination or fears of potential harm to oneself or others, that may be 
perceived as inappropriate or unreasonable.  Compulsions, on the other hand, are repetitive, 
stereotyped behaviours, such as hand washing or checking behaviours, or covert mental 
rituals (e.g. silently counting or repeating words) that individuals with OCD feel compelled to 
perform in response to obsessions, or to prevent some dreaded situation or event.  By 
definition, their insight could waver from good to very poor, but most patients with OCD have 
good insight and at some point recognize that the obsessions or compulsions are excessive 
or unreasonable (APA, 1994).  Their realisation of the discrepancy between the knowledge 
that obsessions and compulsions are irrational on the one hand, and the overwhelming urge 
to perform them on the other hand, contribute to the immense suffering associated with the 
disorder.   
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As was noted earlier, there may be different approaches to the characterization of OCD:  In 
the 19th and early 20th century, Freud and other psychoanalysts substituted the early 
connection between obsessive-compulsive symptoms and psychosis with an emphasis on 
the concepts of neurosis and character.  Contemporary thinking suggested a move away 
from psychoanalytic theory towards a more neurobiological approach to OCD.  
Neurobiological research on OCD was given significant impetus by the early finding that this 
disorder, previously often considered to be treatment refractory, responded to the 
serotonergic tricyclic, clomipramine.  In addition to this neurochemical perspective of OCD 
as a disorder involving serotonergic mechanisms, it has also been shown to be related to 
the dopaminergic system (Goodman et al., 1990, 1992).  From a neuro-anatomical 
perspective, OCD is believed to be related to the cortico-striatal system for its role in 
supporting repetitive, compulsory behaviours (disorder of intellect), and to the amygdala for 
its role in fear conditioning and anxiety (disorder of emotion) (Rauch and Baxter, 1998).  In 
addition, family and twin studies have provided evidence for a genetic component in OCD. 
 
1.4 Characterization of OCD: Homogeneous or heterogeneous disorder? 
 
In the last few years, the psychobiological approach has gained ground with significant 
advances in the characterization of the phenomenology and psychobiology of OCD.  In 
particular, studies have addressed the epidemiology (Karno et al., 1988; Weissman et al., 
1994), symptomatology (Rasmussen and Tsuang, 1986; Rettew et al., 1992), neuroanatomy 
(Rauch et al., 1997; Saxena and Rauch, 2000), neurochemistry (Goodman et al., 1990; 
Zohar and Insel, 1987, 1987), pharmacotherapy (Greist and Jefferson, 1998; Jenike, 1992; 
Klein, 1990) and psychotherapy (Greist, 1996; Minichiello et al., 1988) of OCD, with some of 
the findings contributing to the initial conceptualisation of OCD as a relatively homogeneous 
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and specific neuropsychiatric entity, underpinned by particular mechanisms that manifest in 
universal symptoms.   
 
At the same time, research findings suggesting the possibility that OCD is not a 
homogeneous diagnostic entity have become increasingly common in recent years.  Indeed, 
although the cardinal symptoms of OCD (i.e. obsessions / compulsions) are remarkably 
consistent across cultures, it’s specific clinical features and course vary (Leckman et al., 
2001; Skoog and Skoog, 1999).  The variability in the phenotypic expression has led to the 
hypothesis that OCD is a heterogeneous disorder and that this heterogeneity obscures the 
findings of clinical, natural history and treatment response studies and complicates the 
search for vulnerability genes.  This heterogeneity may explain why there have been so 
many inconsistent findings in studies of OCD.   
 
1.5 OCD as a heterogeneous disorder 
 
The heterogeneity of OCD is evident in a number of respects, including it’s phenomenology 
(Section 1.5.1), psychobiology (Section 1.5.2), genetics (Section 1.5.3) and treatment 
response (Section 1.5.4) (Lochner and Stein, 2003a). 
  
1.5.1 Phenomenology 
The symptoms used to define OCD are diverse and include a range of obsessions and 
compulsions.  The predominant symptoms in OCD have been well documented (e.g. 
Nestadt et al., 2002; Rasmussen and Tsuang, 1986; Rettew et al., 1992; Rocca et al. 
1991) and include:  
(1) concerns about contamination or illness, along with compulsive cleaning or  
washing,  
  9
(2) obsessive doubt, with subsequent checking rituals,  
(3) concerns about, and compulsions regarding, symmetry, orderliness, and numbers,  
(4) hoarding/collecting rituals, and  
(5) obsessional slowness. 
Other symptoms (e.g. religious or sexual obsessions and rituals, and so-called 
“miscellaneous” symptoms) have also been described.  An alternative strategy to 
focusing simply on specific symptom types has been to explore symptom clusters, or 
“groupings” of various OCD symptoms that may present simultaneously (Baer, 1994; 
Calamari et al., 1999; Hodgson and Rachman, 1977; Leckman et al., 1997; Summerfeldt 
et al., 1999; Van Oppen et al., 1995), e.g. obsessions and rituals re both symmetry and 
hoarding.   
 
In addition, obsessive-compulsive phenomenology show significant overlap with the 
features of a group of other disorders known as the putative obsessive-compulsive 
spectrum disorders (OCSD’s).  It has been suggested that the OCSD’s comprise a 
number of psychiatric and neuropsychiatric conditions that share enough 
phenomenological and psychobiological features with OCD to be meaningfully grouped 
with it (Hollander, 1993; McElroy et al., 1994; Rasmussen, 1994), arguably adding to the 
heterogeneity of OCD.  Despite consensus in the literature for the existence of an OC 
spectrum, debate about criteria for inclusion into the OC spectrum continues, with some 
authors arguing for more conservative boundaries, including only OCD, Tourette’s 
disorder, tics, trichotillomania, body dysmorphic disorder and hypochondriasis, whereas 
others have argued for a “broad” spectrum that may include additional conditions such 
as eating disorders (anorexia and bulimia nervosa), impulse control disorders (such as 
pathological gambling and compulsive shopping), stereotypical movement disorders 
(with or without self-injury), and some personality disorders (including borderline and 
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obsessive-compulsive personality disorder).  One common feature of these conceptual 
schemes is that OCD is thought to be the prototype for this spectrum of conditions.   
 
Individuals with OCD (compared to other anxiety disorders) are more likely to report a 
lifetime comorbid spectrum condition (Richter et al., 2003), thereby also adding to the 
heterogeneous presentation of OC phenomenology.  Importantly, while most of the 
literature focuses on the relationship between OCD and spectrum disorders, focus on 
the comorbidity of OCD spectrum disorders in OCD is on the increase.  It has been 
suggested that a consideration of such comorbidity may well contribute to delineating the 
heterogeneity of OCD; i.e. the heterogeneous OCD phenotype may possibly be 
subtyped based on the presence of comorbid OCSD’s (Lochner et al., 2005).  
(Classification of OCD symptomatology will be discussed in more detail under Section 
1.6.2.vi “OCD symptom subtypes based on OCD symptomatology assessed with the 
YBOCS-CL” and Section 1.6.3 “Subtyping built upon comorbidity”.) 
 
1.5.2 Psychobiology 
Findings from neuropsychiatric, neurochemical, and neuroimmunological studies are 
relevant here:  Several neurological disorders may result in OCD symptoms, although 
such patients may form only a small proportion of those having OCD (Grimshaw, 1964).  
Moreover, OCD patients differ in extent and location of neuropsychiatric impairment 
(Stein et al., 1994), and these differences may also be useful in subtyping the disorder 
(More on subtyping in Section 1.6).  Neuropsychiatric heterogeneity may be seen in 
studies of neurological soft signs and in neuropsychological function, 
electroencephalography (EEG), and brain imaging.   
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A relationship between neurological soft signs and OCD has been suggested.  For 
example, OCD patients have elevated levels of neurological soft signs compared to 
normal controls (Hollander et al., 1991).  Hymas et al. (1991) found that patients with 
obsessional slowness invariably had increased neurological soft signs.  In addition, it 
has been suggested that patients with increased neurological soft signs may have 
increased ventricular-brain ratio in comparison to normal controls (Stein et al., 1993).  
Increased neurological soft signs may also predict poor response to pharmacotherapy 
(Hollander et al., 1991; Thienemann and Koran, 1995).  Furthermore, a specific OCD 
clinical profile may be correlated to organicity; for instance, Thomsen and Jensen (1991) 
compared 61 child and adolescent OCD patients with 177 matched control patients for 
organic features as assessed by neurological signs, electrophysiological abnormalities, 
specific developmental disorder, and attention deficit.  Significantly more OCD patients 
than controls were assigned to the organic class, with neurological soft signs being the 
most sensitive and specific indicator of organicity.  Behavioural problems and loss of 
temper were significantly more frequent in the non-organic class, whereas symptoms of 
phobia and depression were more often present in the organic class.  Yaryura-Tobias et 
al. (2000) also investigated an “organic” and a control, “non-organic” group of OCD 
patients and found some differences in their clinical profiles.  A subgroup of OCD 
patients has abnormal EEG’s (Stein et al., 1994).  Similarly, Deltito (1994) suggested 
that some OCD patients have symptoms like those of temporal lobe epilepsy, such as 
irritability, confusion, psychosis, or other cognitive impairments, which may well have 
implications for treatment.  Quantitative EEG patterns have also been reported to differ 
between responders and non-responders to medication (Prichep et al., 1993).   
 
Functional neuroimaging studies have advanced the understanding of the brain 
mediation of OCD by orbitofrontal-subcortical circuitry (Baxter et al., 1994), but much is 
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still unknown (Robinson et al., 1995).  Indeed, it has been suggested that phenotypic 
heterogeneity may account for many of the inconsistencies among previous 
neuroimaging studies of OCD (Cummings et al., 1988; Rauch and Baxter, 1998; 
Savage, 1997; Saxena et al., 1998, 2000). 
 
Slowness of thinking (bradyphrenia) and slowness of movement (bradykinesia) are 
symptoms of subcortical neurological disorders; for example, those of the basal ganglia, 
such as Parkinson’s disease (Cummings et al., 1988; Savage et al., 1997).  Similarly, 
obsessional slowness in OCD patients may reflect basal ganglia damage, but rather 
than being a separate group of OCD patients, these patients may simply be a subtype 
with more severe psychopathology.   
 
Functional brain imaging has documented that OCD patients have increased prefrontal 
activity compared to normal controls (Insel, 1992).  Positron emission tomography 
studies of OCD have consistently identified hypermetabolism in the orbitofrontal cortex, 
the caudate nucleus, and (sometimes) the anterior cingulate cortex (Baxter et al., 1994; 
Saxena et al., 1998; Saxena and Rauch, 2000).  OCD patients with more motoric 
symptoms (e.g. tics) may also be more likely than OCD patients without such symptoms 
to have involvement of the putamen (Rauch and Baxter, 1998), although this hypothesis 
remains to be validated.  It has also been suggested that patients with tic-related OCD 
may have more abnormal motor cortex excitability than OCD patients without tics 
(Greenberg et al., 2000).  Relatively few studies have explored functional brain imaging 
in acquired OCD (i.e. OCD associated with neurologic disorders).  In a review of the 
brain single positron emission computerized tomography (SPECT) scans of patients with 
various neurological conditions also presenting with OCD, Hugo et al. (1999) reported 
that all of these patients demonstrated decreased blood flow in the temporal lobes and 
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cortical perfusion abnormalities in the frontal lobes.  Indeed, abnormal blood flow may be 
seen in a number of different brain regions in acquired OCD (Hugo et al., 1999).  In a 
study investigating OCD associated with brain lesions, Berthier et al. (1996) found that in 
a patient group with acquired OCD, neuroimaging disclosed abnormalities in a variety of 
regions involving either the cerebral cortex (frontal, temporal, or cingulate regions), the 
basal ganglia, or both.  The study also suggested that patients with focal brain lesions 
(acquired OCD) had a negative familial history and later age of onset of OCD symptoms 
than patients with idiopathic OCD (Berthier et al., 1996).  There have been some efforts 
to use factor analyses to identify neural correlates of symptom clusters.  For example, 
Rauch and Savage (Rauch and Savage, 1997) found the severity of 
religious/aggressive/sexual obsessions and checking was positively related to regional 
cerebral blood flow in the striatum bilaterally.  Distinct trends were also observed for the 
other factors, or symptom dimensions.  These findings provide support for the 
hypothesis that dysfunction within separate neurocircuitry systems may principally 
mediate particular symptom clusters.  In brief, neurological soft signs are common 
among OCD patients and may be associated with an “organic” subtype of OCD.  
Functional neuroimaging studies have suggested that OCD patients have increased 
prefrontal activity and hypermetabolism in the orbitofrontal cortex, the caudate nucleus, 
and other regions. 
 
Hollander et al. have reported that only some patients’ conditions exacerbate after 
administration of the partial serotonin agonist m-chlorophenylpiperazine (m-CPP) 
(Hollander et al., 1993a).  Interestingly, exacerbation of OCD symptoms after 
administration of m-CPP is correlated with increased cerebral blood flow in the frontal 
cortex (Hollander et al., 1995).  It may be hypothesized that increased frontal activity in 
some patients with OCD is in itself a compensatory mechanism.  These preliminary 
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neurobiological findings are consistent with a hypothesis that exacerbation of OCD after 
administration of a serotonin autoreceptor agonist may be an indication of compensatory 
postsynaptic serotonergic up-regulation.  Such up-regulation may be associated with 
increased frontal activity and relatively poor response to serotonergic agents (Stein et 
al., 1999).   
 
Regarding the neuroimmunology findings in OCD:  Swedo and Leonard (1994) noted 
that a proportion of patients with Sydenham’s chorea meets diagnostic criteria for OCD 
and often have tics.  Sydenham’s chorea is an involuntary movement disorder that 
develops in some children following a group A beta-hemolytic streptococcal (GABHS) 
infection.  Some of these patients’ movements either are or resemble tics.  This 
condition is also characterized by increased antineural antibodies, suggesting that an 
autoimmune process may be responsible for basal ganglia damage and OCD in these 
patients (Swedo et al., 1994).  Conversely, an increasing body of evidence provides 
support for the postulate that OCD and tic disorders may arise from poststreptococcal 
autoimmunity (Allen et al., 1995).  The term PANDAS (for “pediatric autoimmune 
neuropsychiatric disorders associated with streptococcal infections”) refers to patients 
with tics and obsessive-compulsive symptoms induced by streptococcal infections 
(Leonard and Swedo, 2001).  Leonard and Swedo (2001) provide five criteria for this 
condition: presence of OCD or tic disorder; prepubertal symptom onset; sudden onset or 
episodic course of symptoms; temporal association between streptococcal infections 
and exacerbation of neuropsychiatric symptoms; and neurological abnormalities. 
 
It has been found that expression of D8/17 (a particular B-lymphocyte antigen) was 
significantly higher in children with PANDAS, in Sydenham’s chorea (Swedo et al., 
1997), and in childhood-onset OCD or Tourette’s disorder (TD), compared to normal 
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controls (Murphy et al., 1997).  Indeed, the identification of subtypes such as PANDAS 
may allow for testing of models of pathogenesis and also potentially lead to the 
development of novel treatment and prevention strategies (Minichiello et al., 1990).  Both 
antibiotic prophylaxis to prevent streptococcal-triggered exacerbations and 
immunomodulatory interventions (such as intravenous immunoglobulin or therapeutic 
plasma exchange) have been studied (Leonard et al., 2001).  With regard to the latter 
treatment strategy, long-term (2–5 years) follow-up revealed continued symptom 
improvement for the majority of patients, particularly when antibiotic prophylaxis had 
been effective in preventing recurrent streptococcal infections (Leonard et al., 2001). 
 
1.5.3 Family studies / genetics 
Family studies of OCD have suggested that OCD is a heterogeneous condition, with 
some cases being familial and others being isolated (Albert et al., 2002).  Early studies 
completed prior to 1970 suggested that OCD is a familial disorder (Brown, 1942; 
Kringlen, 1965, 1970; Lewis, 1936; Lo, 1967; Rosenberg, 1967).  Prevalence rates 
among first-degree relatives of OCD probands have been reported ranging between 
0.7% and 4.5% (Insel et al., 1983; McKeon and Murray, 1987; Rasmussen and Tsuang, 
1986).  Findings from more recent systematic studies have provided further support for a 
familial component for the expression of some forms of OCD (Bellodi et al., 1992; Black 
et al., 1992; Lenane et al., 1990; Leonard et al., 1992; Nicolini et al., 1993; Pauls et al., 
1995; Riddle et al., 1990).  In a recent study conducted to determine whether OCD is 
familial and to investigate possible familial subtypes, it was found that age of onset of 
OCD is valuable in characterizing a familial subtype (Nestadt et al., 2000).  Several 
studies support the hypothesis that familial loading for OCD is associated with early 
onset (Lenane et al., 1990; Nestadt et al., 2000).  In addition, Pauls et al. (1995) found 
that the relatives of probands with early onset were at higher risk for both OCD and tics, 
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supporting the concept that early age of onset characterizes a familial subtype of OCD.  
(More on subtyping based on age of onset in Section 1.6.1.ii.)   
 
Furthermore, it has been reported that OCD patients and their family members also have 
a high prevalence of various putative OCD spectrum disorders (OCSD’s) (including body 
dysmorphic disorder and pathological grooming behaviours) (Bienvenu et al., 2000).  
Bellodi et al. (2001) found that the risk for OCSD’s (in particular, OCD and tic disorders) 
is higher in families of patients with eating disorders, suggesting that eating disorders 
may also characterize a phenomenological and familial OCD subtype. 
 
The heterogeneity of OCD has possibly confounded genetic investigation, as suggested 
by many inconsistent findings in studies of OCD.  Nevertheless, the genetic study of 
OCD has made tremendous progress in the last decade.  Controlled family studies and 
segregation analyses provide consistent support for the familial nature of OCD and a 
major gene locus has been implicated.  Arguably, the lack of clear results from studies 
using molecular genetics could be ascribed to the use of the conventional set of 
diagnostic criteria that still classifies OCD as a unitary nosographic entity (Cavallini et al., 
2002).  Nevertheless, more recently a segregation analyses have shown that the 
symmetry / ordering subtype showed a major gene effect for OCD, while both symmetry 
/ ordering and obsessions / checking showed dominant major gene effects in a TS 
sample with OCD symptoms.  Research into the role of different candidate genes in the 
identified OCD subtypes is scarce, suggesting the need for further work.       
 
1.5.4 Treatment studies  
Treatment studies suggest that SRI’s are more effective than noradrenergic reuptake 
inhibitors in the treatment of OCD (Zohar et al., 1987).  This result is apparent not only in 
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adults with OCD, but also in children and adolescents with OCD (Leonard et al., 1989).  
About 40–60% of OCD patients respond to the first trial of an SRI (Jenike et al., 1992).  
A proportion of non-responders to a single SRI will respond to administration of a second 
SRI (Pigott et al., 1990).  As was previously mentioned, while serotonin is the 
neurotransmitter most commonly implicated in obsessive-compulsive and related 
disorders, there is also evidence for dopaminergic mediation of these conditions 
(Goodman et al., 1990, 1992).  Indeed, augmentation of SRI’s with dopamine blockers 
has been found useful in treatment-refractory OCD (Mohr et al., 2002). 
 
In addition, results from treatment studies suggest that there are multiple factors 
influencing treatment response.  For example, studies are conflicting about whether any 
particular symptom subtype of OCD is easier to treat or more likely to benefit from 
particular treatments.  (More on OCD symptom subtypes and treatment response under 
Section 1.7.2 “OCD subtypes and associated outcome”.) 
 
Some studies have also suggested that variables such as sex, age, and severity and 
duration of OCD may predict pharmacotherapy outcome.  For example, Alarcon et al. 
(Alarcon et al., 1993) showed that higher initial scores on the Yale-Brown Obsessive-
Compulsive Symptoms Severity Scale (YBOCS-SS) were associated with poorer 
response to treatment.  In addition, the combination of longer length of illness, 
continuous course, and predominance of compulsive behaviours has been found to be 
associated with poorer response to medication (Alarcon et al., 1993; Ravizza et al., 
1995).  Different follow-up studies of childhood, adolescent, and adulthood OCD have 
also related initial severity of OCD to post-treatment severity (Leonard et al., 1993; 
Mataix-Cols et al., 1999; Thomsen et al., 1995).  There are other studies, however, that 
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have found that these variables did not predict poor response in pharmacotherapy trials 
(Clomipramine Collaborative Group, 1991; Thoren et al., 1980). 
 
The available literature on level of insight as a predictor of response to behavioural 
therapy is inconsistent, and the data concerning insight and medication response are 
sparse (Attiullah et al., 2000).  It has been suggested that OCD patients with poor insight 
may have a different treatment response than patients with better insight (Attiullah et al., 
2000), but the relationship between the degree of insight and outcome of therapy 
remains unclear (Kozak et al., 1994).  Recently, in a study evaluating which clinical 
variables might influence the anti-OCD effect of proserotonergic drugs, non-responders 
had a higher frequency of poor insight (Erzegovesi et al., 2001); indeed, poor insight was 
found to be the best predictor of poor drug-treatment response.  Nevertheless, the 
treatment of OCD patients with poor insight may sometimes lead to a shift to good 
insight with concomitant improvement of OCD severity and depressive status 
(Matsunaga et al., 2002).  Matsunaga et al. (2002) also found that in OCD, comorbid 
schizotypal personality disorders (PD’s) compromised prognosis; both OCD with poor 
insight and comorbid schizotypal PD were found to be associated with failure to gain 
better insight during treatment.   
 
It has been suggested that people with later onset of OCD (who are more commonly 
females) have the best chance of responding to medication.  For example, in the study 
by Do Rosario-Campos et al. (Do Rosario-Campos et al., 2001), the group with early-
onset OCD responded less well to treatment with SRI’s than late-onset OCD patients 
(Again, more on OCD symptom subtypes and treatment response under Section 1.7.2 
“OCD subtypes and associated outcome”.)   
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Likewise, another study showed that female OCD patients were more likely than males 
to respond to therapy with the selective SRI, fluvoxamine (Mundo et al., 1999).  It has 
also been argued that OCD females have lower monoamine oxidase A (MAO-A) activity 
than OCD males (Camarena et al., 2001) and that this association might indicate a 
beneficial effect of MAO-A inhibitors in a particular subtype of OCD females. 
 
It has been suggested that male OCD patients have relatively increased neurological 
soft signs and tics compared to females (Stein et al., 1994), while neurological soft signs 
or tics have been associated, in turn, with increased ventricular-brain ratios (Stein et al., 
1993) and worse response to SRI’s (Hollander et al., 1991; McDougle et al., 1994).  
Indeed, increased neurological soft signs (associated with males) have been predictive 
of poorer response to pharmacotherapy in some studies (Hollander et al., 1991) 
(although in others, this variable did not predict worse outcome at follow-up (Thieneman 
et al., 1995; Thomsen, 1995)).  It should be noted that not all studies agree with the 
finding that the course of OCD is worse in males (Lensi et al., 1996); arguably, the 
relationship between male gender and worse course may be largely explained by taking 
into account those with early brain trauma or similar dysfunction.  Indeed, a number of 
studies have indicated that age, age of onset, and gender are not significant prognostic 
factors (DeVeaugh-Geiss et al., 1992; Thomsen et al., 1995).  In particular, some studies 
have found that gender has no effect in predicting response to SRI’s in OCD (Ackerman 
et al., 1998).   
 
Comorbidity of mood and anxiety disorders in childhood and adolescent OCD has been 
found not to predict outcome at follow-up (Thomsen, 1995).  In addition, several 
controlled studies have shown that neither the presence nor the initial severity of 
depression has any impact on therapeutic outcome in adults with OCD (den Boer, 1997; 
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Zitterl et al., 1990).  The SRI’s fluoxetine and fluvoxamine have beneficial effects in 
OCD, irrespective of the presence or severity of initial depressive symptoms (Goodman 
et al., 1989, 1990; Perse et al., 1987), and the Clomipramine Collaborative Group (1991) 
found that comorbid depression did not predict responsiveness to the serotonergic 
tricyclic, clomipramine.  Interestingly, it was found that the tricyclic antidepressant, 
imipramine improved depressive symptoms in depressed OCD patients (although this 
improvement did not potentiate the effects of behavioural therapy for OCD) (Foa et al., 
1992).  Comorbid posttraumatic stress disorder (PTSD) may be associated, however, 
with worse prognosis of OCD (Gershuny et al., 2002). 
 
A retrospective, case-controlled analysis by McDougle et al. found that fluvoxamine 
alone was less effective in OCD patients with tics than in patients without tics (McDougle 
et al., 1993).  In a continuation of this research, the researchers found (McDougle et al., 
1994) that treatment-refractory OCD patients with comorbid chronic tic disorders (such 
as TS) responded to augmentation of fluvoxamine with a traditional antipsychotic 
(haloperidol), whereas this strategy was of little benefit for patients without tics.  In two 
subsequent studies, the atypical antipsychotics olanzapine and risperidone 
(respectively) were added to the treatment of patients refractory to treatment with 
fluvoxamine alone (Bogetto et al., 2000; McDougle et al., 2000), but no difference was 
found in response between OCD patients with and without comorbid diagnoses of 
chronic tic or schizotypal disorder. 
 
The comorbid diagnosis of schizophrenia and OCD (or of OCD with psychotic features) 
seems to portend a worse prognosis than for either condition alone.  Despite the paucity 
of literature on the topic, there is some evidence that patients with both these conditions 
may improve on treatment with a combination of antiobsessional and antipsychotic drugs 
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(Dowling et al., 1995; Ganesan et al., 2001).  Nevertheless, it has been noted that 
administration of atypical antipsychotic agents may be associated with the first onset or 
worsening of OC symptoms in schizophrenia (Cheung, 2001; de Haan et al., 2002; 
Khullar et al., 2001). 
 
It has been suggested that comorbid PD’s may have prognostic significance in the 
treatment of OCD (Minichiello et al., 1987; Pfohl et al., 1991).  Pfohl et al. (1991) noted 
that in 22 OCD patients who received the Structured Interview for the Diagnosis of 
Personality Disorder prior to treatment with clomipramine, 11 responders had 
significantly fewer total Axis II-traits than did the 11 non-responders.  Baer et al. (1992) 
have demonstrated that the presence of schizotypal, borderline, and avoidant PD, in 
tandem with the total number of PD’s, did predict poor treatment outcome (with 
clomipramine).  Also, a retrospective analysis of 43 OCD patients demonstrated that 
those with comorbid schizotypal PD (33%) were comparatively unresponsive to both 
pharmacotherapy (Jenike et al., 1986) and behavioural therapy (Minichiello et al., 1987).  
Similarly, there is evidence that schizotypal PD is not the only PD that is a consistent 
predictor of poor outcome in OCD (Baer et al., 1992).  Hermesh et al. (1987) reported 
that in 39 OCD patients, all of those with borderline personality (20%) failed to respond 
to either pharmacotherapy or behavioural therapy, primarily because of poor 
compliance.  However, some studies have failed to confirm the finding of an association 
between PD’s in OCD patients and (poorer) treatment outcome.  In the study by 
Steketee (1990), comparisons of those OCD patients who did and did not qualify for 
schizotypal, histrionic, avoidant and dependent, or any other type of PD revealed only 
marginal associations to treatment gains.  In fact, PD patients had slightly better 
immediate treatment outcome, although this difference was not significant.  Similarly, the 
investigation of Mavissakalian et al. (1990) on the relationship between personality and 
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treatment outcome provided no strong support for the notion that personality factors 
have prognostic significance in the treatment of OCD. 
 
Importantly, the finding that the presence of particular comorbid PD’s in OCD may 
predict poor treatment outcome is open to more than one interpretation, suggesting 
either a specific effect of the particular Axis II disorder, or a non-specific effect of 
increased OCD severity.  In view of the particular set of PD’s that apparently affect 
treatment outcome (schizotypal, borderline, avoidant), there is some reason to believe 
that the first explanation may be correct.  Nevertheless, since the total number of PD 
traits and specific diagnoses are correlated with OCD symptom severity, there is also 
some basis for taking the second explanation seriously.  Additional research is 
necessary. 
 
In summary, comorbidity of OCD with mood and anxiety disorders does not affect 
treatment outcome, while comorbid tics and schizophrenia both are associated with 
worse outcomes.  Among comorbid Axis II conditions, schizotypal PD appears to predict 
worse outcome in the treatment of OCD. 
 
An analysis of differences between the side-effect profiles of clomipramine and more 
selective SRI’s in OCD suggested that good response to both drugs (clomipramine and 
fluoxetine) was associated with initial nervousness and sexual complaints (Ackerman et 
al., 1999).  More specifically, good response to clomipramine was associated with later 
age of OCD onset and certain early side-effects that may reflect the sensitivity of 
responders to clomipramine’s serotonergic actions.  Replication of the data is necessary. 
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It has been demonstrated that patients with OCD have increased brain activity in the 
basal ganglia, that this hyperactivity increases further during exposure to feared stimuli, 
and that it decreases after successful SRI administration or behavioural therapy (Insel, 
1992; Rauch and Savage, 1997).  Not all patients respond to this treatment however, 
suggesting that structures other than the basal ganglia may have a role in mediating 
OCD symptoms.  Indeed, the underlying differences in the neurobiology between 
responders and non-responders to SRI’s are only partly understood.  As mentioned 
earlier, for example, there is evidence that non-responders are more likely to have 
comorbid tics (McDougle et al., 1993), increased neurological soft signs (Hollander et al., 
1991), and atypical EEG’s (Prichep et al., 1993). 
 
In addition, functional brain imaging has documented that OCD patients have increased 
prefrontal activity compared to normal controls (Insel et al., 1992), and it has been 
suggested that increased blood flow in the frontal regions predicts poor response to 
medication (Brody et al., 1998).  More specifically, it has been found that lower 
pretreatment metabolism in the right orbitofrontal cortex and anterior cingulate gyrus is 
associated with a better response to serotonergic drugs (Saxena et al., 2001).  It was 
also found that higher normalized metabolism in the left orbitofrontal cortex region was 
associated with greater improvement in a behavioural therapy group, but with worse 
outcome in a fluoxetine-treated group (Brody et al., 1998).  These findings indicate that 
OCD patients with differing patterns of metabolism preferentially respond to behavioural 
therapy versus medication. 
 
In some, but not all, studies, increased neurological soft signs predict poor response to 
pharmacotherapy and behavioural treatment (Bolton et al., 2000; Thienemann et al., 
1995).  Some authors have suggested that OCD patients with abnormal findings on EEG 
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may respond to anticonvulsant therapy (Prichep et al., 1993).  Deltito (1994) found that 
OCD patients who develop symptoms like those of temporal lobe epilepsy did better 
when begun on valproate prior to SRI treatment. 
 
Symptoms of OCD may be acutely exacerbated by administration of certain serotonin 
agonists.  Studies of the response of OCD patients to administration of m-CPP have 
been mixed, with some studies reporting abnormal behavioural and neuroendocrine 
responses (Hollander et al., 1992, 1994), but with other studies failing to confirm these 
reports (Goodman et al., 1995).  As noted before, it has been suggested that only some 
patients’ conditions exacerbate after administration of m-CPP, and that exacerbation of 
OCD symptoms in this situation was a negative predictor of response to 
pharmacotherapy (in particular, SRI’s) (Hollander et al., 1993a).    
 
Furthermore, it has been suggested that parental OCD modifies a child’s response to 
medication.  Leonard et al. (1993) have found that presence of parental Axis I psychiatric 
diagnosis predicted poorer OCD outcome in children.  There have also been findings to 
the contrary, however.  In a study to determine the role of familial psychiatric pathology 
in outpatient treatment with fluoxetine, it was found that OCD patients with parents who 
have OCD showed a clinically and statistically significant reduction in symptoms 
following treatment.  In addition, Erzegovesi et al. (2001) have found that when 
compared to non-responders, responders to SRI’s had a significantly higher frequency of 
positive family history for OCD in their first-degree relatives.  These findings suggest that 
family psychopathology, especially the presence of OCD, may predict better response to 
treatment.  Further research would be valuable. 
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In summary, this extensive body of data from studies on the phenomenology, 
psychobiology, genetics and treatment response of this disorder provides support for the 
hypothesis of a heterogeneous nature of OCD. 
 
1.6 Subtyping of heterogeneous OCD 
 
As noted earlier, delineating OCD into a number of more homogeneous subtypes may be 
useful to integrate heterogeneous data on its symptomatology, psychobiology, genetics and 
treatment response.  If distinct subtypes of OCD do exist, one may hypothesize that each of 
these subtypes is possibly associated with specific clinical variables (e.g. trauma history), as 
well as treatment response, biological markers, or genetic transmission.  Moreover, it has 
been argued that if reliable and valid subtypes of OCD do exist, failure to identify these 
subtypes and to adequately characterize OCD patients’ heterogeneity will hinder 
refinements in etiologic theory and treatment intervention (Calamari et al., 1999).  Until now, 
the identification of valid, reliable and consistent subtypes has remained almost elusive 
however.  Nevertheless, there has been a number of different approaches to the 
identification of OCD subtypes, with most of these efforts giving prominence to subtyping 
built upon demographic and clinical characteristics (e.g. sex, age of onset of OCD, course of 
the disease) (Eichstedt and Arnold, 2001; Geller et al., 1998; Minichiello et al., 1990; 
Noshirvani et al., 1991), presence of comorbid psychiatric conditions (e.g. tics, OCSD’s) 
(Mataix-Cols et al., 2000; Nestadt et al., 2003; Sobin et al., 2000), and nature of obsessive-
compulsive symptomatology (Baer, 1994; Calamari et al., 1999; Hantouche and Lancrenon, 
1996; Leckman et al., 1997; Mataix-Cols et al., 1999; Summerfeldt et al., 1999).  Lately, 
identification of dimensions or subtypes has focused on using factor analytic techniques on 
generally recognized OCD symptom checklists. 
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1.6.1 Subtyping built upon demographic and clinical characteristics 
 
i. Gender 
Although there are some inconsistencies, gender-related differences have been observed in 
OCD symptomatology.  Cleaning symptoms (Bogetto et al., 1999; Castle et al., 1995; 
Khanna and Mukherjee, 1992; Lensi et al., 1996; Marks, 1987; Minichiello et al., 1990; 
Rachman and Hodgson, 1980; Stern and Cobb, 1978) and aggressive obsessions (Lensi et 
al., 1996) have been reported to be more common in females with OCD, while primary 
obsessive slowness (Bogetto et al., 1999), obsessions/compulsions (symmetry and 
exactness (Lensi et al., 1996; Rasmussen et al., 1986) and numbers (Skoog, 1965; Swedo 
and Rapoport, 1989), touching rituals (Fischer et al., 1997), and sexual (Bogetto et al., 1999; 
Lensi et al., 1996) or “odd” (Lensi et al., 1996) symptoms have been found to be more 
common in OCD males.  It should be noted, however, that some studies provide contrasting 
findings, such as increased contamination obsessions in males (Fischer et al., 1997).   
 
Zohar (1999) suggested that, similar to adults, there may also be gender differences in the 
symptom types in children and adolescents with OCD (e.g., more checking behaviour in 
boys, and more cleaning behaviour in girls).  Evidence shows that the course of OCD may 
also be affected by gender.  For example, in addition to evidence that OCD has a worse 
course in males (Castle et al., 1995), some studies indicate that males predominate in 
childhood OCD (Castle et al., 1995; Lensi et al., 1996; Noshirvani et al., 1991; Rettew et al., 
1992) and are more likely to have a chronic rather than episodic course (Castle et al., 1995; 
Ravizza et al., 1997; Thomsen, 1995).  It should be noted, however, that not all studies 
agree that the course of OCD is worse in males (Lensi et al., 1996).  
 
  27
Several studies have found that gender may significantly affect comorbidity.  Increased 
comorbidity of depression (Castle et al., 1995; Noshirvani et al., 1991), eating disorders 
(Bogetto et al., 1999; Castle et al., 1995; Kasvikis et al., 1986; Lennkh et al., 1998; 
Noshirvani et al., 1991; Welner et al., 1976), and panic attacks (Lensi et al., 1996) have 
been reported in females with OCD, and increased comorbidity of social phobia (Bogetto et 
al., 1999; Marks, 1987), substance-related disorders (Bogetto et al., 1999; Noshirvani et al., 
1991), and hypomanic episodes (Bogetto et al., 1999; Lensi et al., 1996; Perugi et al., 1997) 
have been reported in OCD males.  These findings are generally consistent with the 
prevalence rates of such disorders in non-OCD populations. Based on reports of increased 
comorbidity of depression in women with OCD (Castle et al., 1995; Noshirvani et al., 1991), 
it has been suggested that the greater frequency of later-onset OCD in women is partially 
explained by the well-known association of depression and OC phenomena (Noshirvani et 
al., 1991).  Furthermore, differential PD pathology between males and females has been 
noted.  For example, in a study of PD’s and social and interpersonal features among 
Japanese patients with OCD, it was found that cluster A PD’s, especially schizotypal PD, 
were more frequently diagnosed in males, and borderline and dependent PD’s, in females 
(Matsunaga et al., 2000).    
 
Evidence from twin and family studies supports a role for gender in the genetics of OCD.  
For example, a recent segregation analysis of families provided some evidence for a major 
gene underlying OCD (Nestadt et al., 2000a).  Of particular interest in this study was 
evidence for genetic heterogeneity on the basis of gender of the proband, which supports 
the hypothesis of different genetic/environmental exposures in at least some families with 
OCD (Nestadt et al., 2000a).  Similarly, on the basis of their segregation analysis, Cavallini 
et al. (1999) suggested a dominant model of transmission with penetrance differing in males 
and females.  The possibility of gender differences in genetic susceptibility for OCD has also 
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been suggested (Camarena et al., 2001).  This particular study replicated the findings of a 
sexually dimorphic effect of the MAO-A gene in OCD (an excess of allele 1 in OCD females 
with major depressive disorder was confirmed), indicating that OCD females have lower 
MAO-A activity than OCD males. 
 
Arguably, the worse outcomes for OCD males could be explained by early brain trauma or 
similar neurological dysfunction. It is notable that when compared to female patients, male 
patients appear to have more increased neurological soft signs (Stein et al., 1994), which 
include abnormalities of fine motor coordination, as well as involuntary and mirror 
movements and visual-spatial dysfunction.  (Similarly, OCD males are more likely to have 
tics; see discussion below.)  By comparison, females may present with OCD during the 
menarche (Rasmussen and Eisen, 1988), the premenstrual phase (Williams and Koran, 
1997), pregnancy (Diaz et al., 1997; Neziroglu et al., 1992), puerperium (Altshuler et al., 
1998; Maina et al., 1999), and even menopause (Lochner et al., 2003).  Based on such 
findings, it may be hypothesized that some forms of OCD may involve gender-specific 
mechanisms, including hormonal and genetic mechanisms (Camarena et al., 1998; 
Karayiorgou et al., 1997, 1999).  Further research is necessary to delineate the precise 
mechanisms involved. 
 
In general, there appears to be gender differences in the genetics, course, and clinical 
manifestations of OCD.  Gender differences in comorbid psychiatric disorders generally 
match the gender differences for these disorders in non-OCD population.  Overall, when 
compared to women with OCD, males with OCD appear to have earlier onset, a more 
severe course, and more neurological soft signs. 
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 ii. Age of onset 
It has been suggested that childhood-onset OCD represents a phenomenologically and 
etiologically distinct subtype of OCD, bearing a close genetic relationship to tic disorders and 
possibly sharing a common or similar pathogenesis (Eichstedt and Arnold, 2001; Geller et 
al., 1998).  For example, a recent study by Do Rosario-Campos et al. (2001) found that early 
onset was associated with higher frequencies of sensory phenomena and of comorbid tic 
disorders, and with higher severity and frequency of tic-like compulsions.  Likewise, in 
contrast to adults, children with OCD often present with pure compulsions—for example, 
washing compulsions and repeating compulsions, without any apparent obsessive thoughts 
(Swedo et al., 1989).  It has also been suggested that patients with a very early onset of 
OCD (younger than six years old) were more likely to have compulsions rather than 
obsessions (Honjo et al., 1989; Rettew et al., 1992).  These compulsions would typically 
include elaborate washing or checking rituals without cognitive obsessions (Swedo et al., 
1992).  In an investigation of possible family subtypes, Nestadt et al. (2000) found that age 
of onset of obsessive-compulsive symptoms in the case proband is strongly related to 
familiality; no case of OCD symptoms was detected in the relatives of patients whose age of 
onset was 18 years or older.  Similar findings by others (Lenane et al., 1990; Pauls et al., 
1995) support the hypothesis that familial loading for OCD is associated with early onset.  
Thus, early age of onset may be valuable in characterizing a familial subtype of OCD.   
 
To summarize, when compared to later-onset OCD, childhood-onset OCD is associated with 
higher rates of compulsions and comorbid tic disorders.  In addition, childhood-onset OCD 
appears to be much more strongly genetically transmitted. 
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iii. Course of the disease 
Several studies support theories of OCD as an illness with fluctuating severity (Thomsen, 
1995) and varied clinical manifestations that change over time (Rettew et al., 1992).  The 
course of OCD has been differentiated into different groups, including episodic and 
continuous/chronic (Ravizza et al., 1997), with OCD being chronic in approximately half of 
all cases (Thomsen and Mikkelsen, 1995).  It has been suggested that factors such as age, 
gender, and severity of childhood OCD symptomatology may play a role in the course of the 
condition (i.e., as episodic or chronic) (Ravizza et al., 1997).  In one study, for example, it 
was found that in childhood, more females than males have an episodic course of OCD, 
whereas just as many females as males suffered from OCD, either chronically or 
episodically, in adulthood (Thomsen, 1995). 
 
In agreement with studies indicating that patients with an episodic course of the disorder 
may be a distinct subgroup within the whole group of obsessive-compulsive patients, 
multivariate stepwise discriminant analysis revealed a positive and significant relationship 
between episodic course on the one hand, and family history of mood disorders, lifetime 
comorbidity for panic and bipolar II disorders, late age of onset, and negative correlation with 
generalized anxiety disorder (GAD), on the other (Perugi et al., 1998; Thomsen, 1995).  In a 
retrospective study of 62 OCD patients, the long-term course of OCD and its relationship to 
depression were investigated.  Five courses of OCD were differentiated: continuous and 
unchanging (27.4%), continuous with deterioration (9.7%), continuous with improvement 
(24.4%), episodic with partial remission (24.2%), and episodic with full remission (11.3%).  
There was no difference between primary versus secondary depression on the prognosis of 
OCD, and there was also no difference between continuous versus episodic course on 
either primary or secondary depression (Demal et al., 1993).  In one study, however, it was 
found that severity of OCD in childhood plays a determining role in the course and outcome 
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of OCD; that is, longer duration of obsessive-compulsive symptoms in childhood (chronic 
course) predicts a poor outcome (presence of OCD) in adulthood (Thomsen, 1995).  
Furthermore, some studies have found a correlation between continuous course and poorer 
response to pharmacotherapy (Alarcon et al., 1993; Ravizza et al., 1995).  It remains 
unclear what factors predict a chronic deteriorative course (Rasmussen and Eisen, 1991).   
 
1.6.2 Subtyping built upon OCD symptomatology 
 
As noted previously, a focus on the nature of OCD symptomatology as a classifying variable 
has been one of the most common strategies for identifying OCD subgroups, and has been 
receiving increased attention in recent years.   
 
i. OCD symptomatology: A dichotomy? 
Earliest efforts to subtype OCD suggested a broad distinction between obsessions and 
compulsions.  This dichotomy continues to be recognized in current diagnostic systems such 
as the DSM-IV (APA, 1994).  However, it has increasingly been suggested that the diversity 
of the presentation of OCD necessitates a more multidimensional approach.   
 
ii. OCD symptomatology: A multidimensional approach 
Even approaching the matter from a multidimensional perspective is not without restrictions.  
In particular, attempts to dissect dimensions or subtypes of OCD have limitations – either by 
excluding some of the “miscellaneous” symptoms included in some of the OCD-scales, or by 
using restricted symptom scales or even inadequate statistical packages.  Moreover, 
symptom-based taxonomies have often only focused on OCD patients’ major or most 
prominent compulsions (e.g. checking, or washing) (e.g. Hodgson and Rachman, 1977).  
Such classifications are then based on a single, dominant compulsion and therefore limited, 
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as most patients tend to present with multiple types of obsessions and compulsions.  
Although the formation of OCD symptom subtypes based on a single dominant compulsion 
continues to be used as a subtyping strategy (e.g. Matsunaga et al., 2001), some 
researchers have cautioned that grouping OCD patients based solely on behavioural 
similarities may be problematic (Summerfeldt et al., 1999) and that a more comprehensive 
approach incorporating more than just compulsive behaviour or rituals is needed.   
 
Because of the complex patterns of obsessions and compulsions characteristic of OCD, the 
multivariate statistical methods of cluster and factor analysis have been applied as a useful 
way to identify the latent dimensions of symptom measures or to classify heterogeneous 
data into “smaller” more homogeneous categories.  Generally speaking, these methods 
were specifically designed to reduce a number of variables and to detect structure in the 
relationships between variables, i.e. to classify variables (Kim and Mueller, 1978, 1978).     
 
iii. Studies using factor analysis 
As noted earlier, lately most of these studies have used factor analysis of OCD symptoms 
that were assessed by specific symptom scales as a way of subtyping OCD.  In short, the 
purpose of factor analysis is to find a new set of variables, fewer in number than the original 
variables, which express that which is common among the original variables (Cattell, 1978, 
p16).  For example, an early principal-components factor analysis of the 30 item of the 
Maudsley Obsessional Compulsive Inventory (MOCI) in 100 patients yielded four factors: 
checking, cleaning, slowness, and doubting (Hodgson and Rachman, 1977).  The MOCI 
comprises only 30 items however, which are biased towards the symptoms of cleaning and 
checking, while other symptoms, such as aggressive obsessions and hoarding compulsions, 
are underrepresented (Baer, 1994).  Van Oppen et al. (1995) evaluated the factor structure 
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of a similar scale — the Padua Inventory (Sanavio, 1988) — and five factors were identified: 
impulses, washing, checking, rumination, and precision.   
 
The widely recognized YBOCS-CL is a clinician-rated measure that is more comprehensive 
than the earlier scales (Goodman et al., 1989).  More recently, it was emphasized that an 
objective approach relying upon exploratory factor analysis or similar data reduction / 
classification techniques using the YBOCS-CL to detect empirical grouping in large 
standardized arrays of symptoms is needed (Summerfeldt et al., 1999).  The YBOCS-CL 
corrects the item-selection bias of the MOCI and Padua Inventory (Baer, 1994).  Improving 
on these limitations characteristic of the other scales, factor analytic studies of a priori 
clinically derived symptom categories or individual OCD symptoms using the YBOCS-CL 
have consistently found that these fall into 3 to 6 factors, namely aggressive / checking, 
contamination, symmetry / ordering and hoarding symptoms (Baer, 1994; Calamari et al., 
1999; Cavallini et al., 2002; Denys et al., 2004; Feinstein et al., 2003; Leckman et al., 1997; 
Mataix-Cols et al., 1999; Summerfeldt et al., 1999).   
 
These symptom dimensions appear to be common in the majority of analyses, despite 
somewhat different methodological approaches.  In particular, Baer’s factor analysis of the 
YBOCS-CL yielded three factors: symmetry/hoarding, contamination/cleaning, and “pure 
obsessions” (Baer, 1994).  Similarly, the 1996-study by Hantouche and Lancrenon also 
reported a symptomatic clustering of obsessions and compulsions into these three major 
categories (1996).  Partially similar, Leckman et al. (1997) more recently identified four 
different dimensional factors using the YBOCS-CL, including obsessions and checking, 
symmetry and ordering (including other compulsions such as counting, arranging and 
repeating), cleanliness and washing, and hoarding.  Using the same instrument and 
implementing confirmatory factor analysis, Summerfeldt et al. (1999) confirmed these 
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findings with their specification of obsessions/checking, symmetry/ordering, 
contamination/cleaning, and hoarding.  A principal components analysis by Mataix-Cols et 
al. (1999) identified five factors explaining as much as 65.5% of the variance in outcome, i.e. 
symmetry/ordering, hoarding, contamination/cleaning, aggressive/checking, and 
sexual/religious obsessions.  In addition, a very recent factor analysis of the clinically-
derived categories and the individual items of the YBOCS-CL rendered results with 
considerable overlap with factor clusters from prior studies (Feinstein et al., 2003).   
 
Importantly, in factor analysis, variance is partitioned between factors and one person may 
have loadings on all of the identified factors (Baily, 1994); i.e. at any one time, OCD patients 
may have symptoms from more than one of these identified factors.   
 
In summary, to date, a number of factor analysis studies have been published, assessing 
more than 2000 patients (Baer, 1994; Cavallini et al., 2002; Feinstein et al., 2003; Foa et al., 
2002; Hantouche and Lancrenon, 1996; Leckman et al., 1997, 2003; Mataix-Cols et al., 
1999, 2002; Summerfeldt et al., 1999; Tek and Ulug, 2001).  In all of these studies 3 to 6 OC 
factors or dimensions have been identified, accounting for almost 70% of the variance 
(Mataix-Cols et al., 2005).   
  
iv. Studies using cluster analysis 
In cluster analysis variables are grouped together according to the high correlations they 
have with one another (Cattell, 1978).  In addition, in contrast to factor analysis, in cluster 
analysis, patients are unambiguously assigned to these identified groups created by 
maximizing between-group differences and minimizing within-group variability on the chosen 
set of measures; in other words, each patient falls into only one cluster.  (Conversely, as 
noted before, in factor analysis, an object may have loadings on all of the identified factors.)  
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Use of cluster analysis has gained ground in recent years, with some investigators 
suggesting that cluster analysis may be a superior method for identifying OCD subtypes 
(Calamari et al., 1999). 
 
A cluster analysis of the items of the YBOCS-CL by Calamari et al. (1999) identified five 
definitive symptom-based groupings based on the YBOCS-CL, including harming, hoarding, 
contamination, certainty, and obsessionals; the core symptoms of these identified subgroups 
being comparable to factors identified in the previous factor analysis studies with the 
YBOCS-CL (Baer, 1994; Leckman et al., 1997; Summerfeldt et al., 1999).  In a recent 
attempt to replicate and extend their previous symptom-based subgroup taxonomy also 
using cluster analysis, Calamari et al. (2004) suggested that the rules for determining the 
number of symptom subgroups supported a more complex model.  In addition, with their 
between-sample comparisons, the contamination subgroup came out as the only stable 
subgroup in both a 5- and 7-group taxonomy.  A harming subgroup was consistently 
identified as well.  Between-sample stability was not so strong for symmetry, certainty, and 
obsessionals subgroups.  Hoarding as a distinctive subgroup was unstable in the separate 
samples.  However, when they combined their present sample with the 1999-sample, a 
reliable hoarding subgroup was found.  In summary, they presented with both a 5- and 7-
subgroup taxonomy, with greater support for the 7-subgroup model; this model being the 
most complex (and probably the most clinically impractical) symptom-based taxonomy to 
date.  In addition, their findings emphasized the need for using larger clinical samples to 
identify OCD-subgroups.   
 
A summary of all published OCD classification studies (i.e. factor and cluster analyses) of 
OC symptoms using the YBOCS-CL are listed in Table 1. 
TABLE 1. OCD classification studies using the YBOCS-CL   
Study Year Nr of 
patients 
Analysis technique  Total 
variance 
explained 
(%) 
Nr of factors / 
clusters 
Identified factors / clusters  
Baer, 1994 1994 107 Principal components analysis, 
current symptoms 
48% 3 1. Symmetry and hoarding 
2. Contamination and cleaning 
3. Pure obsessions 
Hantouche & Lancrenon, 
1996 
1996 615 Principal components analysis, 
current symptoms 
32.5% 3 1. Predominantly compulsive  
2. Predominantly obsessive 
3. Mixed 
Leckman et al., 1997 1997 292 Principal components analysis, 
lifetime symptoms 
63.5% 4 1. Obsessions and checking  
2. Symmetry and ordering 
3. Cleanliness and washing 
4. Hoarding 
Calamari et al., 1999 1999 106 Cluster analysis 65.5% 5 1. Harming 
2. Hoarding 
3. Contamination 
4. Certainty 
5. Obsessional 
Summerfeldt et al., 1999  1999 203 Confirmatory factor analysis, 
current symptoms 
Not 
available 
4 1. Aggressive, sexual, religious,  
    somatic obsessions and checking 
2. Symmetry and repeating, ordering  
    and counting 
3. Contamination and cleaning, washing 
4. Hoarding obsessions and  
    compulsions 
Mataix-Cols et al., 1999 1999 354 Principal components analysis, 
current symptoms 
62.5% 5 1. Symmetry and ordering 
2. Hoarding 
3. Contamination and cleaning 
4. Aggressive and checking obsessions 
5. Sexual and religious obsessions 
Tek and Ulug, 2001 2001 45 Principal components analysis, 
current symptoms 
65.5% 5 1. Contamination / cleaning 
2. Symmetry / ordering 
3. Aggressive / counting 
4. Sexual / religious obsessions 
5. Checking / hoarding compulsions 
Cavallini et al., 2002 2002 180 Principal components analysis, 
lifetime symptoms 
59.87% 5 1. Contamination / washing 
2. Hoarding 
3. Aggressive 
4. Symmetry 
5. Repetitive rituals  
Mataix-Cols et al., 2002 2002 153 Principal components analysis, 
current symptoms 
Not 
available 
5 1. Aggressive / checking 
2. Contamination / washing 
3. Symmetry / ordering 
  37
4. Hoarding 
5. Sexual / Somatic  
Feinstein et al., 2003 2003 160 1.) Principal components analysis 
performed on clinically derived 
categories, current symptoms 
 
 
 
 
 
2.) Principal components analysis 
performed on individual items, 
current symptoms 
54.2% 
 
 
 
 
 
 
 
 
39.3% 
4 
 
 
 
 
 
 
 
 
4 
1. Symmetry / ordering / counting /  
    arranging / repeating / need to touch 
2. Aggressive and contamination  
    obsessions / checking /  
    cleaning compulsions 
3. Hoarding 
4. Religious / sexual obsessions (pure  
    obsessions)  
 
1. Harm obsessions / checking  
2. Disgust with contaminants / cleaning  
    compulsions 
3. Sexual obsessions 
4. Hoarding / symmetry / repeating 
Calamari et al., 2004 2004 220 Cluster analysis Not 
available 
7 1. Contamination 
2. Harming 
3. Hoarding 
4. Symmetry 
5. Obsessionals 
6. Certainty 
7. Harming / Contamination 
Denys et al., 2004 2004 335 Principal components analysis, 
current symptoms 
41.7% 5 1. Contamination / cleaning 
2. Aggressive / sexual, religious,  
    somatic obsessions 
3. Somatic obsessions and checking 
4. Symmetry and perfectionism 
5. High risk assessment and checking  
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v. OCD symptom subtypes: Prevalence 
In terms of prevalence of the various OCD symptom subtypes, an examination of 65 studies 
that classified patients according to such subtypes found that patients with primarily cleaning or 
checking compulsions predominated, accounting for 75% of the treatment population (Ball et al., 
1996).  Patients with multiple compulsions or other compulsions such as exactness, counting, 
hoarding, or slowness rituals were underrepresented, making up only 12% of the subjects—
which is markedly less than clinical epidemiological estimates (Ball et al., 1996).   
 
vi. OCD symptom subtypes based on OCD symptomatology assessed with the  
     YBOCS-CL: Limitations 
In general, the YBOCS-CL has been chosen as an OCD-scale to be factor / cluster analysed 
because of its extensive use in OCD clinical assessment and research.  As noted before, this 
checklist is indeed a relatively comprehensive OCD symptom measure, with a bigger range of 
symptoms that are assessed in comparison to other OCD symptom measures (see Addendum 
8 for a copy of this scale).   
 
However, it has been suggested that alternative comprehensive measures of OCD symptoms 
with well established psychometrics are needed, given that the YBOCS-CL provides for 
relatively limited assessment of several types of obsessions and compulsions, i.e. symptoms 
that are related to the subgroups identified in some of the more complex models.  In addition, 
one may argue that only very basic assessment of hoarding symptomatology, of symmetry and 
exactness, of somatic concerns, and of counting and ordering is found on the YBOCS-CL.  In 
addition, the so-called “other” and “miscellaneous” categories contain items / symptoms that are 
idiosyncratic and heterogeneous, respectively, and although important symptoms are included 
in these categories, these sections have no logical coherence or empirical support.  Calamari et 
al. (2004), focusing on developing a symptom-based OCD subgroup taxonomy using cluster 
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analysis, suggested that the instability that was observed in their identified subgroups (such as 
“obsessionals”, “hoarding”, and “symmetry”) have resulted from the limitations of the 
measurement of symptoms important to these subtypes.  In fact, they noted that a much more 
comprehensive assessment of symptoms than that which can be accomplished with a 
modification of the YBOCS-CL will likely be needed to comprehensively measure the complex 
symptom heterogeneity of OCD.   
 
Nevertheless, despite these limitations, one has to bear in mind that currently the YBOCS-CL is 
one of the most comprehensive measures of OCD symptomatology available.  Future efforts to 
subtype OCD (based on symptomatology) will probably continue using this measure until it has 
been modified and/or a better or more comprehensive measure of OCD symptoms is 
established.  
 
1.6.3 Subtyping built upon comorbidity 
 
Another approach to subtyping OCD may be to consider issues of comorbidity.  Indeed, there is 
growing interest in the categorization of OCD as a heterogeneous phenomenon into more 
homogeneous subtypes by examining comorbidity (Nestadt et al., 2003).  OCD patients often 
report comorbid psychiatric conditions.  In fact, comorbidity in OCD appears to represent the 
rule rather than the exception, with this condition being commonly comorbid with a number of 
psychiatric conditions:  After major depressive disorder, the most common comorbid disorders 
reported in patients with OCD are other anxiety disorders (e.g. posttraumatic stress disorder), 
eating disorders, alcohol abuse, and the putative OCSD’s.  For instance, in their attempt to 
characterize psychopathological classes of disorders related to OCD to distinguish more 
homogeneous phenotypes with distinct etiologies, Nestadt et al. (2003) suggested that the OCD 
phenotype is expressed in two different subgroups based on the presence of additional clinical 
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syndromes that frequently accompany the condition.  One of the subgroups was characterized 
by panic disorder / agoraphobia and tic disorders, and the other by generalized anxiety disorder, 
major depressive disorder (recurrent), and the OCSD’s.  Subtyping based on such comorbidity 
is not the main focus in the current thesis; however, future work on the structure of comorbid 
disorders in OCD should address the inclusion of all of these conditions. 
 
Increasing attention has also been paid to the fact that individuals with OCD are likely to report 
a lifetime comorbid obsessive-compulsive spectrum condition (Richter et al., 2003), with a 
recent clinical study suggesting that just more than half of their participants with OCD currently 
met criteria for at least one putative OCSD, and that 67.1% had a lifetime history of at least one 
comorbid OCSD (du Toit et al., 2001).  Subsequently, it has also been suggested that the 
heterogeneous OCD phenotype may comprise a number of subtypes based on the presence of 
such comorbid OCSD’s, each with specific pathophysiological mechanisms and treatment 
outcomes.  For example, as mentioned before, many patients with OCD have comorbid tics 
and/or TD, and patients with comorbid tics may have a particular phenomenology, neurobiology 
(e.g. involving the dopamine system), requiring somewhat different treatments.  In addition to 
tics or TD, there are other commonly comorbid OCD spectrum conditions in patients with OCD, 
e.g. body dysmorphic disorder (BDD) and hypochondriasis, trichotillomania, stereotypic 
movement disorder and self-injury, as well as bulimia nervosa, kleptomania and pathological 
gambling.  However, while the majority of OCD patients suffer from at least one comorbid 
OCSD (du Toit et al., 2001), there has been relatively little systematic investigation of the 
structure and implications of such comorbidity.  Nevertheless, based on existing data, one might 
hypothesize that comorbid OCD and OCSD’s in general fall into a number of homogeneous 
groups, including:  
1.) patients with tics or other involuntary movements (including TD);  
2.) a group of patients with somatic obsessions (including the somatoform disorders of  
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BDD, hypochondriasis;  
3.) patients with stereotypic or grooming symptoms (including trichotillomania (TTM),  
stereotypical movement disorder (SMD) and self-injury), and  
4.) patients demonstrating impulsive features (including eating disorders such as bulimia  
nervosa, kleptomania, and pathological gambling).   
More research is needed to investigate these hypotheses. 
 
In addition to OCD subtyping based on comorbidity with OCSD’s, emerging evidence shows 
that OCD may be comorbid with psychotic conditions (Attiullah et al., 2000).  For instance, it 
was found that compared to OCD patients without psychosis, patients with OCD and psychotic 
features were more likely to be male, be single, have a deteriorative course, and have had their 
first professional contact at a younger age (Eisen and Rasmussen, 1993).  Data from a study by 
Perugi et al. (1997) also indicate that when comorbidity occurs with bipolar and unipolar 
affective disorders, it has a differential impact on the clinical characteristics, comorbidity, and 
course of OCD.   
 
A range of comorbid Axis II disorders has also been found in OCD patients, with those of cluster 
C the most prevalent (Baer et al., 1990; Bejerot et al., 1998; Black et al., 1993; Matsunaga et 
al., 1998; Mavissakalian et al., 1990, 1990; Thomsen and Mikkelsen, 1993).  Existence of a 
schizotypy subtype of OCD, associated with three clinical features that have previously been 
associated with psychosis, i.e. counting compulsions, learning disabilities, and phobia, has also 
been suggested (Eisen et al., 1993; McDougle et al., 1990; Norman et al., 1996; Sobin et al., 
2000).  OCD with schizotypy has also been associated with poor insight that remained poor 
even after treatment (Matsunaga et al., 2002).   
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Overall, OCD has high rates of comorbidity with a number of Axis I and II disorders.  Among the 
Axis I disorders, OCSD’s are among those most often comorbid with OCD.  Focussing on 
conditions that may be etiologically related to OCD and possibly due to the same underlying 
mechanisms, may enhance the probability of finding susceptibility genes for OCD.  Preliminary 
data suggest that dissecting comorbidity in OCD, and perhaps comorbidity with OCSD’s in 
particular, is a useful way of subtyping OCD; e.g. OCD with tics may represent a genetically 
meaningful subtype.  Much additional work remains to be done. 
 
1.7 OCD subtypes and associated features 
 
In summary, in recent years increasing attention has been paid to subtyping OCD, and 
specifically subtyping based upon demographic and clinical characteristics (e.g. age of onset of 
OCD), obsessive-compulsive symptomatology and comorbidity patterns.  Findings suggest 
relative consistency.  Most authors agree that childhood-onset OCD is a valid subtype of OCD 
that is associated with higher rates of compulsions and comorbid tic disorders, and is strongly 
genetically transmitted.  Findings rendered by the other two approaches (i.e. symptomatology, 
comorbidity patterns) to subtyping OCD are currently a somewhat more contentious matter 
emphasizing the need for further research.  Nevertheless, one may hypothesize that ultimately 
the utility of any subtyping approach awaits evaluations of subtype-related differences in 
etiological processes including clinical (e.g. trauma history) and genetic features, as well as 
outcome (treatment) studies.   
 
1.7.1 OCD subtypes and associated etiological (clinical and genetic) features 
 
Increased subtyping efforts have indeed been accompanied by a number of studies 
investigating the matter of OCD subtypes and their associated features:  For example, in a 
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study by Khanna and Mukherjee (1992) it was suggested that checkers can be 
sociodemographically and clinically differentiated from washers, emphasizing the importance of 
exploration of features associated with the main obsessive-compulsive symptomatology.  It was 
found that checkers were more likely to be single and male and have an earlier age of onset, 
with the mixed group on the other hand (patients who are both washers and checkers) 
appearing to be a female-dominated variant of the checkers group.  Furthermore, drawing on 
the work of Janet (reviewed by Pitman (1987)), Rasmussen and Eisen (1991) have suggested 
that OCD can be subtyped on the basis of three core features—namely, abnormal risk 
assessment, pathological doubt, and incompleteness.  These core features were shown to be 
related to the clinical features of OCD and to comorbid disorders.  More specifically, it was 
suggested that symptoms involving incompleteness are likely to be associated with tics and 
compulsive personality traits, while other symptoms are likely to be associated with increased 
anxiety and comorbid anxiety disorders (Rasmussen and Eisen, 1991).  Baer (1994) has 
provided empirical data partially consistent with such a hypothesis, noting that the 
“symmetry/hoarding” cluster of symptoms, which is often characterized by incompleteness, was 
significantly related to tics (TS or chronic tic disorder) and to obsessive-compulsive personality 
disorder.  Another study found a significantly higher rate of sexual and religious obsessions, and 
a significantly lower rate of checking rituals, in OCD patients with comorbid bipolar disorder, 
compared to nonbipolar OCD patients (Perugi et al., 1997).  Frost et al. (2000) found that, 
compared to non-hoarding OCD and other anxiety disorder patients, OCD patients with 
hoarding scored higher on anxiety, depression, and social disability.   
 
In addition, clinicians have long described the emergence of obsessive-compulsive symptoms in 
the aftermath of psychological or emotional trauma.  However, this concept lost ground as 
psychodynamic theories about OCD became less popular and as neurobiological data on OCD 
emerged.  Certainly, clinicians should be reminded not to confuse OCD and PTSD (Pitman, 
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1993).  Nevertheless, there is recent work suggesting that in some cases of OCD, psychological 
trauma may play a role (de Silva and Marks, 1999; Trumbull et al., 2001).  More work is needed 
to determine whether there is a significant association between a history of specific traumatic 
experiences and OCD subtypes, and if so, what the implications are.     
 
In contrast, however, to the above findings that linked OCD symptomatology at baseline with 
other clinical variables (such as comorbidity), a prospective longitudinal study of 79 children and 
adolescents with OCD (Rasmussen et al., 1986) found no significant relationship between the 
type of OCD symptom at baseline and age, gender, and duration of illness.  Similarly, in a 
series of 250 OCD patients, Rasmussen and Eisen (1988) found no significant relationship 
between the type of symptom and age at onset, gender, course of illness, or comorbid 
conditions.  It is nevertheless possible that the above studies did not include enough subjects 
having potentially unique symptoms (Takeuchi et al., 1997), and thus lacked the power to show 
a relationship between rarer symptoms and demographic or clinical variables.  For example, it 
has been suggested that “obsessional slowness” (the tendency towards pathological orderliness 
and having to undertake tasks in a precise and particular pattern), as originally characterized, 
can be differentiated from slowness secondary to rituals (Rachman, 1974).  Later authors have 
argued, however, that such cases can invariably be reanalyzed as secondary to obsessions, 
compulsions, or avoidance strategies (Galderisi et al., 1995; Veale et al., 1993), and therefore 
do not carry particular clinical significance.  Notably, symptoms may differ in OCD patients 
along several other clinical variables, such as insight, duration of illness, continuity of 
symptoms, ratio of obsessions to compulsions, bizarreness of obsessions, fixity of belief, control 
over symptoms, resistance to symptoms, and overall severity. 
 
In terms of neurochemistry / genetics, Cavallini et al. (2002) have suggested a trend towards 
positive association between their fifth factor, including counting and repeating rituals, and an 
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insertion/deletion polymorphism in the promoter region of the serotonin transporter gene (5-
HTTLPR).  In another study, the symmetry/ordering subtype also showed greater inheritance of 
OCD (Alsobrook et al., 1999).  Interestingly, in a recent factor analysis of obsessive-compulsive 
symptomatology in patients with Tourette’s disorder, Leckman et al. (2003) identified two 
symptom dimensions; i.e. aggressive, sexual, and religious obsessions and checking 
compulsions (Factor 1) and symmetry and ordering obsessions and compulsions (Factor 2), 
and found that familial factors (genetic or environmental) contribute significantly to OCD 
symptom dimension phenotypes in families with Tourette’s disorder.  Rauch et al. (1998) have 
also suggested that OCD patients with higher scores on the so-called “obsessional” factor 
showed a positive correlation with blood flow in the striatum bilaterally.  Importantly however, 
findings on the relationship between symptom dimensions and some of these variables have 
not always been consistent across studies.   
 
In summary, the dimensional structure of OCD symptoms is still not fully delineated.  
Nevertheless, continued attempts to quantify phenotypic OC traits may help to identify more 
robust endophenotypes.  Very little work has been carried out to identify endophenotypes for 
OCD, with the possible exception of structural and functional neuroimaging studies.  OCD 
“endophenotypes” can be conceptualized as “latent genetically influenced traits, which may be 
related only indirectly to the classic (OC) symptoms defined in the DSM-IV” (Gottesman et al., 
1997).  As such, endophenotypes (whether physiological, psychological, functional or structural 
in nature) reflect an underlying susceptibility to the OCD phenotype.  Therefore, the rationale for 
using endophenotypes when studying an illness such as OCD, is based on the assumption that 
the number of genes required to produce variations in OCD traits may be fewer (and thus 
possibly easier to identify) than those involved in producing the OCD diagnosis (Gottesman and 
Gould, 2003).  
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1.7.2 OCD subtypes and associated outcome 
 
Arguably, the nature of the delineated OCD subtypes will have implications for associated 
impairment and treatment outcome.  For example, returning to some of the findings from the 
above mentioned treatment studies:   
 
Some studies have found that cleaning symptoms may respond best to exposure methods 
(Buchanan et al., 1996; Rachman and Hodgson, 1980), whereas checking rituals predicted 
poorer outcome in some behavioural therapy studies (Basoglu et al., 1988; Rachman and 
Hodgson, 1980).  Other studies have, however, not found differences in treatment response 
between patients with cleaning and checking (Foa and Goldstein, 1978).  More recently, it has 
been suggested that improvement with behavioural therapy is more likely only with patients 
having either cleaning or checking compulsions, but not both (Ball et al., 1996).  There is a 
relative absence of documentation concerning the outcome of behavioural therapy for 
obsessive-compulsive symptoms other than cleaning and checking; other subgroups (such as 
patients with ordering compulsions, hoarding rituals, or obsessional slowness) have rarely been 
included in trials of such therapy (Ball et al., 1996).  This lack of data is perhaps not surprising in 
that some studies have suggested that patients with non-cleaning compulsions may be more 
likely not to enter behavioural therapy (Marks et al., 1988).  Even so, several studies have found 
that patients with non-cleaning compulsions and obsessions (e.g., those with obsessional 
slowness or in whom obsessions predominate) are unresponsive to behavioural therapy 
(Basoglu et al., 1988; Christensen et al., 1987; Clark et al., 1982; Marks, 1987; Minichiello et al., 
1988).  
 
It has been suggested that washing symptoms do worse with SRI’s (Alarcon et al., 1993; 
Ravizza et al., 1995).  Hoarding symptoms have also been associated with worse response to 
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treatment with SRI’s (Black et al., 1998; Mataix-Cols et al., 1999) as well as premature drop-out 
from behaviour therapy (Mataix-Cols et al., 2002).  Furthermore, high scores on hoarding and 
sexual/religious symptoms have also been found to predict poor treatment response (Mataix-
Cols et al., 2002).  Similarly, somatic obsessions have been reported to condition a poor 
prognosis for drug treatment (Erzegovesi et al., 2001).  In another treatment study, a subgroup 
of OCD patients with principal symmetry obsessions responded to treatment with the 
monoamine oxidase inhibitor phenelzine whereas other symptom groups did not (Jenike et al., 
1997).  
 
In addition to treatment response, disease outcome may also refer to the extent of the disability 
or functional impairment associated with the symptoms.  Indeed, treatment response and 
disability are related concepts, i.e. only partly but not entirely similar.  For instance, it may be 
argued that a treatment responder spends significantly less time on his OC symptoms, he/she 
has fewer OC symptoms and experiences less distress due to the illness after receiving 
treatment compared to a non-responder.  On the other hand however, treatment response is 
related but not necessarily synonymous with less “disability” or less functional impairment.  The 
concept of disability includes impairment in a number of different domains of functioning 
including family life, school / work, marriage, friendship, activities of daily living etc.  In fact, 
patients presenting with different OCD symptom dimensions may have similar treatment 
response, but may differ in terms of the extent and nature of their associated disability.  For 
example, as noted earlier, it has been found that “hoarding” is associated with higher scores on 
anxiety, depression, family and social disability measures than other subtypes of OCD (Frost et 
al., 2000).  Data on the issue of disability and symptom subtypes are lacking, but one may 
argue that efforts to determine the extent to which the identified symptom dimensions or 
subtypes determine outcome (i.e. both treatment outcome, disability), may contribute to a more 
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precise determination of the pathogenesis of OCD symptoms for a more accurate projection of 
future outcomes, and ultimately, for better treatment. 
 
In conclusion, studies of the phenomenology, psychobiology, genetics and family relationships, 
and neuro-imaging of OCD support the view that OCD is not simply a homogeneous entity.  
Rather, increasing evidence suggests that OCD indeed is a heterogeneous disorder, with 
different subtypes or dimensions that are characterized by differing pathophysiological 
mechanisms and treatment outcomes.  Classification of OCD into a number of possibly 
more homogeneous subtypes has been shown to provide a useful means of integrating 
data on its symptomatology, neurobiology, and treatment response.  In addition, existing 
data support the significant association between some of the identified subtypes of OCD and 
specific clinical variables (e.g. trauma history), treatment response, biological markers, or 
genetic transmission in OCD.  Until now, the identification of valid, reliable, meaningful and 
consistent OCD subtypes has remained elusive however, justifying more research into this area 
to also facilitate refinements in etiologic theory and prediction of outcome for each identified 
subtype.  Replication and consistency of findings will contribute to more effective treatment 
intervention and management of disability associated with this condition. 
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CHAPTER 2 
METHODS 
 
 
2.1 Participants 
 
The study was based on existing data obtained from patients participating in the Genetics of 
Anxiety Disorders Project (MRC Unit on Anxiety Disorders; project number: 99/013, approved 
by the Institutional Review Board of the University of Stellenbosch), as well as additional data, 
which the candidate and her colleagues collected over a period of 4 years.  In total, 282 
participants with obsessive-compulsive disorder (OCD) were recruited during this time and 
included in this project.  Due to a number of reasons, there were a few patients who were 
excluded from the analyses: For example, those patients who scored less than 8 on the so-
called Yale-Brown Obsessive-Compulsive Symptoms Severity Scale (YBOCS-SS), which may 
be indicative of subclinical OCD, were excluded.  Other reasons for patient exclusion include 
the following: Self-report questionnaires which were not completed or returned to the research 
unit, or where there was a change of address without giving notice to the researchers so that 
those patients could not be followed up when additional material was added to the interview 
schedule.  Each of the subsequent chapters will indicate the exact number of the total group of 
participants that was actually included in the various analyses. 
 
To be eligible, patients had to meet the Diagnostic and Statistic Manual of Mental Disorders 4th 
Edition (DSM-IV) (APA, 1994) criteria for a primary diagnosis of OCD on the Structured Clinical 
Interview for Axis I Disorders - Patient Version (SCID-I/P) (First et al., 1998), and had to provide 
written informed consent for the study.  Patients were recruited from a wide range of sources 
(the OCD Association of South Africa, community based primary care practitioners, and 
  50
specialist psychiatrists).  Inclusion into this project was subject to informed consent from all 
relevant parties and was guided by the inclusion and exclusion criteria. 
 
2.1.1 Inclusion criteria: 
 
i. Patient group:  
• The patient has a primary DSM-IV diagnosis of OCD, with or without any 
obsessive-compulsive spectrum disorders (OCSD’s).   
• The patient or his/her parents has given signed informed consent. 
• The patient was willing to comply with study procedures. 
 
ii. Control group:  
• Controls did not undergo diagnostic interviews and were randomly selected from 
a community sample; therefore this group can be assumed to be a convenience 
sample, representative of the local general population. 
 
2.1.2 Exclusion criteria: 
 
• Patients with any primary Axis I disorders other than OCD (as determined with 
the SCID-I/P and -OCSD clinical interview).   
• Patients who did not appear to comprehend adequately the aims and practical 
implications of this protocol. 
• Patients who did not provide consent after reading the information and consent 
forms. 
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2.2 Data collection  
 
2.2.1 Interview 
 
After recruitment of a participant, and obtaining written informed consent, each individual was 
subjected to a semi-structured interview, either personally performed by the candidate or other 
experienced clinical researchers employed at the MRC Unit on Anxiety and Stress Disorders.  
Demographic data, including current age, age at onset of the illness, ethnicity, highest 
education level and current employment status, were obtained.  The SCID-I/P, and selected 
parts of the Structured Clinical Interview for Axis II Disorders - Patient Version (SCID-II/P) 
(including OC, avoidant, schizotypal and borderline personality disorders) (First et al., 1998) 
were used to assess comorbidity.  Both these structured diagnostic instruments are used very 
frequently in Psychiatry research.  In addition, a newly developed Structured Clinical Interview 
for the Diagnosis of putative Obsessive-Compulsive Spectrum Disorders (SCID-OCSD) (du Toit 
et al., 2001) was administered to assess OCD-related conditions not covered by the SCID-I/P.   
 
2.2.2 Rating scales 
 
The Yale-Brown Obsessive-Compulsive Symptom Checklist (YBOCS-CL) and Severity Scale 
(YBOCS-SS) (Goodman et al., 1989b, 1989c) were used allowing assessment of the typology 
and severity of obsessive-compulsive symptoms, respectively.  Each of the 74 items of the 
YBOCS-CL represents a single obsessive or compulsive symptom.  These items are sometimes 
grouped together into 13 to 14 broad or major symptom categories based on their core 
characteristics.  This scale was developed in 1986, has very frequently been used in research 
and clinical settings since, and is generally assumed to have good validity and reliability 
(although data on the psychometric properties of the YBOCS-SS is relatively limited).   
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Patients' level of insight into the senselessness or excessiveness of their OC symptoms was 
assessed using the relevant YBOCS-SS item (Goodman et al., 1989c).   
 
The presence/absence of tics (current and/or past) was clinically assessed.  
 
For patients who had received an adequate trial of pharmacotherapy with a serotonin reuptake 
inhibitor (SRI) (i.e. at least 10 weeks on the medication with a minimum of 6 weeks on mid-
range dose) and/or formal cognitive behaviour therapy (CBT) (i.e. 8 or more sessions with an 
expert OCD/CBT psychotherapist), response was assessed on the global improvement item of 
the Clinical Global Impression (CGI) scale; subjects with CGI scores of 1 (“very much 
improved”) or 2 (“much improved”) were defined as treatment responders (Guy, 1976), with the 
rest defined as non-responders or treatment resistant / refractory.   
 
The Childhood Trauma Questionnaire (CTQ) (Bernstein et al., 1994) was used as a self-report 
questionnaire to assess the nature and severity of childhood trauma.  Subscales of the CTQ 
include measures of emotional abuse, physical abuse, sexual abuse, emotional neglect and 
physical neglect.  Reliability and validity of the CTQ had been well researched and the scale 
appears to be a useful measure of childhood trauma (Bernstein et al., 1997). 
 
The Disability Profile questionnaire (DP) (Schneier et al., 1994) was included in the clinical 
interview to assess current (past two weeks) and lifetime impairment in eight domains (alpha 
coefficients: 0.87 for current rating, and 0.90 for lifetime rating).  Each item is rated separately 
for current and for most severe lifetime disability on a 5-point, descriptively anchored scale 
ranging from 0 (no impairment) to 4 (severe impairment).  It was initially developed for use in 
patients with social anxiety disorder (SAD).  Nevertheless, as the DP has since been used in a 
number of studies to assess disability in patients with other anxiety disorders (Mogotsi et al., 
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2000), this scale was administered in the present interviews with OCD patients.  However, test-
retest and inter-rater reliability have not yet been established for this scale (Mendlowicz and 
Stein, 2000).   
 
The self-report Temperament and Character Inventory (TCI) (Cloninger et al., 1994) was also 
used to measure behaviours associated with seven personality dimensions, namely novelty 
seeking, harm avoidance, reward dependence, persistence, self-directedness, cooperativeness, 
and self-transcendence.   
 
In conclusion, these assessment scales and semi-structured questions allowed the researcher 
to diagnose each individual according to DSM-criteria (APA, 1994), and to assess OCD 
symptomatology, overall OCD symptom severity, the extent of disability or impairment due to 
OCD, temperament and character traits, as well as participants’ history of interpersonal trauma. 
 
2.2.3 Genotyping 
 
DNA was extracted from venous blood (10-30 ml) in a Caucasian subset of OCD patients and 
controls, including patients and controls from the genetically homogeneous Afrikaner 
population, and was genotyped for polymorphisms in genes involved in monoamine function, 
which had previously been hypothesized to be relevant to OCD (Hemmings et al., 2003).  The 
polymorphisms investigated were: a 48 base pair (bp) variable number of tandem repeats 
(VNTR) in the third exon of dopamine receptor type 4 (DRD4) (Lichter et al., 1993), a 40bp 
VNTR in the 3’ untranslated region of dopamine transporter (DAT) (Vandenbergh et al., 1992), a 
44bp insertion/deletion polymorphism in the promoter region of the serotonin transporter (5-
HTTLPR) (Heils et al., 1996) and single nucleotide polymorphisms in the serotonin receptor 
type 1B serotonin receptor type 1B (5HT1B, previously referred to as 5HT1DB) (G861C) (G861C) 
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(Sidenberg et al., 1993), the serotonin receptor type 2A (5-HT2A ) (T102C) (Warren et al., 1993), 
tyrosine hydroxylase (TH) (Val81Met) (Ishiguro et al., 1998), catechol-O-methyl transferase 
(COMT) (Val58Met) (Karayiorgou et al., 1997) and monoamine oxidase A (MAO-A) 
(C1460T/EcoRV) (Hotamisligil and Breakefield, 1991).  Previously described genotyping 
protocols (Hemmings et al., 2003) were followed. 
 
 
2.3 Data analyses 
 
The data analyses were performed using different statistical procedures, each of which will be 
discussed in the appropriate sections in the chapters that follow. 
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CHAPTER 3 
PROFILE OF THE OBSESSIVE-COMPULSIVE DISORDER SAMPLE: 
BASED ON ASSESSMENT WITH THE YALE-BROWN OBSESSIVE-COMPULSIVE 
SYMPTOM CHECKLIST  
 
 
Abstract 
The Yale-Brown Obsessive-Compulsive Symptom Checklist (YBOCS-CL) is considered to be 
an important instrument in the comprehensive assessment of patients’ obsessive-compulsive 
symptom profile and has extensively been used in the data collection phase of most obsessive-
compulsive disorder (OCD) research.  In this chapter, it was aimed to lay the groundwork for the 
subsequent investigations with: 
(1) firstly, a review of available descriptive data on the YBOCS-CL, with 
(2) secondly, a discussion of the rationale for using the YBOCS-CL in these investigations, 
and then, 
(3) finally, provision of a profile of the present OCD sample based on their YBOCS-CL 
responses.   
This profile includes for example, the frequencies in which the major obsessive-compulsive 
symptom categories were reported, the mean number of symptoms reported by the patients and 
the frequency with which each individual item of the YBOCS-CL (i.e. symptom) was reported, as 
well as the association of each of these items / symptoms with specific demographic (gender, 
age, population) and clinical variables (total OCD severity and disability).  The findings suggest 
that the present sample is not dissimilar to OCD samples used in other investigations.  Thus, 
analyses and findings using this patient population and checklist would arguably render 
information comparable and applicable to other OCD patients.  
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3.1 Introduction 
 
The Yale-Brown Obsessive-Compulsive Symptom Checklist (YBOCS-CL) is an important 
instrument in the comprehensive assessment of patients’ obsessive-compulsive symptom 
profile and has extensively been used in the data collection phase of most obsessive-
compulsive disorder (OCD) research.  In this chapter, it was aimed to lay the groundwork for the 
subsequent investigations (e.g. Chapter 4) with: 
(1) firstly, a review of available descriptive data on the YBOCS-CL, with 
(2) secondly, a discussion of the rationale for using the YBOCS-CL in these investigations, 
and then, 
(3) finally, provision of a profile of the present OCD sample based on their YBOCS-CL 
 responses.   
 
3.1.1 The YBOCS-CL compared to other obsessive-compulsive symptom  
checklists 
 
The YBOCS-CL was initially developed as an ancillary instrument to assist in the scoring of the 
Yale-Brown Obsessive-Compulsive Symptoms Severity Scale (YBOCS-SS) (Goodman et al., 
1989b, 1989c).  There has been renewed and increased interest in the use of the YBOCS-CL in 
OCD studies as it has been shown to have a number of advantages over other measures of 
OCD symptoms.  For instance, it gained popularity with the increasing dissatisfaction with self-
administrative measures of OCD such as the Maudsley Obsessive-Compulsive Inventory 
(MOCI) and the Padua Inventory (PI) (Goodman and Price, 1992; Taylor, 1998), on the grounds 
that it covers more symptoms and that the other scales are strongly influenced by non-OCD 
symptoms such as depression (Frost et al., 1996).  Furthermore, the YBOCS-CL measures 
symptoms independently from overall illness severity compared to the other self-administered 
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measures of OCD symptoms where the symptom scores are confounded by overall illness 
severity, as the same subscale is used to measure both the presence of a given symptom and 
its severity.     
 
Ironically, while the YBOCS-SS has been extensively studied in the past decade, and despite its 
frequent use in studies of OCD symptomatology, not much is known about the psychometric 
properties of the ancillary YBOCS-CL (Mataix-Cols et al., 2004) except for its factor structure 
(Baer, 1994; Hantouche and Lancrenon, 1996; Leckman et al., 1997; Mataix-Cols et al., 2002, 
1999; Summerfeldt et al., 1999) and test-retest reliability (Mataix-Cols et al., 2002).  To rectify 
the situation, Mataix-Cols et al. (2004) have recently assessed its convergent and divergent 
(discriminant) reliability with a comparison of the YBOCS-CL with the MOCI and the PI.  To 
establish convergent validity, it must be showed that measures that should be related are in 
reality related, i.e. one should be able to show a correspondence or convergence between 
similar constructs.  For example, if the contamination / washing subscales of the YBOCS-CL, 
MOCI and PI correlate significantly, the convergent validity of these scales is adequate.  On the 
other hand, to establish discriminant validity, it must be showed that measures that should not 
be related, are in reality not related, i.e. one should be able to discriminate between dissimilar 
constructs.  For example, there must be weaker correlations between non-corresponding 
symptom subscales such as the contamination / washing subscale of the MOCI and the 
checking subscale of the YBOCS-CL.  The findings of the above-mentioned study suggest that 
the convergent reliability of the YBOCS-CL was generally poor when correlated with self-
administrative instruments (such as the MOCI and the PI).  Mataix-Cols et al. (2004) suggested 
that this finding could partially be explained by the incomplete coverage of some OCD 
symptoms in these self-administered scales.  The divergent reliability of the YBOCS-CL was 
adequate and it appeared to be a relatively pure measure of OCD symptomatology, 
independent from overall symptom severity and state variables.  The use of this scale is likely to 
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continue and/or increase; thus further research of the psychometric properties of this scale is 
warranted. 
 
 3.1.2 Layout of the YBOCS-CL 
 
3.1.2.i The individual items 
As noted before, the version of the YBOCS-CL (Goodman et al., 1989b, 1989c) used in this 
investigation comprises 74 items with each item representing a single obsessive or compulsive 
symptom.  Responses are scored on a continuum, i.e. each of the YBOCS-CL items is scored 0 
(not present), 1 (the symptom is present but not considered to be a primary concern), or 2 (the 
symptom is present and considered a principal problem).   
 
  3.1.2.ii The major symptom categories 
In addition to the division made between obsessions and compulsions, users of the scale have 
divided the items of the YBOCS-CL into a number of broad “major” symptom categories based 
on similarities amongst the various items.  The major symptom categories with an example item 
of each are presented in Table 1.  
 
 
TABLE 1. The major symptom categories with example items 
OBSESSIONS EXAMPLE ITEMS 
Aggressive or harm-related obsessions E.g. “fear that I might harm others” 
Contamination obsessions E.g. “concerns with dirt or germs” 
Sexual obsessions E.g. “content involves homosexuality” 
Hoarding / saving obsessions I.e. an obsession with hoarding of objects, for reasons other than for their 
monetary or sentimental value 
Religious obsessions E.g. “concern with sacrilege or blasphemy” 
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Symmetry obsessions E.g. “obsession with the need for symmetry or exactness” 
Somatic or body-focused obsessions E.g. “concern with illness or disease” 
COMPULSIONS EXAMPLE ITEMS 
Cleaning or washing compulsions E.g. “excessive or ritualized handwashing” 
Checking E.g. “checking locks, stove, appliances, etc” 
Repeating rituals  E.g. “re-reading or re-writing” 
Counting I.e. the compulsion to count most things with which the person comes into 
contact, e.g. to count lampposts when driving 
Ordering and arranging I.e. constantly tidying up or arranging things to be “perfect”, “symmetrical” 
or “in the right order” 
Hoarding compulsions I.e. keeping or saving useless things, e.g. piling up old newspapers or 
keeping junkmail 
Mental compulsions E.g. “special words, images, or numbers repeated mentally to neutralise 
anxiety (e.g. lucky numbers)” 
 
 
3.1.3 Use of the YBOCS-CL in the present OCD sample 
 
3.1.3.i Binary vs ordinal data 
Somewhat different from previous investigations where the YBOCS-CL was used, the 
responses of the participants in this project to these items were categorical and binary (present / 
absent).   
More specifically, in these assessments,  
a.) a score of 2 was given if the symptom was present only in the past, 
b.) a score of 1 if the symptom was currently present, and  
c.) a score of 0 was given if the symptom was absent.   
In other words, in most of the data collection interviews, distinctions between “principal/primary” 
and “present, but not primary” symptoms (as was the case in previous factor analysis studies), 
were not made.  Importantly, in the cluster analyses of data described in Chapters 4, 5 and 6, 
statistical techniques appropriate for this type of data were selected, but also comparable to 
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those used in other investigations.  (Currently, data collected using the usual pattern of 
administration, i.e. similar to that used in previous investigations, are also increasing.)   
 
3.1.3.ii “Miscellaneous” and “Other” items 
In addition to the easily “classifiable” and clinically well-recognized OCD symptoms targeted 
under the major symptom categories, the YBOCS-CL also contains a number of items 
assessing ‘miscellaneous’ and ‘other’ OCD symptoms:  The ‘miscellaneous’ category includes 
symptoms that patients sometimes present with but which do not ‘comfortably’ fit into any of the 
specific symptom categories.  Summerfeldt et al. (2003) recently suggested that there are 
reliable associations among the established symptom dimensions and a number of these 
miscellaneous symptoms of OCD, providing justification for incorporating these items into a data 
reduction analysis of obsessive-compulsive symptomatology.  However, following the example 
of most of the earlier (and some of the most recent) investigations with the YBOCS-CL, it was 
decided to exclude these items to ensure consistency with most of these previously reported 
factor analysis studies where the YBOCS-CL was implemented (Baer, 1994; Leckman et al., 
1997; Summerfeldt et al., 1999).   
 
The ‘other’ items allow the interviewer to include symptoms specific to the participant being 
rated (i.e. instead of just indicating the presence / absence of an already described symptom, 
the interviewer has to enter the patient’s description of his/her symptom verbatim).  As the 
content of these customized items were expected to be unique for each person, and the item 
content therefore not standardized, it was argued that inclusion of these items in the analyses 
would not be psychometrically sound, and were also excluded from the analyses.   
 
In summary, after the above-mentioned exclusions, 45 items remained and were used for the 
subsequent analyses (Table 2).  In other words, this investigation (of, for example, the 
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frequencies of the major symptom categories and the mean number and median of items / 
symptoms endorsed by the respondents, as well as the frequency with which each item was 
reported,) has focused on these 45 items.   
 
Table 2 provides a list of the 45 items that were included in the current and subsequent 
analyses, after exclusion of the ‘miscellaneous’ and ‘other’ items:   
 
 
TABLE 2. The 45 YBOCS-CL - items included in the current and subsequent analyses  
Item nr Item description  
1 Fear that I might harm myself 
2 Fear that I might harm others 
3 Violent or horrific images 
4 Fear of blurting out obscenities or insults 
5 Fear of doing something else embarrassing 
6 Fear that I will act on unwanted impulses (e.g. to stab friend) 
7 Fear that I will steal things 
8 Fear that I will harm others because of not being careful enough (e.g. hit/run MVA) 
9 Fear that I will be responsible for something else terrible happening (e.g. fire, burglary) 
10 Concerns or disgust with bodily waste or secretion (e.g. urine, faeces and saliva) 
11 Concern with dirt or germs 
12 Excessive concern with environmental contaminants (e.g. asbestos, radiation, toxic waste) 
13 Excessive concern with household items (e.g. cleaners, solvents) 
14 Excessive concern with animals (e.g. insects) 
15 Bothered by sticky substances or residues 
16 Concerned that I will get ill because of contaminant 
17 Concerned that I will get others ill by spreading contamination (aggressive) 
18 No concern with consequences of contamination other than how it might feel 
19 Forbidden or perverse sexual thoughts / images / impulses 
20 Content (of obsession) involves children or incest 
21 Content (of obsession) involves homosexuality 
22 (Obsession with) sexual behaviour toward others (aggressive) 
23 Hoarding / Saving obsessions 
24 Concerned with sacrilege and blasphemy  
25 Excessive concern with right / wrong, morality 
  62
26 Obsession with need for symmetry or exactness - Accompanied by magical thinking (e.g. concerned 
that mother will have accident unless things are in the right place) 
27 Obsession with need for symmetry or exactness - Not accompanied by magical thinking  
28 Concern with illness or disease 
29 Excessive concern with a body part or an aspect of appearance (e.g. dysmorphophobia) 
30 Excessive or ritualised handwashing 
31 Excessive or ritualised showering, bathing, teeth brushing, grooming or toilet routine 
32 Compulsions involving cleaning of household items or other inanimate objects 
33 Other measures (than those in item 32) to prevent or remove contact with contaminants 
34 Checking locks, stove, appliances, etc. 
35 Checking that I did not / will not harm others 
36 Checking that I did not / will not harm self 
37 Checking that nothing terrible did / will happen 
38 Checking that I did not make a mistake 
39 Checking tied to somatic obsessions 
40 Re-reading or re-writing 
41 Need to repeat routine activities (e.g. in / out door, up / down from chair, i.e. repeating rituals) 
42 Counting compulsions 
43 Ordering / Arranging compulsions 
44 Hoarding / Collecting compulsions 
45 Mental compulsions (e.g. special words, prayers, images, numbers repeated mentally or repeated in set 
manner to neutralise anxiety; mental reviewing e.g. reviewing of conversations) 
 
 
3.1.3.iii “Current” vs “past” symptomatology  
In addition, following the example of Baer (1994) and Summerfeldt et al. (1999), only ratings of 
current symptoms (i.e. present = 1, or absent = 0) were included in the analyses, since 
inaccuracies or bias in participants’ recall of non-current (past) symptoms may have influenced 
results.  In other words, for the sake of the current analyses, symptoms reported as “past only”, 
were marked as “currently absent”. 
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3.1.3.iv “Subclinical” vs “clinical” obsessive-compulsive  
 symptomatology  
Assessment of total OCD severity with the YBOCS-SS renders scores from 0 to a maximum of 
40.  Patients with scores less than 8 may be considered to have subclinical OCD (Goodman et 
al., 1989c), i.e. the total severity of the obsessive-compulsive symptoms is not considered to be 
severe enough to warrant a diagnosis of clinical OCD.  In order to establish a sample of patients 
all with clinically significant OCD, it was decided to exclude those few patients who had 
YBOCS-SS scores less than 8 from the study sample (i.e. those with OCD of subclinical 
severity).  These patients may perhaps have been treatment responders, i.e. with a significant 
reduction in their OC severity scores after treatment.   
 
In conclusion, in this chapter it was aimed to lay the groundwork for subsequent investigations 
where responses to the YBOCS-CL were analyzed.  This scene-setting chapter includes an 
investigation and discussion of a number of issues including, for example, the frequencies of the 
major symptom categories (as they are currently categorized in the YBOCS-CL) and the mean 
number and median of items / symptoms presented by these patients, as well as the frequency 
with which each item was endorsed.  In order to further expand the comprehensiveness of this 
sample profile, data on the associations between some of the items / symptoms with 
sociodemographics (gender, age, population group) and clinical variables (total impairment and 
total OCD severity) are also presented.   
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3.2 Results 
 
 3.2.1 Sociodemographic findings 
 
The YBOCS-CL was originally administered to 282 OCD patients, with ages ranging from 16 to 
71.  From this group, only 261, i.e. those with an OCD severity score higher than 7 (i.e. mild to 
severe OCD), were included (N=261: mean age: 34.1 ± 12.9).  56% of the total sample obtained 
a higher education diploma or university / college degree after successful completeion of high 
school. 
 
Population group stratification was important for subsequent genetic investigations:  A subset of 
the total sample was Caucasian (N=230), including subjects from the genetically homogeneous 
Afrikaner population (N=110).  Their DNA was extracted from venous blood and was genotyped 
for polymorphisms in genes involved in monoamine function. 
 
The non-Caucasian subset of the sample (N=31) included subjects from the so-called ‘colored’ 
(N=8), Malay (3), Black (N=1), Indian / Asiatic (11) and so-called “other ethnic group” (including 
Portuguese, Italian etc) (N=8) communities of South Africa.  Notably, given the focus of this 
study on recruiting subjects from the Caucasian (and Afrikaner) population groups, the sample 
studied here is not representative of the stratification of the entire South African population. 
 
 3.2.2 Clinical findings 
 
 3.2.2.i Gender and age of onset 
Of the 261 patients, 130 were female (mean age: 36.7 ± 14.5) and 131 male (mean age: 31.6 ± 
10.5).  Onset age of OCD ranged from 2 to 51 years (mean: 17.8 ± 10.3). 
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 3.2.2.ii The YBOCS-SS findings 
Scores on the YBOCS-SS ranged from 8 to 39 (i.e. from mild to very severe), with a mean 
score of 21.1 ± 6.4. 
 
3.2.2.iii The Disability Profile (DP) findings 
Total disability scores on the DP ranged from 1 to 30 (the maximum score possible is 32), i.e. 
patients reported varying degrees of disability, from very little to major disability or impairment 
due to OCD, with a mean total score of 12.1 ± 5.8. 
 
 3.2.2.iv The YBOCS-CL findings 
The patients reported a mean of 12 (current) OCD symptoms (as listed in the YBOCS-CL), with 
the number of symptoms endorsed by individuals ranging between 0 and 42.  Table 3 presents 
the items from the one that was reported most frequently, i.e. “Mental compulsions”, through to 
the one least often reported, i.e. “Fear will steal things”, together with the number of patients 
(and percentage of the total sample) that reported the particular symptom.  
 
 
TABLE 3. Frequencies in which YBOCS-CL - items were reported (N=261) – in descending 
order 
Item 
nr 
Item description Number of 
times an item 
was reported 
(frequency) 
Percentage (%) 
of patients 
reporting this 
symptom 
45 Mental compulsions (e.g. special words, images, numbers 
repeated mentally to neutralize anxiety) 
169 64.8% 
38 Checking that did not make mistake 140 53.6% 
40 Re-reading or re-writing 126 48.3% 
11 Concern with dirt or germs 123 47.1% 
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43 Ordering / Arranging compulsions 108 41.4% 
34 Checking locks, stoves, appliances, etc. 105 40.2% 
42 Counting compulsions 105 40.2% 
30 Excessive or ritualised handwashing 100 38.3% 
27 Obsession with need for symmetry or exactness - Not 
accompanied by magical thinking 
95 36.4% 
10 Concerns or disgust with bodily waste or secretion (e.g. urine, 
faeces and saliva) 
90 34.5% 
31 Excessive or ritualised showering, bathing, toothbrushing, 
grooming or toilet routine 
83 31.8% 
32 Involves cleaning of household items or other inanimate objects 83 31.8% 
2 Fear I might harm others 81 31.0% 
37 Checking that nothing terrible did / will happen 78 29.9% 
33 Other measures (other than cleaning / washing) to prevent or 
remove contact with contaminants 
76 29.1% 
9 Fear will be responsible for something terrible happening 75 38.7% 
41 Need to repeat routine activities (e.g. in / out door, up / down 
from chair) 
75 28.7% 
25 Excess concern with right / wrong, morality 74 28.4% 
35 Checking that did not / will not harm others 70 26.8% 
28 Concern with illness or disease 69 26.4% 
5 Fear of doing something else (other than blurting out obscenities 
or insults) embarrassing 
66 25.3% 
8 Fear will harm others because not careful enough (e.g. hit / run 
MVA) 
66 25.3% 
16 Concerned will get ill because of contaminant 66 25.3% 
15 Bothered by sticky substances or residues 65 24.9% 
3 Violent or horrific images 58 22.2% 
23 Hoarding / Saving obsessions 58 22.2% 
44 Hoarding / collecting compulsions 58 22.2% 
13 Excessive concern with household items (e.g. cleaners, solvents) 56 21.5% 
24 Concerned with sacrilege and blasphemy 55 21.1% 
12 Excessive concern with environmental contaminants (e.g. 
asbestos, radiation, toxic waste) 
52 19.9% 
19 Forbidden or perverse sexual thoughts / images / impulses 52 19.9% 
26 Obsession with need for symmetry or exactness – Accompanied 
by magical thinking 
50 19.2% 
36 Checking that did not / will not harm self 48 18.4% 
1 Fear that I might harm myself 46 17.6% 
4 Fear of blurting out obscenities or insults 46 17.6% 
14 Excessive concern with animals (e.g. insects) 46 17.6% 
6 Fear will act on unwanted impulses (e.g. to stab friend) 45 17.2% 
  67
39 Checking tied to somatic obsessions 45 17.2% 
29 Excessive concern with body part or aspect of appearance (e.g. 
dysmorphophobia) 
43 16.5% 
17 Concerned will get others ill by spreading contamination 
(aggressive) 
35 13.4% 
21 Content involves homosexuality 27 10.3% 
18 No concern with consequences of contamination other than how 
it might feel 
24 9.2% 
20 Sexual obsessions: Content involves children or incest 23 8.8% 
22 Sexual behaviour toward others (aggressive) 14 5.4% 
7 Fear will steal things 9 3.4% 
 
 
The distribution of 14 selected major symptom categories in the present sample was tabulated 
(Table 4), with the most common symptoms being contamination, aggressive and symmetry 
obsessions, and checking, mental rituals and repeating.  
 
 
TABLE 4. Frequencies of the major symptom categories of the YBOCS-CL in 261 OCD 
patients 
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Symptom category Number / percentage of patients reporting items within 
this symptom category 
 N % 
OBSESSIONS   
Contamination 162 62.1% 
Aggressive / harm 156 59.8% 
Symmetry 132 50.6% 
Somatic 93 35.6% 
Religious 89 34.1% 
Sexual 58 22.2% 
Hoarding 58 22.2% 
   
COMPULSIONS   
Checking 186 71.3% 
Mental rituals 169 64.8% 
Repeating rituals  143 54.8% 
Cleaning / washing 134 51.3% 
Ordering 108 41.4% 
Counting 105 40.2% 
Hoarding 58 22.2% 
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3.2.3 Associated features 
 
3.2.3.a.i Number of obsessive-compulsive symptoms vs total OCD 
severity (YBOCS-SS) score:  
The number of obsessive-compulsive symptoms reported was 
significantly associated with the total OCD severity (Pearson 
correlation: r = 0.27; p < 0.001).  (A figure illustrating this 
relationship is available from the candidate upon request.) 
 
3.2.3.a.ii Number of obsessive-compulsive symptoms vs total lifetime 
disability (Disability scale) due to OCD: 
The number of obsessive-compulsive symptoms reported was 
also significantly associated with the total lifetime disability 
(Pearson correlation: r = 0.19; p=0.009).  (A figure illustrating this 
relationship is available from the candidate.) 
  
3.2.3.a.iii Number of obsessive-compulsive symptoms vs age: 
Patients’ age at the time of interview and the number of symptoms 
that they reported were not significantly related; however there 
was a tendency for younger patients to present with an increased 
number of OCD symptoms (Pearson correlation r = - 0.11; p = 
0.07). 
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3.2.3.a.iv Number of obsessive-compulsive symptoms vs age of onset: 
Patients with a younger age of onset of OCD had a significantly 
increased number of obsessive-compulsive symptoms (Pearson 
correlation r = - 0.19; p = 0.003). 
 
3.2.3.a.v Number of obsessive-compulsive symptoms vs gender: 
The number of symptoms reported by males and females was 
similar; the mean number of obsessive-compulsive symptoms 
reported by males and females was 12 (SD: 8) and 11 (SD: 7) 
respectively. 
 
3.2.3.a.vi Number of obsessive-compulsive symptoms vs population 
group (i.e. Caucasian / non-Caucasian): 
The Caucasian and non-Caucasian population groups did not 
differ significantly in terms of the number of symptoms reported; 
both groups reported a mean number of 12 (with standard 
deviations of 8 and 7, respectively) symptoms.   
 
3.2.3.b.i Association between individual obsessive-compulsive 
symptoms and age: 
Six of the harm-related obsessions (item number 1, 2, 3, 4, 6, 9), 
harm-related checking (item number 36, 37), and forbidden or 
perverse sexual thoughts / images / impulses (item number 19, 
21) were significantly associated with patients of a younger age 
compared to those who did not report these items.  Patients with 
concerns with illness or disease (somatic obsessions) (item 
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number 28) or excessive or ritualized handwashing (item number 
30) were also younger at the time of the interview.  Patients with 
hoarding symptoms (item number 23 and 44) as well as those 
who reported counting compulsions (item number 42) were 
significantly older than those without hoarding.  (Student’s t-test)  
(A table illustrating these associations is available from the 
candidate upon request.)  
 
The significant relationship found between age and the various 
major symptom categories confirmed the present findings of 
significant associations found between age at the time of the 
interview and the individual symptoms.  (Student’s t-test)   
(A table illustrating these associations is available from the 
candidate upon request.)  
 
3.2.3.b.ii Association between individual obsessive-compulsive 
symptoms and onset age of OCD: 
Patients with aggressive or harm-related obsessions (items 
number 1, 2, 3, 5, 6, and 9) had a significantly younger age of 
onset of OCD compared to those who did not report these items.  
In addition, patients reporting forbidden or perverse sexual 
thoughts / images / impulses (item number 19), an obsession with 
symmetry or exactness (accompanied by magical thinking, item 
number 26), an excessive concern with some part of his/her 
appearance (e.g. dysmorphophobia, item number 29), compulsive 
checking (item number 35, 38), as well as repeating rituals (re-
  72
reading or re-writing) (item number 40) were also significantly 
associated with younger age of onset of OCD compared to those 
without these symptoms (Table 5).  (Student’s t-test) 
 
 
TABLE 5. Statistically significant associations between individual obsessive-compulsive  
  symptoms and onset age 
Onset age (SD) Item nr Item description 
With item / 
symptom 
Without 
item / 
symptom 
t P 
1 Fear that I might harm myself 15.5 (7.1) 18.3 (10.8) 2.1 0.04 
2 Fear that I might harm others  14.6 (8.0) 19.2 (10.9) 3.6 <0.001 
3 Violent or horrific images 14.9 (8.1) 18.7 (10.7) 2.8 0.006 
5 Fear of doing something embarrassing 14.9 (7.8) 18.7 (10.8) 2.9 0.004 
6 Fear that I will act on unwanted impulses 14.7 (8.1) 18.5 (10.6) 2.1 0.04 
9 Fear that I will be responsible for something 
terrible happening 
14.4 (8.1) 19.3 (10.8) 3.9 <0.001 
19 Forbidden or perverse sexual thoughts / 
images / impulses 
15.3 (7.3) 18.5 (10.8) 2.4 0.02 
26 Obsession with need for symmetry or 
exactness (with magical thinking) 
14.5 (9.0) 18.6 (10.5) 2.4 0.02 
29 Excessive concern with body part or an 
aspect of appearance 
13.5 (7.2) 18.6 (10.6) 3.6  0.001 
35 Checking that did not / will not harm others  15.7 (8.9) 18.6 (10.7) 2.0 <0.05 
38 Checking that did not make mistake 16.3 (9.4) 19.6 (11.0) 2.5 0.01 
40 Re-reading or re-writing 15.2 (8.0) 20.4 (11.7) 4.0 <0.001 
 
 
The significant associations found between individual symptoms 
and onset age of OCD were confirmed by the associations found 
between the various major symptom categories and age of onset 
of OCD.  (Student’s t-test) 
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(A table illustrating these associations is available from the 
candidate upon request.)    
 
3.2.3.b.iii Association between individual obsessive-compulsive  
symptoms and gender: 
Significantly more females than males reported an excessive 
concern with animals or insects (a contamination obsession; item 
number 14), an obsession with the need for symmetry or 
exactness (not accompanied by magical thinking) (item number 
27), excessive cleaning of household items or other inanimate 
objects (item number 32), and counting compulsions (item number 
42).  More males reported sexual obsessions e.g. “forbidden or 
perverse sexual thoughts / images / impulses” (item number 19) 
and sexual obsessions concerning children or incest (item number 
20), concern with illness or disease (item number 28), as well as 
harm-related checking (i.e. checking that he/she did not harm self) 
(item number 36) (Table 6).  (Chi - squared test) 
 
 
(Table 6 follows on the next page.) 
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TABLE 6. Statistically significant associations between individual obsessive-compulsive  
symptoms and gender  
Gender 
(with symptom / item) 
Item nr Item description 
Male 
(n=131) 
Female 
(n=130) 
χ2 p 
14 Excessive concern with animals or 
insects (contamination obsession) 
16 (12.2%) 30 (23.1%) 5.4 0.02 
19 Forbidden or perverse sexual thoughts / 
images / impulses 
37 (28.2%) 15 (11.5%) 11.7 0.001 
20 Content involves children or incest 
(sexual obsession) 
17 (13.0%) 6 (4.6%) 5.9 0.02 
27 Obsession with need for symmetry or 
exactness (Not accompanied by 
magical thinking) 
40 (30.5%) 55 (42.3%) 3.9 <0.05 
28 Concern with illness or disease 42 (32.1%) 27 (20.8%) 4.3 0.04 
32 Involves cleaning of household items or 
other inanimate objects 
33 (25.2%) 50 (38.5%) 5.3 0.02 
36 Checking that did not / will not harm self 31 (23.7%) 17 (13.1%) 4.9 0.03 
42 Counting compulsions 44 (33.6%) 61 (46.9%) 4.8 0.03 
 
 
Similar tendencies were found in the associations between gender 
and the major symptom categories.  (Chi - squared test) 
(A table illustrating these associations is available from the 
candidate upon request.)  
 
3.2.3.b.iv Association between individual obsessive-compulsive 
symptoms and population group (i.e. Caucasian vs non-
Caucasian): 
Caucasian patients more often reported hoarding obsessions and 
compulsions (item number 23 and 44), whereas non-Caucasians 
more often reported excessive or ritualised handwashing, 
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showering and cleaning of household items or other inanimate 
objects (item number 30, 31 and 32) (Table 7).  (Chi - squared 
test) 
 
There is a tendency (perhaps particularly in South Africa) to want 
to exclude population group / race unless there are clear reasons 
where it might come in.  It was decided to include this information 
here, given the focus on genetics in subsequent investigations 
(see following chapters).  For genetics, inclusion of population / 
race can be important because some variants are found more 
often in some groups.   
 
 
TABLE 7. Statistically significant associations between individual obsessive-compulsive 
symptoms and population group 
Population group 
(with symptom / item) 
Item nr Item description 
Caucasian 
(n=230) 
Non-
Caucasian 
(n=31) 
χ2 p 
23 Hoarding / saving obsessions 56 (24.3%) 2 (6.5%) 6.3 0.01 
30 Excessive or ritualized handwashing 83 (36.1%) 17 (54.8%) 3.9 <0.05 
31 Excessive or ritualized showering, etc. 68 (29.6%) 15 (48.4%) 4.2 0.04 
32 Involves cleaning of household items or other 
inanimate objects 
68 (29.6%) 15 (48.4%) 4.2 0.04 
44 Hoarding / collecting compulsions 56 (24.3%) 2 (6.5%) 6.3 0.01 
 
 
Investigation of the associations between gender and the major 
symptom categories rendered similar findings.  (Chi - squared 
test) 
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(A table illustrating these associations is available from the 
candidate upon request.)  
 
3.2.3.b.v Effect of presence / absence of each obsessive-compulsive 
symptom on the total mean OCD severity (YBOCS-SS) 
scores: 
As noted before, OCD severity scores (on the YBOCS-SS) ranged 
from 8 to 39 (i.e. from mild to very severe), with a mean score of 
21.1 ± 6.4.  Table 8 indicates the impact of the presence or 
absence of 45 YBOCS-CL items on the total OCD severity score.  
Focussing on, for example, the 9 most frequently occurring OC 
symptoms (highlighted in yellow), it is clear that if any of these are 
present, the mean severity score is more than the 95% upper 
bound.  Presence of item nr 31 (‘Excessive or ritualised 
showering, bathing, etc.’) was associated with the highest severity 
score.  Similar trends were noticed for the other cleaning / 
washing compulsions, emphasizing the strong impact that 
contamination symptoms may have on general OCD severity.  On 
the other hand, it is not clear why presence of item nr 19 
(‘Forbidden or perverse sexual thought / images / impulses’) was 
associated with a decrease in the total YBOCS-SS score.    
 
 
(Table 8 follows on the next page.) 
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TABLE 8. Effect of presence / absence of each obsessive-compulsive symptom on the total mean OCD severity (YBOCS-SS) scores* 
 
YBOCS-CL item label   
Mean YBOCS-SS-
score if absent 
YBOCS-CL item 
number 
Mean YBOCS-SS-
score if present  
Fear that I might harm myself  20.97 Item nr 1 21.39  
Fear that I might harm others  20.98 Item nr 2 21.19  
Violent or horrific images  21.03 Item nr 3 21.09  
Fear of blurting out obscenities or insults  20.62 Item nr 4 23.04 More than 95% limit 
Fear of doing something else embarrassing  21.05 Item nr 5 21.05  
Fear that I will act on unwanted impulses (e.g. 
to stab friend)  21.05 Item nr 6 21.02  
Fear that I will steal things  21.05 Item nr 7 20.89  
Fear that I will harm others because of not 
being careful enough (e.g. hit/run MVA)  20.78 Item nr 8 21.82  
Fear that I will be responsible for something 
else terrible happening (e.g. fire, burglary)  20.57 Item nr 9 22.23 More than 95% limit 
Concerns or disgust with bodily waste or 
secretion (e.g. urine, faeces and saliva)  20.65 Item nr 10 21.80  
Concern with dirt or germs Less than 5% limit 19.34 Item nr 11  22.96 More than 95% limit 
Excessive concern with environmental 
contaminants (e.g. asbestos, radiation, toxic 
waste)  20.79 Item nr 12 22.08 More than 95% limit 
Excessive concern with household items (e.g. 
cleaners, solvents)  20.64 Item nr 13 22.52 More than 95% limit 
Excessive concern with animals (e.g. insects)  20.82 Item nr 14 22.09 More than 95% limit 
Bothered by sticky substances or residues  20.40 Item nr 15 23.00 More than 95% limit 
Concerned that I will get ill because of  20.96 Item nr 16 21.29  
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contaminant 
Concerned that I will get others ill by spreading 
contamination (aggressive)  20.81 Item nr 17 22.57 More than 95% limit 
No concern with consequences of 
contamination other than how it might feel  20.82 Item nr 18 23.20 More than 95% limit 
Forbidden or perverse sexual thoughts / images 
/ impulses More than 95% limit 21.44 Item nr 19 19.44 Less than 5% limit 
Content (of obsession) involves children or 
incest  21.08 Item nr 20 20.74  
Content (of obsession) involves homosexuality  21.22 Item nr 21 19.56 Less than 5% limit 
(Obsession with) sexual behaviour toward 
others (aggressive)  21.04 Item nr 22 21.21  
Hoarding / Saving obsessions  20.90 Item nr 23 21.55  
Concerned with sacrilege and blasphemy   21.00 Item nr 24 21.20  
Excessive concern with right / wrong, morality  20.99 Item nr 25 21.18  
Obsession with need for symmetry or exactness 
- Accompanied by magical thinking (e.g. 
concerned that mother will have accident unless 
things are in the right place)  20.60 Item nr 26 22.94 More than 95% limit 
Obsession with need for symmetry or exactness 
- Not accompanied by magical thinking  Less than 5% limit 20.08 Item nr 27 22.73 More than 95% limit 
Concern with illness or disease  20.63 Item nr 28 22.22 More than 95% limit 
Excessive concern with a body part or an 
aspect of appearance (e.g. dysmorphophobia)  20.66 Item nr 29 23.00 More than 95% limit 
Excessive or ritualised handwashing Less than 5% limit 19.83 Item nr 30 23.01 More than 95% limit 
Excessive or ritualised showering, bathing, Less than 5% limit 19.63 Item nr 31 24.08 More than 95% limit 
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teeth brushing, grooming or toilet routine 
Compulsions involving cleaning of household 
items or other inanimate objects Less than 5% limit 19.87 Item nr 32 23.58 More than 95% limit 
Other measures (than those in item 32) to 
prevent or remove contact with contaminants Less than 5% limit 20.22 Item nr 33 23.05 More than 95% limit 
Checking locks, stove, appliances, etc.  20.39 Item nr 34 22.02 More than 95% limit 
Checking that I did not / will not harm others  20.92 Item nr 35 21.40  
Checking that I did not / will not harm self  21.15 Item nr 36 20.58  
Checking that nothing terrible did / will happen  20.53 Item nr 37 22.26 More than 95% limit 
Checking that I did not make a mistake Less than 5% limit 19.36 Item nr 38 22.50 More than 95% limit 
Checking tied to somatic obsessions  21.00 Item nr 39 21.27  
Re-reading or re-writing Less than 5% limit 20.01 Item nr 40 22.16 More than 95% limit 
Need to repeat routine activities (e.g. in / out 
door, up / down from chair, i.e. repeating rituals)  20.44 Item nr 41 22.55 More than 95% limit 
Counting compulsions Less than 5% limit 20.06 Item nr 42 22.51 More than 95% limit 
Ordering / Arranging compulsions Less than 5% limit 19.96 Item nr 43 22.58 More than 95% limit 
Hoarding / Collecting compulsions  20.71 Item nr 44 22.22 More than 95% limit 
Mental compulsions (e.g. special words, 
prayers, images, numbers repeated mentally or 
repeated in set manner to neutralise anxiety; 
mental reviewing e.g. reviewing of 
conversations) Less than 5% limit 19.73 Item nr 45 21.76  
* The 9 most frequently occurring OC symptoms are highlighted in yellow 
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3.2.3.c. The major symptom categories and total OCD severity 
(YBOCS-SS) and global disability (Disability Profile) scores 
Given the heterogeneous nature of OCD symptomatology and the 
relatively large number of individual items / symptoms listed in the 
YBOCS-CL, it was decided to not only focus on total OCD severity 
and disability in the OCD group as a whole, but also to present 
data on the total OCD severity (YBOCS-SS) and disability 
(Disability Profile) scores in each of the major symptom categories 
(Table 9).  Findings are consistent with the previous investigation 
of the effect of the presence / absence of each obsessive-
compulsive symptom on the total OCD severity (YBOCS-SS) 
scores.  Turning the attention to the symptom categories in 
particular, the findings suggest that, although not statistically 
different from the others, contamination compulsions, obsessions 
with symmetry/exactness and ordering/arranging compulsions 
were the three symptom categories associated with the highest 
total OCD severity scores, whereas the (three) highest disability 
scores were associated with religious obsessions, hoarding 
compulsions and aggressive/ harm-related obsessions.  
 
 
TABLE 9. Total OCD severity (YBOCS-SS) and disability (Disability Profile) scores in each of  
the major symptom categories 
OCD symptom category Total severity score Total disability score 
 N* Mean SD N** Mean SD 
Aggressive obsessions 156 21.2 6.3 115 13.1 6.3 
Contamination obsessions 162 22.3 6.3 114 12.8 5.8 
Sexual obsessions 58 19.6 5.4 48 12.7 6.5 
  81
Hoarding obsessions 58 21.6 6.1 38 12.8 5.3 
Religious obsessions 89 21.2 6.0 57 13.9 6.3 
Symmetry obsessions 132 22.7 6.3 94 11.9 5.4 
Somatic obsessions 93 22.3 6.2 70 12.6 5.8 
Contamination compulsions 134 22.9 6.2 97 12.6 5.6 
Checking 186 21.9 6.2 134 12.6 5.6 
Repeating rituals 143 22.1 5.8 103 12.1 5.0 
Counting compulsions 105 22.5 6.4 69 12.3 5.8 
Ordering compulsions 108 22.6 6.8 81 11.5 4.74 
Hoarding compulsions 58 22.2 6.0 39 13.2 5.3 
Mental compulsions 169 21.8 6.1 115 12.0 5.7 
N*, N** = number of OCD patients who presented with one / more obsessive-compulsive symptoms included in the specified 
symptom category, for whom there were severity or disability data available, respectively 
 
 
3.3 Discussion 
 
In this chapter it was aimed to lay the groundwork for the subsequent investigations with a 
review of available descriptive literature on the YBOCS-CL, subsequent provision of a rationale 
for using this instrument in this project, together with a profile of the present OCD sample based 
on their YBOCS-CL responses.  The findings suggest that the male:female ratio, age of onset of 
OCD, the mean number and content of obsessive-compulsive symptoms reported, as well as 
the mean and range of the total OCD severity score are similar to those of previous OCD 
investigations.  Moreover, the significant associations found between the number of OC 
symptoms, as well as individual symptoms and symptoms categories, with specific 
sociodemographic (gender, age, population) and clinical variables (total OCD severity and 
disability) respectively, are also relatively similar to those found in the OCD literature (APA, 
1994; Castle et al., 1995; Cavallini et al., 2002, 1999; Goodman et al., 1989a; Rasmussen and 
Tsuang, 1984; Weissman et al., 1994).  (Regarding the findings of signiciant associations, it is 
important to take into consideration that with such a large sample size, the power may 
guarantee statistical significance to even relatively modest findings.)   
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This investigation is consistent with data (APA, 1994) indicating an age of onset of OCD ranging 
from childhood to adulthood, with mean age of onset in adolescence or early adulthood.  In 
addition, similar to other samples, the gender ratio in this sample was more or less equal, 
suggesting that OCD may also be equally common in males and females in the South African 
population.  Furthermore, similar to the data on the prevalence of the various OCD symptom 
subtypes, an examination of 65 studies that classified patients according to such subtypes, 
found that patients with primarily cleaning or checking compulsions predominated, accounting 
for 75% of the treatment population (Ball et al., 1996). 
 
The finding that the number of symptoms reported ranges from none (0) to forty-two (42) is 
interesting, deserving comment, given that only patients with clinical OCD were included in the 
sample.  In other words, there arguably were patients with a diagnosis of OCD in the study 
sample who did not report any of the YBOCS-CL symptoms that were selected for use in the 
investigations.  There are several possible explanations for this: For example, the patient may 
have presented only with the so-called miscellaneous and/or other symptoms that were 
excluded from the analyses.  Moreover, the patient could also have presented with OC 
symptoms that are not currently included in the YBOCS-CL, but which also do not fit into any of 
the existing, even miscellaneous or other, symptom categories.  Absence of YBOCS-CL items 
reported may also reflect on the patient’s level of insight, i.e. in some patients, poor insight may 
hamper the ability to identify and accurately report symptoms.  These ideas suggest that, 
although the YBOCS-CL is considered to be one of the most, if not the most, comprehensive 
symptoms checklists available today, there are grounds for improvement or expansion of the 
current range of symptoms that are assessed.     
 
The statistically significant associations found between the individual symptoms and 
sociodemographic variables such as age at the time of the interview, onset age of OCD, gender 
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and population group, respectively, were confirmed as expected by the associations found 
between the various major symptom categories and these variables.  In particular, a number of 
harm-related obsessions (as well as harm-related checking), sexual obsessions, somatic 
obsessions, and cleaning rituals were associated with younger age at the time of the interview, 
whereas hoarding and counting showed an association with increased age.  Earlier age of onset 
of OCD was found to be associated with harm-related obsessions, obsessive concerns with 
symmetry or exactness, somatic obsessions, compulsive checking and other repeating rituals 
(e.g. re-reading).  Similarly, it has been suggested that, in contrast to adults, children with OCD 
often present with pure compulsions, such as washing and repeating compulsions (Swedo et 
al., 1989).  It has also been suggested that patients with a very early onset of OCD (i.e. younger 
than six years old) are more likely to have compulsions rather than obsessions (Honjo et al., 
1989; Rettew et al., 1992).  These compulsions would typically include elaborate washing or 
checking rituals without cognitive obsessions (Swedo et al., 1992).  Nevertheless, despite some 
differences between child and adult OCD, there appears to be much continuity between the 
clinical presentation of OCD in childhood and that in adulthood (Flament et al., 1988; Rapoport 
et al., 1992; Rasmussen and Tsuang, 1986; Swedo et al., 1989; Toro et al., 1992; Wever and 
Rey, 1997).   
 
Consistent with most of the existing OCD data (Lochner and Stein, 2003a), it was found that 
females more often had specific contamination obsessions with some cleaning rituals, 
symmetry concerns and counting whereas males on the other hand more often had sexual 
obsessions, somatic obsessions (e.g. with illness / disease) and harm-related checking.  
However, as was indicated earlier, the relationship between symptom clusters and variables 
such as age and gender has not always been consistent across studies. 
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In contrast to the present and other existing data linking OCD symptomatology and specific 
sociodemographic variables, there are a number of studies that have suggested that type of 
OCD symptom at baseline was not related to a number of variables, including age, age of 
onset, gender, illness course or comorbidity (Rasmussen and Eisen, 1988; Rasmussen and 
Tsuang, 1986).  It may nevertheless be argued that these studies did not include enough 
subjects having potentially unique symptoms (Takeuchi et al., 1997) and thus may have lacked 
the power to show a relationship between (rarer) symptoms and demographic or clinical 
variables.  Further work is needed to investigate this matter. 
 
Furthermore, the number of symptoms reported may also differ in OCD patients along several 
other variables, such as overall severity and/or disability.  The findings here indeed suggest that 
an increase in the number of obsessive-compulsive symptoms is significantly related to 
increased overall severity and disability.  This does make sense on one level, i.e. given the way 
the instrument is structured, an OCD patient who has very severe contamination symptoms will 
assumably report multiple contamination symptom items.  On a different level, this finding 
encourages further investigation given the fact that the clinical experience of the candidate and 
her colleagues suggests that the presentation of even a very few OC symptoms may be 
associated with severe OCD or extreme disability – however, whereas this is possible, it is 
statistically less likely.  Admittedly, these may have been a few isolated cases.  Nevertheless, 
based on these findings, it may be concluded that generally, patients with more symptoms 
experience worse OCD or disability, and vice versa.  In addition, the present findings suggest 
that some obsessive-compulsive symptoms and categories may be associated with higher 
global severity or more disability than others; the differences were not significant however.  
Nonetheless, comparably, Frost et al. (2000) found that, compared to non-hoarding OCD and 
other anxiety disorder patients, OCD patients with hoarding scored higher on anxiety, 
depression, as well as social disability.  Additional research is required to determine the extent 
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(significance) to which the severity / disability scores differs amongst the different symptom 
categories.  In addition, levels of severity or disability may possibly in turn be related to outcome 
with medication or behaviour therapy; these data were not controlled for treatment stage 
however, necessitating more work in this area.  Arguably, some categories may show a better 
response (i.e. decreased global severity and disability) to specific drugs or psychotherapies.  
For example, a principal components analysis by Mataix-Cols et al. (1999) has suggested that 
higher scores on the hoarding dimension predicted poorer outcome following treatment with 
serotonin reuptake inhibitors, after controlling for baseline severity.  Therefore, it may be 
concluded that this type of data (symptom dimensions) may be useful in, for example, treatment 
studies where patients usually are categorized as OCD / non-OCD (or control) only, and not 
according to their primary obsessive-compulsive symptomatology.   
 
 
3.4 Conclusion 
 
In conclusion, the YBOCS-CL remains an important instrument in the comprehensive 
assessment of patients’ obsessive-compulsive symptom profile.  Also in this patient sample, the 
YBOCS-CL findings arguably provided a good indication of their OC related characteristics, e.g. 
the frequencies in which the major OC symptom categories were reported, the mean number of 
symptoms reported by the patients and the frequency with which each individual item of the 
YBOCS-CL (i.e. symptom) was reported, as well as the association of each of these items / 
symptoms with specific demographic (gender, age, population) and clinical variables (total OCD 
severity and disability).  It may be suggested that the clinical profile of this present sample of 
OCD patients is not dissimilar to that of OCD patients in other investigations elsewhere.  
Subsequent analyses and findings using this patient population and checklist will arguably 
render information comparable to most other OCD patients.   
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This work forms the background to Chapters 4 and 5, which aimed to identify OCD subtypes 
based on their obsessive-compulsive symptomatology assessed with the YBOCS-CL.   
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CHAPTER 4 
THE IDENTIFICATION OF OBSESSIVE-COMPULSIVE DISORDER SUBTYPES 
WITH LATENT CLASS ANALYSIS 
OF OBSESSIVE-COMPULSIVE SYMPTOMATOLOGY 
 
 
Abstract 
There is increasing evidence that obsessive-compulsive disorder (OCD) is a heterogeneous 
disorder, with clinical subtypes that are characterized by differing pathophysiological 
mechanisms and treatment response.  This study aimed to identify clusters of OCD cases 
based on their obsessive-compulsive (OC) symptomatology assessed with the Yale-Brown 
Obsessive-Compulsive Symptom Checklist (YBOCS-CL).  By means of specialized computer 
software, latent class analysis (LCA) was applied to the data matrix, which in its entirety 
consisted of the categorical responses of 261 OCD patients to 45 selected items of the YBOCS-
CL.  The procedure for LCA was to fit a one-class solution first, followed by two-, three-, and 
four-class solutions and so forth, until the best solution was obtained for the items of the 
YBOCS-CL included in the analysis to develop an empirically based typology.  The “best fit” 
comprised six (6) clusters or patient subtypes when the nine (9) most frequently occurring 
obsessive-compulsive symptoms were included in the analysis.  To gain insight into the cluster 
structure, the ways in which clusters of cases differed with respect to specific demographic 
variables (age, gender) and clinical variables (OC symptoms, total OCD severity, treatment 
response, childhood trauma history) were investigated.  Clusters I to VI were labelled ‘Mental 
compulsions’, ‘Maximal disorder’, ‘Minimal disorder’, ‘No checking compulsions, ‘Checking 
compulsions’, and ‘Pure contamination compulsions / washing’, respectively.  The clusters did 
not differ significantly in terms of the clinical features investigated.  Nevertheless, some of the 
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clusters identified with LCA broadly resembled some of the current sub-classifications of OCD 
suggested in the literature.     
 
 
4.1 Introduction 
 
Chapter 1 of this dissertation provides a review of the extensive obsessive-compulsive disorder 
(OCD) literature which suggests that OCD is a heterogeneous condition, with clinical subtypes 
that are characterized by differing pathophysiological mechanisms and treatment outcomes 
(Lochner and Stein, 2003a).  This heterogeneity has possibly confounded the findings of 
clinical, natural history and treatment response studies and has complicated the search for 
vulnerability genes, as suggested by the many inconsistent findings in studies of OCD.  For 
example, responsivity to treatment and prognosis may vary according to obsessive-compulsive 
(OC) symptoms (Erzegovesi et al., 2001; Mataix-Cols et al., 1999), suggesting that there is a 
spectrum of different OC symptoms which may have different biological underpinnings.  
Furthermore, there is a lack of clear results from OCD studies using molecular genetics which 
could arguably be ascribed to the use of the conventional set of diagnostic criteria that still 
classifies OCD as a unitary nosographic entity (Cavallini et al., 2002) instead of focusing on the 
different “entities” or phenotypes of OCD.    
 
It has been suggested that success in accurate and detailed measurement of OCD phenotypes 
and an adequate characterization of OCD patients’ heterogeneity are likely to facilitate 
refinements in genetic, neurobiological, environmental and treatment studies (Calamari et al., 
1999, 2004; Miguel et al., 2005) and may lead to greater clarity concerning course, treatment 
strategies and outcome.  There have been numerous attempts to identify OCD subtypes, with 
the most common strategy being a focus on OCD symptoms as classifying variables.  Factor 
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and cluster analyses are the statistical approaches used most often to subtype OCD 
symptomatology or OCD cases.  In summary, most efforts to classify OCD symptoms assessed 
with symptoms checklists such as the Yale Brown Obsessive-Compulsive Disorder Symptoms 
Checklist (YBOCS-CL) have consistently found that these fall into 3 to 6 symptom dimensions 
or factors, including aggressive / checking, contamination, symmetry / ordering and hoarding 
symptoms (Baer, 1994; Calamari et al., 1999; Cavallini et al., 2002; Denys et al., 2004; 
Feinstein et al., 2003; Leckman, 1993; Mataix-Cols et al., 1999; Summerfeldt et al., 1999).  
Furthermore, it has been suggested that each of the different factors may be associated with 
different demographic, clinical and genetic features (Lochner and Stein, 2003a); findings in this 
regard have, however not always been consistent across studies, indicating the need for further 
research.   
 
In addition to the standard data reduction procedures, there is another statistical classification 
method currently gaining ground given its many advantages over above these methods with 
their apparent limitations, i.e. latent class analysis (LCA).  LCA is used to empirically determine 
typologies of categorical data (i.e. data indicating, for example, the absence or presence of a 
particular symptom) on specific disorders as it occurs in clinical and epidemiological samples.  It 
has been suggested that similarity amongst such OCD case characteristics can be of 
assistance in understanding more of the heterogeneous phenomenon of OCD.  However, 
although this method has been increasingly used in studies to capture the natural clustering of 
specific pathology, it has of yet been used in very few studies with OCD samples (e.g. Nestadt 
et al., 2003).  
 
This investigation of the naturally occurring empirical typology of OCD was an empirical attempt 
at providing answers to the question of whether there is a single broad “OCD” phenotype with 
specific features and a common etiology, or whether there are a number of distinct types with 
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different features and etiologies within this broad framework.  In other words, it was firstly aimed 
to determine the number of clusters / classes that renders the best fit for the data analysed and 
secondly, to characterize these OCD clusters of cases.   
 
 
4.2 Methods 
 
 4.2.1 Subjects and interview 
Two hundred and eighty two patients with OCD (N=282), with ages ranging from 16 to 71, took 
part in the study.  From this group, only those with an OCD severity score on the Yale-Brown 
Obsessive-Compulsive Symptoms Severity Scale (YBOCS-SS) higher than 7 (i.e. mild to 
severe OCD) were included (N=261: mean age: 34.1 ± 12.9).  Of the 261 patients, 130 were 
female (mean age: 36.7 ± 14.5) and 131 male (mean age: 31.6 ± 10.5).   
 
These patients were referred to this Research Unit from a wide range of sources (the OCD 
Association of South Africa, specialist psychiatrists, and community based primary care 
practitioners).  They were interviewed by a clinical psychologist with expertise in the field (the 
candidate), and met the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (APA, 
1994) criteria for OCD on the Structured Clinical Interview for Axis I Disorders (SCID-I) (First et 
al., 1998).  Referring clinicians were contacted to establish, where possible, a longitudinal 
expert opinion on the diagnostic status of the patient.  
 
As noted previously, the YBOCS-CL was the assessment measure of choice given its extensive 
use in OCD research.  Previous factor analytic studies based their work on the assumption that 
the YBOCS-CL is a comprehensive checklist of OC symptomatology rendering responses of 
continuous (or ordinal) nature (i.e. absent, present, principal or prominent).  In contrast, the 
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responses of the participants to the YBOCS-CL in this project were categorical and binary 
(present / absent).  In other words, the OC symptoms were defined as binary ‘0; 1’ - indicator 
measurements and therefore it was possible to display any combination of symptoms as a 
string of zeroes and ones.  A ‘zero’ represented symptom absence and a ‘one’ the presence of 
a particular OC symptom.  With this data collection, distinction was not made between 
symptoms considered “primary / principal” and “present” as was the case in some previous 
studies.   
 
When an adequate trial of pharmacotherapy with a serotonin reuptake inhibitor (SRI) (i.e. at 
least 10 weeks on the medication with a minimum of 6 weeks on mid-range dose) or cognitive-
behavioural therapy (CBT) (i.e. 8 or more sessions with an expert OCD/CBT psychotherapist) 
had been undertaken, responsivity to pharmacotherapy / psychotherapy was assessed using 
the global improvement item of the Clinical Global Impression (CGI) scale (Guy, 1976).   
 
The self-report Childhood Trauma Questionnaire (CTQ), was used to assess the nature and 
severity of possible childhood interpersonal trauma in the patients.  Sub-scales of the CTQ 
include measures of emotional abuse, physical abuse, sexual abuse, emotional neglect and 
physical neglect.  Reliability and validity of the CTQ have been well researched and the scale 
appears to provide a useful measure of childhood trauma (Bernstein et al., 1997).   
 
 4.2.2 Latent class analysis 
As noted before, traditional factor analysis (FA) is the data-mining model that was used most 
often in past studies of OC symptomatology to extract a relatively small number of meaningful 
“factors” or symptom dimensions from a large number of OC symptoms or variables.  However, 
in recent times this method has been increasingly criticised for its limitations in practice, 
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including the requirement that all variables should be continuous, and the assumption of 
multivariate normality to justify a linear model.   
 
Cluster analysis is theoretically similar to FA, and refers to the classification of similar objects 
(e.g. OC symptoms or OCD patients) into meaningful classes or groups, when both the number 
of classes and the composition or form of the classes are to be determined (Everitt, 1993; 
Kaufman and Rousseeuw, 1990).  When cluster analysis is applied to objects with categorical 
attributes (e.g. data on the presence or absence of symptoms, such as data rendered by the 
present assessment of OCD symptoms with the YBOCS-CL), it is sometimes called latent class 
analysis (LCA) (Bartholomew and Knott, 1999; Goodman, 1974; Lazarsfeld and Henry, 1968; 
Uebersax, 2000); i.e. LCA is actually considered a “categorical analogue” to the traditional FA 
and therefore is appropriate for implementation in the current investigation.  In addition, LCA 
has been shown to have many advantages above FA, and does not have the above limitations, 
making it an attractive choice for the present data analyses.   
 
LCA yields a probabilistic clustering approach, where each “object” (in this case, the OCD 
patient) is assumed to belong to one class or cluster, and it is taken into consideration that there 
may be some uncertainty about an object’s / patient’s cluster membership.  Vermunt and 
Magidson (2002b) suggested that probably one of the most important reasons for the increased 
popularity of LCA as a statistical tool for cluster analysis is the fact that presently high-speed 
computers make these computationally intensive methods practically applicable.  In addition, 
latent class clustering is very flexible in the sense that both simple and complicated 
distributional forms can be used for the observed variables within clusters.  Another advantage 
of this approach is that no decisions have to be made about the scaling of the observed 
variables: For example, when working with normal distributions with unknown variances, the 
results will be the same irrespective of whether the variables are normalized or not.  (This is 
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very different from the standard non-hierarchical cluster methods, where scaling is always an 
issue.)   
 
LCA can be divided into two major classes, namely: (1) clustering of measurements (variables), 
and (2) clustering of cases.  To illustrate, for cluster analysis of measurements / variables, the 
columns of the array in Table 1 may be partitioned according to similarity (e. g. correlations, 
distance measures, etc).  In cluster analysis of cases the rows of this array are grouped 
together according to case characteristics.   
 
 
TABLE 1. The two major classes of cluster analysis 
 
 
 
 
 
Case Sample  
Dimension 
(or  
Observations  
Dimension) 
 
 
 
 
Variable Dimension (or Measurement Dimension) 
Ite
m
 1
 
Ite
m
 2
 
Ite
m
 3
 
Ite
m
 4
 
Ite
m
 5
 
Ite
m
 6
 
Ite
m
 7
 
…
…
. 
Ite
m
 1
0 
         
         
         
         
         
         
         
         
         
         
         
         
         
  94
 4.2.3 Data analysis 
By means of Latent Gold 3.0, a computer program appropriate for LCA, cluster analysis of the 
OCD cases included in this data matrix was done; the data matrix in its entirety consisted of 261 
OCD patients who responded to the 45 selected items of the YBOCS-CL, i.e. the data matrix 
comprised a 261 X 45 table (patients X symptoms).   
 
As discussed before (Chapter 2: Methods), the example of other researchers (e.g. Baer (1994) 
and Summerfeldt et al. (1999)) was followed by including ratings of current symptoms (i.e. 
present=1, or absent=0) in the analysis, since inaccuracies or bias in participants’ recall of non-
current symptoms may have influenced results.  (In other words, symptoms reported only as 
“past” symptoms, were for the sake of the current analysis marked as “absent”). 
 
The YBOCS-CL that was implemented actually comprised 74 items with each item representing 
a single obsessive or compulsive symptom.  Interestingly, in addition to the easily categorized 
and clinically well-recognized OCD symptoms, the YBOCS-CL also contains a number of ‘other’ 
and ‘miscellaneous’ OCD symptoms.  The ‘other’ items allow the interviewer to include 
symptoms specific to the participant being rated.  As the content of these customized items was 
expected to be unique for each person, and the item content therefore not standardized, 
inclusion of these items in the present analysis would not have been psychometrically sound, 
and were therefore excluded from the analysis.  Similarly, the so-called ‘miscellaneous’ 
obsessive and compulsive items were also excluded from these analyses.   
 
The procedure for LCA entailed testing each model in an iterative fashion, i.e. a one-class 
solution was fitted first, followed by two-, three-, and four-class solutions and so forth, until the 
“best” solution was obtained.  The best fitting solution was determined by the evaluation of the 
chi-squared test statistic for fit.  Another criterion taken into consideration to ensure that this 
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was the best model likelihood was based on the fact that the difference between the log-
likelihood of the previous and the current class approximated a chi-squared distribution - if this 
difference was greater than the critical chi-squared statistic, then the current class provided a 
better fit to the data than the previous class.   
 
A further aim of the study was to investigate the association of the identified clusters with 
additional data not included in the LCA, i.e. specific demographic information (age, gender 
distribution) and clinical variables including specific OC symptoms, treatment response, total 
OCD severity and trauma history.     
 
 
4.3 Results 
 
4.3.1 Application of LCA to the YBOCS-CL data 
One of the first lessons learned when implementing the cluster analysis approach of LCA, was 
that a sparse learning set could affect the outcome of the analysis adversely.  For example, if 
the number of nominal indicators (the OC symptoms) used in the cluster analysis was large with 
respect to the number of cases (261 observations or cases for this study), the procedure of LCA 
resulted in asymptotic problems in the estimation process.  In this analysis it was clear from the 
outset that all 45 YBOCS-CL items could not be included in the clustering process if reliable 
output was to be obtained.   
 
There were numerous combinations (absence / presence) of the 45 OC symptoms that could 
have been studied or investigated.  If, for example, ten symptoms were studied, there were 
1024 (=210) different combinations (on the vertices of a hypercube) of strings consisting of 
zeroes and ones.  (See the Methods section in this chapter for an explanation of ‘zeroes’ and 
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‘ones’.)  Not all of these 1024 different combinations were represented in the outcomes, as 
evident in the learning sample of 261 individuals (observations).  If each of the 261 individuals in 
this sample had a different set of the ten selected OC symptoms, there would still have been a 
set of 763 (1024-261) combinations (or outcomes) not represented in the learning set, likely due 
to very low probabilities of those particular outcomes.   
 
Tables 2, 3, and 4 provide illustrations of the marginal frequency and joint frequencies of the 
zero/one-combinations for some of the YBOCS-CL items reported most frequently. 
 
 
TABLE 2. Marginal frequency table of the two most frequently occurring OC symptoms as 
assessed with the YBOCS-CL 
 
Absent Present Marginal rate or incidence
Mental compulsions  
(Item nr 45) 92 169 64.8% 
Checking that did not make 
mistake (Item nr 38) 121 140 53.6% 
 
 
TABLE 3. Joint frequency table of the two most frequently occurring OC symptoms as 
assessed with the YBOCS-CL 
Checking that did not 
make mistake 
(Item nr 38) 
Mental compulsions 
(Item nr 45) 
Frequency Relative Incidence 
Absent Absent 60 23.0% 
Absent Present 61 23.4% 
Present Absent 32* 12.3% 
Present Present 108** 41.4% 
* The minimum cell frequency for the two most frequently occurring OC symptoms was equal to 32 (i.e. reported by 12.3% of the 
sample. 
** The maximum cell frequency was 108 (incidence: 41.1%). 
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Turning the attention to the four most frequently reported OC symptoms (Table 4), it is clear that 
the minimum cell frequency was equal to 3 (incidence: 1.1%) whereas the maximum cell 
frequency was 42 (incidence: 16.1%).  If the occurrences of these four OC symptoms were 
approximately evenly distributed throughout the sixteen cells described by these indicators, the 
frequencies would have varied approximately between 10 and 22 (expected count = 261 / 16 ≈ 
16).   
 
 
TABLE 4. Joint frequency table of the four most frequently occurring OC symptoms as 
assessed with the YBOCS-CL 
Item nr 11a Item nr 40b Item nr 38c Item nr 45d 
Frequency of 
individuals*,** 
Relative 
Incidence 
Absent Absent Absent Absent 33 12.6% 
Absent Absent Absent Present 30 11.5% 
Absent Absent Present Absent 4 1.5% 
Absent Absent Present Present 12 4.6% 
      
Absent Present Absent Absent 5 1.9% 
Absent Present Absent Present 9 3.4% 
Absent Present Present Absent 6 2.3% 
Absent Present Present Present 39 14.9% 
      
Present Absent Absent Absent 19 7.3% 
Present Absent Absent Present 13 5.0% 
Present Absent Present Absent 9 3.4% 
Present Absent Present Present 15 5.7% 
      
Present Present Absent Absent 3 1.1% 
Present Present Absent Present 9 3.4% 
Present Present Present Absent 13 5.0% 
Present Present Present Present 42 16.1% 
 
Item nr 45d Mental Compulsions  Item nr 40b Re-reading or re-writing 
Item nr 38c Checking that did not make mistake Item nr 11a Concern with dirt or germs  
* Frequency of individuals with the preceding combination 
** The four highest frequencies of individuals with the preceding combination are in bold type. 
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From the Stem-and-Leaf Diagram (Figure 1) of the frequencies present in the sixteen cells, it 
can be deduced that only five observed frequencies were contained in the interval between 10 
and 22.  The high frequencies of OC symptoms (i.e. 30, 33, 39 and 42) especially confirmed the 
presence of clustering (Table 4).   
 
 
FIGURE 1. Stem-and-Leaf Diagram of the frequencies of individuals / cases present  
in the 16 cells in the joint distribution of the four highest OC symptoms (items 
nr 11, 40, 38 and 45) 
Stem Leaves 
034 
056999 
1233 
159 
2 
2 
303 
39 
42 
4 
 
 
The distribution of the cell frequencies for higher dimensional tables was also investigated - for 
example, when using the nine indicators (items / OC symptoms) with the highest marginal 
incidences.  In the study of these nine OC symptoms, 512 (=29) different sequences of ‘Absent’ 
and ‘Present’ strings or cells could be formed to describe any outcome.  A Stem-and-Leaf 
Diagram (Figure 2) was constructed for the frequencies present in the 512 cells in the joint 
distribution of the nine most frequently occurring OC symptoms.  The majority of the cells were 
empty (or zero), i.e. 362 out of 512 possible combinations (cells) of the nine OC symptoms.  In 
other words, no individual cases satisfied these 362 OC symptom combinations.  From the 
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frequency distribution, it is clear that a further 107 cells contained single occurrences.  The rest 
of the distribution is also available in Figure 2.  The largest frequency in this 9-way table was 25 
occurring in the cell where all the OC symptoms were absent.  In contrast, in the cell where all 
nine OC symptoms were present, the frequency was 8.  Again, both these relatively high 
frequencies confirm the presence of clustering.    
 
(Figure 2 follows on the next page.) 
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FIGURE 2. Stem-and-Leaf Diagram of the frequencies present in the 512 cells in the joint 
distribution of the nine most frequently occurring OC symptoms* 
Stem Leaves 
Frequency 
of cells 
Empty Cells 00000 00000 00000 00000 00000 00000………………………………… 00000 00 362
1 00000 00000 ………………………………… 00000 00000 00 107
2 00000 00000 00000 00000 00 22
3 00000 00000 10
4 00000 00 7
5  0
6  0
7  0
8 0 1
9 0 1
10 0 1
11  0
12  0
13  0
14  0
15  0
16  0
17  0
18  0
19  0
20  0
21  0
22  0
23  0
24  0
25 0 1
 Total number of cells 512
*The nine most frequently occurring YBOCS-CL items are items nr 11, 27, 30, 34, 38, 40, 42, 43, and 45 
 
 
If the unusual assumption of evenly distributed occurrences over the 512 cells were made, the 
expected count per cell was 0.51 (261 / 512).  By this criterion the 9-way table would be 
assumed to be sparse.  The same conclusion was reached by studying the observed marginal 
frequency table.  Forty-three of the cell frequencies were equal to 2 or more, confirming the 
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presence of clustering within this 9-way table.  It may be observed that the proportion of very 
small frequencies increased as the dimensions increased (compare the proportion of small 
frequencies in Tables 3 and 4).   
   
Importantly, the deductions made and models derived after the application of any statistical 
technique depend on the data used as a learning set.  In this investigation, various groups 
(partitions) of the OC symptoms were used as exploratory learning sets.  The frequency of 25 
(the maximum) originated from the cell (absent, absent …… absent); thus, for 25 individuals 
none of the nine OC symptoms were present.  From the experience gained in applying LCA, it 
was learned that estimation problems occurred when applied to data that would have given rise 
to sparse frequency arrays.   
 
Importantly, when using additional indicators in LCA, the potential for computational instability 
increased.  Interestingly, the one OC symptom definitely not considered for methodological 
reasons due to its low prevalence (only 9 out of a total sample of 261 cases), was YBOCS-CL 
item nr 7: ‘Fear will steal things’.   
 
In summary, the motivation for concentrating on the nine most prevalent OC symptoms for LCA 
as assessed with the YBOCS-CL was that the LCA technique selected for application worked 
efficiently when the multi-way contingency table was not too sparse.  For the 9-way table under 
consideration, 362 of the cells were equal to zero.  However, the Latent Class technique 
appeared to handle sparse data better than a likelihood estimation approach for higher order 
interactions.  The extra benefit of this approach was to confirm the presence of clusters in the 
data for the nine most prevalent OC symptoms.  Similar to multi-way contingency table analysis, 
the estimation and inferential process was more efficient when the marginal rates or 
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probabilities (of the different OC symptoms) were close to 50%.  This was the case for the nine 
most prevalent OC symptoms.   
 
4.3.2 Application of LCA to the nine most frequent indicators (OC symptoms)  
The cluster module of LCA offered an opportunity to find ‘optimal’ partitions (clusters) of the 261 
observations / cases.  Given the fact that in this type of analysis the definitions and context of 
the OC symptoms are of importance, the 9 most frequently reported OC symptoms are listed 
below with their YBOCS-CL item numbers and the frequency of occurrence of each (Table 5).   
 
 
TABLE 5. The YBOCS-CL item descriptions and numbers of the nine most prevalent OC 
symptoms and the frequency of occurrence of each in 261 OCD patients 
Order  Item 
number 
Frequency / Number 
of times an item was 
reported  
Item description 
1 45 169 Mental compulsions 
2 38 140 Checking that did not make a mistake 
3 40 126 Re-reading or re-writing 
4 11 123 Concern with dirt or germs 
5 43 108 Ordering / arranging compulsions 
6 34 105 Checking locks, stove, appliances, etc. 
7 42 105 Counting compulsions 
8 30 100 Excessive or ritualised hand washing 
9 27 95 Need for symmetry or exactness not accompanied by magical thinking 
 
 
An investigation of the associations amongst the nine most prevalent YBOCS-CL items / OC 
symptoms suggested that some of these items were very strongly related to one another (e.g. 
YBOCS-CL items number 11 and 30, and 38 and 40 respectively).  Surprisingly, item nr 27 
(“Need for symmetry or exactness not accompanied by magical thinking”) was neither 
significantly associated with item nr 43 (“Ordering / arranging compulsions”), nor with any of the 
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other eight OC symptoms (Table 6).  These associations amongst the nine YBOCS-CL items 
may have had an impact on the way in which the clusters were formed.  For example, one of 
the cells in this 9-way table contained 25 individuals (see Figure 2) in a particular cell indicating 
that there was clustering present where the mean or expected number of individuals per cell 
was 0.51. 
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TABLE 6. Graphical display of associations between the nine most prevalent symptoms* 
 
* The thicker the connecting line between items, the stronger the association (all significant) 
Checking locks,
stoves, etc Mental
Item nr 34 compulsions Item nr 45
Checking for
mistakes Item nr 38
Re-reading
& re-writing Item nr 42
Item nr 40 Counting
compulsions
Item nr 30 Item nr 11 Item nr 43
Excessive or ritualised Concern with Ordering/
hand washing dirt and germs arranging
compulsions
Item nr 27
Need for symmetry or
exactness
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Table 7 provides information used to decide on the optimal number of clusters present when the 
information in the nine most frequent indicators (OC symptoms) was utilised.  Basically, as 
noted before, the procedure of LCA requires fitting a one-class solution first, followed by two-, 
three-, and four-class solutions and so forth, until the best solution is obtained.  More 
specifically, if the Bootstrap p-value for each cluster set was significant (e. g. p<0.05), it 
indicated that ‘Model fit’ was not achieved.   
 
A measure of model ‘fit’ was whether the added information, proceeding from an ‘N-cluster’ to 
an ‘N+1-cluster’, was significant.  For example, the Four-cluster model displayed sufficient fit on 
the 5% level (Bootstrap p-value 0.0623); however, the information added by the fourth cluster 
was highly significant (p-value of the difference: 7.49E-10).  Subsequently, studying the test 
statistics of the Five-cluster model, it could be observed that the fit of the model has improved 
(Bootstrap p-value = 0.1175), but the p-value of the difference suggests that it was still useful to 
include the fifth cluster.  At the level of the Six-cluster model, the fit improved further (Bootstrap 
p-value = 0.1963); however, the p-value of the difference was equal to 2.2% suggesting that it 
may be useful to include an additional cluster.  Considering the Seven-cluster model, it was 
evident that the fit was still sufficient but that the seventh cluster did not add much to the 
improvement of the fit, given that the p-value of the difference was now not significant 
(0.35567).  In conclusion, the Six-cluster model provided the best fit for the data used. 
 
 
(Table 7 follows on the next page.) 
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TABLE 7. Model fitting statistics for the nine indicators (OC symptoms) occurring most 
frequently 
1-Cluster Model 
Chi-Squared Statistics     
Degrees of freedom (df) 502 p-value 
Bootstrap
p-value Standard error 
L-squared (L²) 748.6667 5.10E-12 0 0
Calculated measures     
Bootstrap p-value - L² estimate Not calculable; p-value = 0  
     
2-Cluster Model 
Chi-Squared Statistics     
Degrees of freedom (df) 492 p-value 
Bootstrap
p-value Standard error 
L-squared (L²) 489.3347 0.52 0 0
Calculated measures     
Bootstrap p-value - L² estimate Not calculable; p-value = 0  
     
3-Cluster Model 
Chi-Squared Statistics     
Degrees of freedom (df) 482 p-value 
Bootstrap
p-value Standard error 
L-squared (L²) 405.9986 0.99 0.001 0.0005
Calculated measures     
Bootstrap p-value - L² estimate 583.6697    
     
4-Cluster Model 
Chi-Squared Statistics     
Degrees of freedom (df) 472 p-value 
Bootstrap
p-value Standard error 
L-squared (L²) 364.1514 1 0.0623 0.0038
Calculated measures     
Bootstrap p-value - L² estimate 520.0649    
Associated degrees of freedom  10   
Difference between measures of fit 63.60   
p-value of the difference  7.49E-10   
     
5-Cluster Model 
Chi-Squared Statistics     
Degrees of freedom (df) 462 p-value 
Bootstrap
p-value Standard error 
L-squared (L²) 335.1637 1 0.1175 0.0051
Calculated measures     
Bootstrap p-value - L² estimate 498.3485    
Associated degrees of freedom  10   
Difference between measures of fit 21.72   
p-value of the difference  0.016616   
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6-Cluster Model 
Chi-Squared Statistics     
Degrees of freedom (df) 452 p-value 
Bootstrap
p-value Standard error 
L-squared (L²) 309.3184 1 0.1963 0.0063
Calculated measures     
Bootstrap p-value - L² estimate 477.5052    
Associated degrees of freedom  10   
Difference between measures of fit 20.84   
p-value of the difference  0.022213   
     
7-Cluster Model 
Chi-Squared Statistics     
Degrees of freedom (df) 442 p-value 
Bootstrap
p-value Standard error 
L-squared (L²) 290.2815 1 0.197 0.0063
Calculated measures     
Bootstrap p-value - L² estimate 467.1411    
Associated degrees of freedom  10   
Difference between measures of fit 11.02   
p-value of the difference  0.355666   
     
8-Cluster Model 
Chi-Squared Statistics     
Degrees of freedom (df) 432 p-value 
Bootstrap
p-value Standard error 
L-squared (L²) 275.533 1 0.1533 0.0057
Calculated measures     
Bootstrap p-value - L² estimate 462.059    
Associated degrees of freedom  10   
Difference between measures of fit 5.08   
p-value of the difference  0.885631   
 
 
Focussing the attention to the comparison of the Six-Cluster solution with a Four-Cluster 
solution (which also demonstrated good fit) (Table 8), it may be suggested that a Four-Cluster 
solution may be advantageous to describe a simpler structure in the data.  Nevertheless, the 
sample size allowed the identification of the six clusters, which arguably rendered a better 
understanding of the relevant data.  Importantly, the two solutions did not show a significant 
difference (Test statistic chi-squared = 592.83; p value = 0.000).  
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TABLE 8. Frequencies of patients with a Six-cluster solution vs a Four-cluster solution* 
Four-cluster solution  Six-cluster 
solution I II III IV Total 
I 58    58 
II  54 1  55 
III 3  3 47 53 
IV 29  8  37 
V 4 20 9  33 
VI   25  25 
Total 94 74 46 47 261 
*Test statistic chi-squared = 592.83; p value = 0.000 
 
 
Focussing the attention on the comparison between the Six-cluster and Four-cluster solution 
with the genders separated, the findings again suggested that the solutions (Four- vs Six-) were 
similar (males: Test statistic chi-squared = 305.11; p value = 0.000; females: Test statistic chi-
squared = 286.69; p value = 0.000).   
 
 4.3.3 Characterization of the six identified clusters 
The cluster sizes (i.e. number of patients included in each) were equal to 58, 55, 53, 37, 33 and 
25 for the six clusters, respectively.  The 261 cases were more or less evenly distributed 
amongst the six clusters with the smallest frequency in Cluster 6 (N=25).   
 
Based on their associated clinical features, the identified clusters can be described and labelled 
as follows:  
The first cluster was largest (58 cases) with strong associations with the OC symptoms of 
checking for mistakes, mental compulsions (including the repeating of special words, images, 
numbers, prayers, mental counting, list-making and reviewing of conversations) and re-reading / 
re-writing and was therefore labelled ‘Predominantly mental compulsions’.  Cluster II was 
associated with the highest OCD severity scores for both genders and was labelled ‘Maximal 
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disorder‘.  Cluster III was labelled ‘Minimal disorder’ as the patients in Cluster III had the lowest 
mean OCD severity score and the lowest frequency of associated OC symptoms.  Cluster IV 
was negatively associated with checking, i.e. none of the patients included in this cluster 
reported checking for mistakes or very few reported checking of doors, locks etc, and was 
therefore labelled ‘No checking compulsions’.  Given the very strong positive association with 
checking (for mistakes) (100% of patients on Cluster V), Cluster V was labelled ‘Checking 
compulsions’.  A very strong positive association with contamination fears and related 
compulsions was noted for Cluster VI, justifying the label of ‘Pure Contamination compulsions / 
washing’.   
 
To gain further insight into the structure of these identified clusters, attention was turned to the 
way in which clusters differed with respect to (i) the nine OC symptoms included in the LCA, (ii) 
gender and (iii) age distribution, (iv) total OCD-severity, (v) treatment response, and (vi) 
childhood trauma history.   
 
4.3.3.i   The relationship of each of the nine most prevalent OC symptoms with the 
six clusters of cases  
In the next few tables, the findings of the present investigation of the relationship of the six 
clusters with each of the nine most frequently reported OC symptoms are shown.  The column 
percentages of the absence and presence of the corresponding YBOCS-CL item were 
calculated for each cluster and compared to the general rate of this particular YBOCS-CL item 
within the study sample.  The data are presented in order of decreasing occurrence frequency 
of the YBOCS-CL items. 
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The most frequently occurring YBOCS-CL item, item nr 45 (‘Mental compulsions’), was 
positively associated with Cluster I (88%) and negatively associated with Cluster III (28%) 
(Table 9). 
 
 
TABLE 9. The distribution of the absence or presence of YBOCS-CL item nr 45 ‘Mental 
compulsions’ in the six clusters 
 Cluster Number and Label  
Item nr 45 Data 
I 
Predominantly 
mental 
compulsions 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No checking 
compulsions 
V 
Checking 
compulsions 
VI 
Pure 
Contamination 
compulsions / 
washing Total 
Absent Count 7 14 38 8 10 15 92 
 Column % 12% 25% 72% 22% 30% 60% 35% 
Present Count 51 41 15 29 23 10 169 
 Column % 88% 75% 28% 78% 70% 40% 65% 
Column Totals 58 55 53 37 33 25 261 
 
 
In Table 10, the strong positive associations between YBOCS-CL item 38 (‘Checking that did 
not make a mistake’) and Clusters V (100%), II (95%) and I (91%) are shown.  This OC 
symptom also showed a strong negative association with Clusters IV (0%), VI (0%) and III (4%).    
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TABLE 10. The distribution of the absence or presence of YBOCS-CL item nr 38 ‘Checking 
that did not make a mistake’ in the six clusters  
 Cluster Number  
Item nr 38  
I 
Predominantly 
mental 
compulsions 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No checking 
compulsions 
V 
Checking 
compulsions 
VI 
Pure 
Contamination 
compulsions / 
washing Total 
Absent Count 5 3 51 37 0 25 121 
 Column % 9% 5% 96% 100% 0% 100% 46% 
Present Count 53 52 2 0 33 0 140 
 Column % 91% 95% 4% 0% 100% 0% 54% 
Column Totals 58 55 53 37 33 25 261 
 
 
YBOCS-CL item nr 40 (‘Re-reading or re-writing’) was positively associated with Clusters I 
(76%) and II (76%).  It showed a negative association with Cluster III (6%) (Table 11).   
 
 
TABLE 11. The distribution of the absence or presence of YBOCS-CL item nr 40 ‘Re-reading 
or re-writing’ in the six clusters 
 Cluster Number  
Item nr 40  
I 
Predominantly 
mental 
compulsions 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No checking 
compulsions 
V 
Checking 
compulsions 
VI 
Pure 
Contamination 
compulsions / 
washing Total 
Absent Count 14 13 50 29 12 17 135 
 Column % 24% 24% 94% 78% 36% 68% 52% 
Present Count 44 42 3 8 21 8 126 
 Column % 76% 76% 6% 22% 64% 32% 48% 
Column Totals 58 55 53 37 33 25 261 
 
 
YBOCS-CL item nr 11 (‘Concern with dirt or germs’) was reported absent by all of the cases 
included in Cluster I, i.e. no association between this OC symptom and Cluster I (0%), but it 
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showed a positive association with Clusters II (96%) and VI (96%).  This OC symptom (item nr 
11) was also, to a lesser extent, positively associated with Cluster V (85%), and, also to a lesser 
extent, negatively associated with Cluster III (17%) (Table 12). 
 
 
TABLE 12. The distribution of the absence or presence of YBOCS-CL item nr 11 ‘Concern with 
dirt or germs’ in the six clusters 
 Cluster Number   
Item nr 11  
I 
Predominantly 
mental 
compulsions 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No checking 
compulsions 
V 
Checking 
compulsions 
VI 
Pure 
Contamination 
compulsions / 
washing Total 
Absent  Count 58 2 44 28 5 1 138 
 Column % 100% 4% 83% 76% 15% 4% 53% 
Present Count  53 9 9 28 24 123 
 Column % 0% 96% 17% 24% 85% 96% 47% 
Column Totals 58 55 53 37 33 25 261 
 
 
There was a strong positive link between YBOCS-CL item 43 (‘Ordering / arranging 
compulsions’) and Cluster II (87%), while there was a strong negative link with Clusters III (0%), 
V (12%) and VI (16%), respectively (Table 13).   
 
(Table 13 follows on the next page.) 
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TABLE 13. The distribution of the absence or presence of YBOCS-CL item nr 43 ‘Ordering / 
arranging compulsions’ in the six clusters 
 Cluster Number  
Item nr 43  
I 
Predominantly 
mental 
compulsions 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No checking 
compulsions
V 
Checking 
compulsions 
VI 
Pure 
Contamination 
compulsions / 
washing Total 
Absent Count 30 7 53 13 29 21 153 
 Column % 52% 13% 100% 35% 88% 84% 59% 
Present Count 28 48 0 24 4 4 108 
 Column % 48% 87% 0% 65% 12% 16% 41% 
Column Totals 58 55 53 37 33 25 261 
 
 
The OC symptom described by YBOCS-CL item nr 34 (‘Checking locks, stove, appliances, etc.’) 
was positively linked to Cluster II (69%) whereas this item showed a negative association with 
Clusters VI (8%), III (13%) and IV (16%), respectively (Table 14). 
 
 
TABLE 14. The distribution of the absence or presence of YBOCS-CL item nr 34 ‘Checking 
locks, stove, appliances, etc.’ in the six clusters 
 Cluster Number  
Item nr 34  
I 
Predominantly 
mental 
compulsions 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No checking 
compulsions
V 
Checking 
compulsions 
VI 
Pure 
Contamination 
compulsions / 
washing Total 
Absent Count 25 17 46 31 14 23 156 
 Column % 43% 31% 87% 84% 42% 92% 60% 
Present Count 33 38 7 6 19 2 105 
 Column % 57% 69% 13% 16% 58% 8% 40% 
Column Totals 58 55 53 37 33 25 261 
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Table 15 indicates the positive association of item nr 42 (‘Counting compulsions’) with Clusters 
II (65%) and IV (65%), and the strong negative association with Clusters III (0%) and VI (4%).   
 
 
TABLE 15. The distribution of the absence or presence of YBOCS-CL item nr 42 ‘Counting 
compulsions’ in the six clusters 
 Cluster Number  
Item nr 42  
I 
Predominantly 
mental 
compulsions 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No checking 
compulsions
V 
Checking 
compulsions 
VI 
Pure 
Contamination 
compulsions / 
washing Total 
Absent Count 27 19 53 13 20 24 156 
 Column % 47% 35% 100% 35% 61% 96% 60% 
Present Count 31 36 0 24 13 1 105 
 Column % 53% 65% 0% 65% 39% 4% 40% 
Column Totals 58 55 53 37 33 25 261 
 
 
Table 16 indicates that YBOCS-CL item nr 30 (‘Excessive or ritualized handwashing’) was not 
associated with Cluster I (0%), but was definitely positively associated with Cluster VI (100%).  
In addition, this OC symptom also showed a strong positive association with Clusters II (75%) 
and V (79%), and a strong negative association with Cluster III (4%).  
 
(Table 16 follows on the next page.) 
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TABLE 16. The distribution of the absence or presence of YBOCS-CL item nr 30 ‘Excessive or 
ritualised hand washing’ in the six clusters 
 Cluster Number  
Item nr 30  
I 
Predominantly 
mental 
compulsions 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No checking 
compulsions
V 
Checking 
compulsions 
VI 
Pure 
Contamination 
compulsions / 
washing Total 
Absent Count 58 14 51 31 7 0 161 
 Column % 100% 25% 96% 84% 21% 0% 62% 
Present Count 0 41 2 6 26 25 100 
 Column % 0% 75% 4% 16% 79% 100% 38% 
Column Totals 58 55 53 37 33 25 261 
 
 
YBOCS-CL item nr 27 (‘Need for symmetry or exactness not accompanied by magical thinking’) 
was definitely not associated with Clusters III (0%) and V (0%).  This OC symptom was 
positively associated with Cluster II (82%) (Table 17). 
 
 
TABLE 17. The distribution of the absence or presence of YBOCS-CL item nr 27 ‘Need for 
symmetry or exactness not accompanied by magical thinking’ in the six clusters  
 Cluster Number  
Item nr 27  
I 
Predominantly 
mental 
compulsions 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No checking 
compulsions
V 
Checking 
compulsions 
VI 
Pure 
Contamination 
compulsions / 
washing Total 
Absent Count 35 10 53 17 33 18 166 
 Column % 60% 18% 100% 46% 100% 72% 64% 
Present Count 23 45 0 20  0 7 95 
 Column % 40% 82% 0% 54% 0% 28% 36% 
Column Totals 58 55 53 37 33 25 261 
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 4.3.3.ii   The gender distribution within the six clusters 
The gender distribution within the six clusters (Table 18) was relatively even except for Clusters 
IV and VI which included as few as 13 (35%) and as many as 15 (60%) males, respectively.     
 
 
TABLE 18. The gender distribution within the six clusters 
 Cluster Number 
Gender  
I 
Predominantly 
mental 
compulsions 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No checking 
compulsions
V 
Checking 
compulsions 
VI 
Pure 
Contamination 
compulsions / 
washing Total 
Male Count 28 26 30 13 19 15 131 
  Column % 48% 47% 57% 35% 58% 60% 50% 
Female Count 30 29 23 24 14 10 130 
  Column % 52% 53% 43% 65% 42% 40% 50% 
Total  58 55 53 37 33 25 261 
Column %  100% 100% 100% 100% 100% 100% 100% 
 
 
 4.3.3.iii   The age distribution within the six clusters 
In Table 19 the descriptive statistics of the age at the time of the interview of the patients were 
studied with respect to gender within the six clusters.  The average age of the male group (31.6 
years) was younger than that of the female group (36.7 years).  The lowest average age for 
males was 25.6 years in Cluster V, whereas the highest average age was 38.1 years for males 
in Cluster II.  For females, the lowest average age was 34.3 years in Cluster VI, and the highest 
average age was 39.2 years in Cluster III.  It was interesting to observe that for the males the 
difference between the minimum and maximum average age within the clusters was more than 
12 years and much less for the corresponding range for the females (5 years).   
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TABLE 19. The descriptive statistics of age with respect to gender within the six clusters  
 Cluster Number  
Gender  
I 
Predominantl
y mental 
compulsions 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No checking 
compulsions
V 
Checking 
compulsions 
VI 
Pure 
Contaminatio
n 
compulsions / 
washing Total 
Male Count 28 26 30 13 19 15 131 
 Average age 35.3 38.1 29.6 27.5 25.6 28.7 31.6 
 StdDev 11.5 9.8 8.4 8.6 9.4 9.2 10.5 
 Min 16 24 18 16 16 16 16 
 Max 55 54 55 47 59 44 59 
Female Count 30 29 23 24 14 10 130 
 Average age 35.3 36.0 39.2 37.9 36.8 34.3 36.7 
 StdDev 12.9 14.4 14.2 15.1 17.9 15.9 14.5 
 Min 16 18 18 16 16 19 16 
 Max 59 69 61 63 65 71 71 
Count All 58 55 53 37 33 25 261 
Average age All 35.3 37.0 33.8 34.2 30.4 30.9 34.1 
StdDev All 12.1 12.3 12.2 14.0 14.5 12.3 12.9 
Min All 16 18 18 16 16 16 16 
Max All 59 69 61 63 65 71 71 
 
 
 4.3.3.iv   Total OCD severity within each of the six clusters 
In the total sample, OCD severity scores (on the YBOCS-SS) ranged from 8 to 39 (i.e. from mild 
to very severe), with a mean score of 21.1 ± 6.4.  In a comparison of the medians of the 
YBOCS-SS scores in all six clusters (using Kruskal-Wallis One-way ANOVA on ranks), it was 
found that the clusters did not differ significantly from one another (Figures & tables illustrating 
the comparison of medians amongst the clusters are available from the candidate upon 
request.)  
 
Turning the attention to the possible associations between the total OCD severity score and the 
genders within each of the different clusters, Table 20 indicates that OCD severity was the 
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mildest in males in Cluster III (15.7).   A similar tendency was observed for the females in 
Cluster III (20.0).  However, compared to the males where a relatively big difference was noted 
between the smallest and second smallest mean severity score (15.7 Æ 19.1), the difference 
between the smallest and second smallest mean for females with OCD was much less (20.0 Æ 
20.6).  For both males (24.7) and females (23.4) in Cluster II, OCD severity was highest.  
Compared to the other clusters, the standard deviation of the mean OCD severity score for 
females in Cluster IV was largest (SD = 8.2), suggesting a large variation in OCD severity in the 
female patients included in this cluster.    
 
 
TABLE 20. The associations between the total OCD severity score and the genders within 
each of the clusters 
 Cluster Number  
Gender  
I 
Predomina
ntly mental 
compulsion
s 
II 
Maximal 
disorder 
I 
Minimal 
disorder 
IV 
No 
checking 
compulsion
s 
V 
Checking 
compulsion
s 
VI 
Pure 
Contaminat
ion 
compulsion
s / washing Total 
Male Count 28 26 30 13 19 15 131 
 
Average OCD severity  
score (YBOCS-SS) 21.7 24.7 15.7 19.1 22.7 21.0 20.7 
 Standard deviation  5.5 5.3 4.2 4.9 6.1 6.5 6.1 
 Minimum 9 16 8 10 10 9 8 
 Maximum 38 36 24 26 33 32 38 
Female Count 30 29 23 24 14 10 130 
 
Average OCD severity  
score (YBOCS-SS) 20.6 23.4 20.0 20.6 21.9 21.9 21.4 
 Standard deviation 6.2 5.8 6.9 8.2 7.1 6.0 6.7 
 Minimum 10 12 9 10 12 16 9 
 Maximum 33 35 35 37 39 33 39 
Count  58 55 53 37 33 25 261 
Average OCD severity score (YBOCS-SS) 21.1 24.0 17.6 20.1 22.4 21.4 21.0 
Standard deviation  5.8 5.5 5.9 7.2 6.5 6.2 6.4 
Minimum  9 12 8 10 10 9 8 
Maximum  38 36 35 37 39 33 39 
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 4.3.3.v   Comparison amongst clusters in terms of treatment response 
Focussing the attention to the treatment response in the six identified clusters, 41 and 177 of 
the total sample of patients (in 6 clusters) reported an adequate treatment trial of CBT and SRI, 
respectively.  (Tables illustrating the frequency of patients in each cluster treated with CBT and 
SRI’s are available from the candidate.) 
 
 4.3.3.v.a   Response to CBT in the six clusters 
The six clusters did not differ significantly from one another in terms of their response to CBT 
(Table 21).  Of the 22 patients in Cluster I who received an adequate trial of CBT, 68% (N=15) 
reported improvement (whether it was minimal, much or very much).  Similarly, twenty-two 
(N=22) of Cluster II received CBT, with 68% of those reporting improvement.  In Cluster III, the 
improvement was more marked, i.e. 90% of the patients with prominent Cluster III-symptoms 
reported improvement.  79% of Cluster IV (N treated = 14), 57% of Cluster V (N treated = 14) 
and 70% of Cluster VI (N treated = 10) reported improvement of their illness when treated with 
CBT.  Interestingly, only one person (in Cluster II) was much worse after receiving CBT.  From 
Table 21 it is also clear that response to CBT was better for patients with lower total OCD 
severity.   
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TABLE 21.               OCD severity scores of patients according to response to CBT in Clusters I – VI:  All patients (N = 261) 
                        RESPONSE TO CBT: CGI – IMPROVEMENT CATEGORIES  
CLUS-
TERS 
 Very much 
improved 
Much improved Minimally improved No change Minimally worse Much worse (blank) Total 
I Patient frequency 2 6 7 6 1 — 36 58 
 Mean severity score (Y-BOCS-SS) 17.50 22.67 16.29 21.33 25.00 — 21.83 21.10 
 StdDev  4.95 7.53 4.64 3.67 — — 5.82 5.81 
 Minimum 14 10 10 15 25 — 9 9 
 Maximum 21 30 24 25 25 — 38 38 
II Patient frequency 5 3 7 6 — 1 33 55 
 Mean severity score (Y-BOCS-SS) 22.60 23.00 23.14 23.17 — 22.00 24.73 24.02 
 StdDev  5.73 10.44 5.08 3.60 — — 5.72 5.54 
 Minimum 18 16 16 17 — 22 12 12 
 Maximum 32 35 30 28 — 22 36 36 
III Patient frequency 3 11 12 3 — — 24 53 
 Mean severity score (Y-BOCS-SS) 20.33 15.64 17.50 18.33 — — 18.13 17.60 
 StdDev  12.70 4.41 3.94 1.53 — — 6.70 5.88 
 Minimum 13 9 12 17 — — 8 8 
 Maximum 35 24 25 20 — — 30 35 
IV Patient frequency 1 5 5 3 — — 23 37 
 Mean severity score (Y-BOCS-SS) 12.00 16.00 19.80 20.33 — — 21.35 20.08 
 StdDev  — 5.24 10.21 0.58 — — 7.21 7.19 
 Minimum 12 10 10 20 — — 10 10 
 Maximum 12 22 34 21 — — 37 37 
V Patient frequency 1 2 5 6 — — 19 33 
 Mean severity score (Y-BOCS-SS) 24.00 22.50 23.60 19.83 — — 22.74 22.36 
 StdDev  — 6.36 4.28 6.43 — — 7.33 6.47 
 Minimum 24 18 16 12 — — 10 10 
 Maximum 24 27 26 27 — — 39 39 
VI Patient frequency — 2 5 3 — — 15 25 
 Mean severity score (Y-BOCS-SS) — 21.00 21.60 21.67 — — 21.27 21.36 
 StdDev  — 4.24 6.66 11.68 — — 5.66 6.18 
 Minimum — 18 14 9 — — 14 9 
 Maximum — 24 32 32 — — 33 33 
Total patient frequency 12 29 41 27 1 1 150 261 
Total Mean severity score (Y_BOCS-SS) 20.42 18.76 19.78 21.00 25.00 22.00 21.86 21.05 
Total StdDev 
7.40 6.53 6.00 5.11 — — 6.58 6.42 
Total Minimum 12 9 10 9 25 22 8 8 
Total Maximum 35 35 34 32 25 22 39 39 
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 4.3.3.v.b   Response to SRI’s in the six clusters 
The six clusters did not differ significantly from one another in terms of their response to 
medication (Table 22).  Thirty-six Cluster I-patients were treated with at least one adequate trial 
of medication (SRIs), with 86% reporting improvement.  Eighty-two percent (82%) of 28 patients 
in Cluster II reported improvement with medication.  Of the 38 patients in Cluster III who were 
treated with medication, 79% reported improvement.  Eighty-two percent (82%) of Cluster IV (N 
treated = 22), 69% of Cluster V (N treated = 26) and 82% of Cluster VI (N treated = 17) reported 
improvement of their OC symptoms when treated with medication.  Again, as with CBT, there 
was only one person (in Cluster IV) who reported that the illness was very much worse after 
medication treatment.   
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TABLE 22.               OCD severity scores of patients according to response to medication in Clusters I – VI:  All patients (N = 261) 
  RESPONSE TO MEDICATION: CGI-IMPROVEMENT CATEGORIES  
CLUS-
TERS  
Very much improved Much improved Minimally improved No change Minimally worse Much worse (blank) Total 
I Patient frequency 5 18 8 5 — — 22 58 
 Mean severity score (Y_BOCS-SS) 14.00 21.28 21.00 21.80 — — 22.45 21.10 
 StdDev  5.70 7.09 4.28 3.83 — — 4.68 5.81 
 Minimum 9 10 14 15 — — 14 9 
 Maximum 23 38 25 24 — — 32 38 
II Patient frequency 6 15 10 7 — — 17 55 
 Mean severity score (Y_BOCS-SS) 22.50 22.67 26.50 23.29 — — 24.59 24.02 
 StdDev  5.50 5.22 5.38 6.24 — — 5.70 5.54 
 Minimum 17 16 17 12 — — 16 12 
 Maximum 32 35 36 29 — — 35 36 
III Patient frequency 3 16 11 8 — — 15 53 
 Mean severity score (Y_BOCS-SS) 15.33 18.44 14.36 19.38 — — 18.60 17.60 
 StdDev  3.21 6.32 4.95 4.57 — — 6.58 5.88 
 Minimum 13 10 8 13 — — 8 8 
 Maximum 19 35 25 25 — — 30 35 
IV Patient frequency 4 11 3 3 — 1 15 37 
 Mean severity score (Y_BOCS-SS) 20.00 19.18 25.00 21.33 — 16.00 19.80 20.08 
 
StdDev  
6.16 9.11 7.00 8.96 — — 6.28 7.19 
 Minimum 11 10 18 11 — 16 10 10 
 Maximum 25 37 32 27 — 16 34 37 
V Patient frequency 3 7 8 6 2 — 7 33 
 Mean severity score (Y_BOCS-SS) 18.00 20.00 22.50 23.00 28.00 — 24.29 22.36 
 StdDev  6.00 6.81 7.73 5.33 1.41 — 6.32 6.47 
 Minimum 12 10 15 13 27 — 12 10 
 Maximum 24 29 39 27 29 — 33 39 
VI Patient frequency 3 7 4 3 — — 8 25 
 Mean severity score (Y_BOCS-SS) 20.00 21.29 22.25 25.33 — — 20.00 21.36 
 StdDev  11.53 5.99 4.35 8.33 — — 4.93 6.18 
 Minimum 9 14 18 16 — — 14 9 
 Maximum 32 33 28 32 — — 29 33 
Total patient frequency 24 74 44 32 2 1 84 261 
Total Mean severity score (Y_BOCS-SS) 18.54 20.51 21.25 22.03 28.00 16.00 21.64 21.05 
Total StdDev 6.59 6.76 6.93 5.64 1.41 — 5.98 6.42 
Total Minimum 9 10 8 11 27 16 8 8 
Total Maximum 32 38 39 32 29 16 35 39 
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4.3.3.vi   Comparison amongst clusters in terms of childhood trauma history 
An investigation of the extent in which the six clusters differed from one another in terms of 
total childhood interpersonal trauma history (assessed with the CTQ) using Kruskal-Wallis 
one-way ANOVA on ranks suggested that the clusters were similar.  Similarly, focussing on 
particular instances of childhood trauma, it was found that the clusters were more or less 
equal in terms of emotional, physical, or sexual abuse, as well as emotional or physical 
neglect.   (Tables & figures [box plots] illustrating the comparison of medians of total 
childhood interpersonal trauma history and of particular instances of childhood trauma in the 
6 clusters are available from the candidate.)  It is clear (from some of the figures) that there 
were a few exceptions in terms of levels of reported interpersonal childhood trauma; for 
example, some of the patients included in Cluster I and Cluster II reported more sexual 
abuse and physical neglect, respectively, than average for that cluster. 
 
 
4.4 Discussion 
 
In this investigation, LCA was conducted in an iterative manner; 1- to 8- class solutions were 
tested on the data.  The findings support the existence of six (6) classes / clusters of OCD 
cases who were not significantly different in terms of total OCD severity, and response to 
treatment with CBT or SRIs.  The clusters were also not different in terms of their reported 
childhood interpersonal trauma history (with a few exceptions).     
 
The first cluster was largest (58 cases) and was labelled ‘Predominantly mental 
compulsions’.  Given the large number of cases included in this cluster, and the fact that 
mental compulsions also comprised the OC symptom that was reported most frequently by 
the total OCD sample (see Chapter 3), the strong associations found between Cluster I and 
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the OC symptoms of checking for mistakes, mental compulsions (including the repeating of 
special words, images, numbers, prayers, mental counting, list-making and reviewing of 
conversations) and re-reading / re-writing were not surprising.  Interestingly, none of the 
patients included in this cluster had contamination fears (i.e. concern with dirt or germs) or 
related compulsions (i.e. excessive or ritualised hand-washing).  Interestingly, Abramowitz 
et al. (2003) have found that mental compulsions were most prevalent among patients with 
intrusive, upsetting religious, violent or sexual thoughts.  In this LCA study however, these 
types of symptoms were not included.  In addition, in a previous study the presence of 
obsessions with a sexual / religious content was an unique factor related to poorer long term 
outcome (Alonso et al., 2001); this is in contrast to the present findings that, compared to 
the other identified clusters, Cluster I had the largest number of patients (31 out of 36, 86%) 
reporting improvement with medication.   
 
The findings suggest that Cluster II was strongly associated with a wide range of different 
OC symptoms, including obsessions with contamination and the obsessive need for 
symmetry / exactness, as well as related compulsions including washing, ordering / 
arranging, checking (for mistakes and doors/ locks, etc.), and other repeating rituals such as 
counting and re-reading/re-writing.  The wide array of symptoms associated with Cluster II 
made selection of an appropriate label difficult; nevertheless, given that Cluster II was also 
associated with the highest OCD severity scores (on the YBOCS-SS) for both genders 
(24.0), it was labelled ‘Maximal disorder‘.  Compared to the average age of male patients in 
other clusters, the males in Cluster II were oldest, i.e. 38.1 years at the time of the interview.   
 
Cluster III was labelled ‘Minimal disorder’ as the patients in Cluster III had the lowest mean 
OCD severity score (17.6) and the lowest frequency of associated OC symptoms.  Given 
the relatively weak associations with all of the OC symptoms analysed, it may be suggested 
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that this particular class of patients may have presented with symptoms other than the 9 
included in the current LCA.  The females included in this cluster had the highest age (39.2 
years) compared to those in other clusters.  Compared to the other clusters, Cluster III had 
the largest number of patients reporting improvement with CBT (i.e. 90%, or 26 out of 29 
patients who had been treated with an adequate trial of CBT).  Some studies have 
suggested that severity of OCD may predict pharmacotherapy outcome; for example, 
Alarcon et al. (1993) found that higher YBOCS-SS scores were associated with poorer 
response to medication.  No consistent predictors of outcome have been identified for the 
psychotherapy of OCD yet.  Indeed, there is a relative absence of documentation 
concerning the outcome of BT for OC symptoms other than washing and checking.  It may 
be hypothesized though that the link between Cluster III and the comparatively best 
response to CBT may possibly be explained by the low OCD severity scores and not by the 
specific symptoms presented by patients included in Cluster II.  More work is needed to 
investigate this issue further. 
 
Cluster IV was negatively associated with checking, i.e. none of the patients included in 
Cluster IV reported checking for mistakes or very few reported checking of doors, locks etc.  
In addition, Cluster IV patients were mostly female (65%).  There was a relatively strong 
positive association with counting compulsions.  This cluster was labelled ‘No checking 
compulsions’.  Although more work is needed to look at gender distribution of OC checkers, 
it has previously been suggested that males more often present with checking compulsions 
(Khanna and Mukherjee, 1992); this is consistent with the finding that this cluster 
characterized by “limited” or no checking consisted mostly of females.   
 
Cluster V was similar to Cluster II in some respects, including symptomatology (including 
obsessions with contamination and related compulsions, and checking), and overall OCD 
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severity (Cluster V was associated with the second highest severity score on the YBOCS-
SS after Cluster II, i.e. 22.4).  In contrast, however to Cluster II, the patients included in 
Cluster V did not report obsessions with symmetry / exactness and ordering / arranging 
compulsions.  Given the very strong positive association with checking (for mistakes) (100% 
of patients on Cluster V), Cluster V was labelled ‘Checking compulsions’.  The “checking” 
subtype has been identified in a number of OCD FA studies, with some studies suggesting a 
strong association with male gender (e.g. more checking behaviour in boys (Zohar, 1999)).  
The findings in the present study also suggest the presence of more males (58%) than 
females (42%) in Cluster V; however this difference was not significant.      
 
A very strong positive association with contamination fears (i.e. concern with dirt or germs) 
(96% of patients) and related compulsions (hand-washing) (100% of patients) was noted for 
Cluster VI.  In contrast to the other clusters which also showed a positive association with 
these contamination-related symptoms, this cluster was not strongly associated with 
checking, or ordering / arranging.  Therefore, the label chosen for this cluster was ‘Pure 
Contamination compulsions / washing’.  Identification of a cluster of patients with mostly 
contamination fears and related compulsions was expected, given that this subgroup has 
been identified in all previous factor analyses.  The gender distribution of Cluster VI was 
uneven as well, with males comprising 60% of this group.  There is much stronger evidence 
in the literature for a link between washing and female gender (Bogetto et al., 1999; Castle 
et al., 1995; Geller et al., 1998; Lensi et al., 1996; Marks, 1987; Minichiello et al., 1990; 
Rachman and Hodgson, 1980; Stern and Cobb, 1978).  Very few findings to the contrary, 
e.g. increased contamination obsessions in males (Fischer et al., 1997), exist.  
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4.5 Limitations 
 4.5.1 Latent class analysis 
As noted before, LCA methodology was chosen for this investigation of OCD subtypes as it 
resolved many of the problems associated with FA (e.g. requiring all variables to be 
continuous, or assuming that underlying latent variables [factors] are measured on an 
interval or ratio scale).  Nevertheless, the LCA technique also had limitations.  In particular, 
LCA has primarily been applied in confirmatory applications involving a relatively small 
number of variables.  Recent advances have suggested that LCA may also be applicable to 
larger exploratory settings (such as this OCD dataset), but this has not yet been tested 
comprehensively.   
 
 4.5.2 Content and number of identified clusters 
Perhaps the most prominent concern relates to the clinical applicability of the LCA findings.  
It has previously been argued that (pure) symptoms are of key importance in defining 
groups of OCD patients (Leckman et al., 1997).  To an extent, the findings here similarly 
suggest that some groups or classes are characterized by “pure” symptoms, e.g. Cluster VI 
(‘Pure contamination compulsions / washing’).  On the other hand, one may argue that 
classes very often are rather characterized by mixed symptoms, e.g. Cluster II (‘Maximal 
disorder’ including a wide variety of OC symptoms), which certainly makes sense from a 
clinical point of view.  Indeed, there is some evidence in support of the latter argument; in 
fact, it is well known that OCD patients mostly present with multiple symptoms at a particular 
point in time, and that these often change over time (Rettew et al., 1992).  Furthermore, in 
addition to Cluster II being characterized by a large variety of different OC symptoms (mixed 
clinical picture), it was also associated with the highest OCD severity.  In summary, existing 
OCD literature and the findings here suggest that, not only does one need to investigate 
OCD phenotypes characterized by pure symptoms or predominantly one type of OC 
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symptom, but also those classes characterized by mixed or a wide array of different OC 
symptoms.     
 
Arguably the consideration of six OCD subtypes or clusters of cases is also not very 
practical.  Based on evidence from previous investigations, it may be argued that OCD may 
possibly be subtyped into fewer, more distinct subtypes, each with unique clinical 
characteristics and treatment outcomes; such data may be more useful in establishing 
etiology and perhaps prognosis in clinical practice. 
 
 4.5.3 Number of indicators / items included in the analysis 
In addition, this dataset comprised 261 OCD cases and 45 variables; however, inclusion of 
more than 9 variables (indicators) into the LCA rendered “unstable” or unreliable output.  
Therefore it was chosen to include the 9 most frequently reported OC symptoms into the 
analyses assuming that these OC symptoms gave a good indication of the symptomatology 
characteristic of the present OCD sample.  Clearly, this assumption may constitute a 
limitation with 9 symptoms perhaps being a very limited representation of OC 
symptomatology in general.  In addition, as in FA, the identified classes / clusters are 
contingent upon the variables entered into the LCA, and this limited number of variables 
entered may have biased findings.  In other words, other symptoms entered may have 
rendered a different solution.  It was clear from the outset however, that all 45 YBOCS-CL 
items could not be included in the LCA if reliable output was to be obtained.  In addition, 
exclusion of so many of the OC symptoms from the analysis is another limitation, given the 
fact that some of these symptoms (hoarding, for example) have been shown to constitute 
(aspects of) important possible OC dimensions in previous studies.  Subsequently, given the 
importance of accurate representation of total OCD symptomatology when subtyping is 
based thereupon, it was attempted to remedy this situation, with implementation of another 
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clustering method using all of the 45 selected YBOCS-CL items (Ward’s method; See 
Chapter 5).  
 
In conclusion, the 6 identified clusters of OCD cases were labelled ‘Predominantly mental 
compulsions’, ‘Maximal disorder’, ‘Minimal disorder’, ‘No checking compulsions’, ‘Checking 
compulsions’, and ‘Contamination compulsions / washing’, respectively.  These clusters did 
not differ significantly from each other in terms of their association with the clinical features 
that were investigated.  Nevertheless, the clusters identified with LCA broadly resembled 
some of the current sub-classifications of OCD symptomatology suggested in the literature.  
More work is needed to address the limitations discussed here. 
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CHAPTER 5 
THE IDENTIFICATION OF OBSESSIVE-COMPULSIVE DISORDER SUBTYPES  
WITH CLUSTER ANALYSIS OF  
OBSESSIVE-COMPULSIVE SYMPTOMATOLOGY 
 
 
Abstract 
This study was an additional attempt to identify OCD subtypes based on their obsessive-
compulsive symptomatology assessed with the Yale-Brown Obsessive-Compulsive 
Symptom Checklist (YBOCS-CL).  Cluster analysis (Ward’s method) was applied to the data 
matrix, which consisted of the responses of 261 OCD patients to 45 selected YBOCS-CL 
items, to develop an empirically based typology for OCD.  An optimal solution was achieved 
for six clusters, which were labeled: I) “Contamination fears / washing”, II) “Hoarding / 
collecting”, III) “Symmetry / ordering / counting / arranging / repeating”, IV) “Sexual”, V) 
“Somatic, religious and diverse” and VI) “Harm-related”.  Increased presentation of 
symptoms characteristic of each of the clusters was associated with specific demographic, 
clinical and, in some cases (i.e. Clusters IV, V and VI), genetic characteristics.  The L/L 
(met/met) genotype of the catechol-O-methyltransferase (COMT) Val158Met polymorphism 
was associated with increased sexual, somatic, religious and diverse, and harm-related 
symptoms of OCD.  Most clusters were significantly correlated with one another.  The 
findings confirm the existence of OCD symptom clusters similar to those obtained in earlier 
studies.  The high correlations amongst clusters, and the fact that clusters were not clearly 
differentiated by their associated demographic, clinical and genetic features, suggest that 
other approaches to optimally characterize the heterogeneity of OCD are still needed.  
However, subtyping OCD based on symptom structure may potentially assist efforts to 
identify more robust endophenotypes. 
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5.1 Introduction 
 
Despite increased research interest in the identification of OCD subtypes and their 
associated features, the existing data are far from definitive and are still subject to revision.  
Therefore, the primary aim of this study was to categorize obsessive-compulsive (OC) 
symptomatology by means of cluster analysis (Ward’s method) of the individual symptoms 
of the Yale-Brown Obsessive-Compulsive Symptom Checklist (YBOCS-CL), in an attempt to 
remedy some of the limitations of the latent class analysis (LCA) of OC symptomatology 
manifested by 261 obsessive-compulsive disorder (OCD) cases that were presented in 
Chapter 4.  Secondly, the associations between the OCD symptom subtypes (the identified 
clusters) and specific demographic, clinical and genetics variables were investigated.   
 
 
5.2 Methodology 
 
 5.2.1 Subjects, interview and genotyping 
This investigation made use of the same YBOCS-CL data obtained from the sample of 261 
patients with OCD (described in Chapters 2 and 4).  As a reminder to the reader, 
interviewing and genotyping procedures are described briefly:  
 
Two hundred and sixty one patients with OCD (N=261), with ages ranging from 16 to 71, 
were included in the study (mean age: 34.1 years (SD: 12.9)).  Of the 261 patients, 130 
were female (mean age: 36.7 years (SD: 14.5)) and 131 male (mean age: 31.6 years (SD: 
10.5)).   
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Demographic data, including current age, age at onset of the illness, gender and ethnicity, 
were obtained).  In addition to the Structured Clinical Interview for Axis I Disorders (SCID-
I/P), selected parts of the SCID-II/P (obsessive-compulsive, avoidant, schizotypal and 
borderline personality disorders, respectively) (First et al., 1998), were used to examine 
lifetime comorbidity.  The SCID-OCSD (Du Toit et al., 2001) was implemented to assess 
comorbid OCD-related conditions not covered by the SCID-I.   
 
The YBOCS-CL, the assessment measure of choice given its extensive use in OCD 
research, was used to assess current OC symptoms.  As noted before, previous factor 
analysis studies based their work on the assumption that the YBOCS-CL is a 
comprehensive checklist of OC symptomatology rendering responses of continuous (or 
ordinal) nature (i.e. absent, present, principal or prominent).  In contrast, the responses of 
the participants to the YBOCS-CL in this project were categorical and binary (present / 
absent).  In other words, the OC symptoms were defined as binary ‘0; 1’ - indicator 
measurements and therefore it was possible to display any combination of symptoms as a 
string of zeroes and ones.  A ‘zero’ represented symptom absence and a ‘one’ the presence 
of a particular OC symptom.  With this data collection, distinction was not made between 
symptoms considered “primary / principal” and “present” as was the case in some previous 
studies.   
 
The presence/absence of tics (current and/or past, motor/vocal) was clinically assessed.   
 
When an adequate trial of pharmacotherapy with a serotonin reuptake inhibitor (SRI) (i.e. at 
least 10 weeks on the medication with a minimum of 6 weeks on mid-range dose) or 
cognitive-behavioural therapy (CBT) (i.e. 8 or more sessions with an expert OCD/CBT 
psychotherapist) had been undertaken, responsivity to pharmacotherapy / psychotherapy 
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was assessed using the global improvement item of the Clinical Global Impression (CGI) 
scale (Guy, 1976).   
 
The self-report Childhood Trauma Questionnaire (CTQ) was used to assess the nature and 
severity of possible childhood interpersonal trauma in the patients (Bernstein et al., 1994).  
Sub-scales of the CTQ include measures of emotional abuse, physical abuse, sexual 
abuse, emotional neglect and physical neglect.  Reliability and validity of the CTQ have 
been well researched and the scale appears to provide a useful measure of childhood 
trauma (Bernstein et al., 1997).   
 
The self-report Temperament and Character Inventory (TCI) (Cloninger et al., 1994) was 
also used to measure behaviours associated with seven personality dimensions, namely 
novelty seeking, harm avoidance, reward dependence, persistence, self-directedness, 
cooperativeness, and self-transcendence.  
 
DNA extracted from venous blood (10-30 ml) in a Caucasian subset of OCD patients 
(N=204), was genotyped to look for polymorphisms in genes involved in monoamine 
function, and previously hypothesized to be relevant to OCD.  The following (7) 
polymorphisms were examined: a 48 base pair (bp) variable number of tandem repeats 
(VNTR) in the third exon of dopamine receptor type 4 (DRD4) (Lichter et al., 1993), a 40bp 
VNTR in the 3’ untranslated region of the dopamine transporter (DAT) (Vandenbergh et al., 
1992), a 44bp insertion/deletion polymorphism in the promoter region of the serotonin 
transporter (5-HTTLPR) (Heils et al., 1996) and restriction fragment length polymorphisms in 
the 5HT1Dβ (G861C) (Sidenberg et al., 1993), the serotonin receptor type 2A (5HT2A ) 
(T102C) (Warren et al., 1993), tyrosine hydroxylase (TH) (Val81Met) (Ishiguro et al., 1998), 
COMT (Val58Met) (Karayiorgou et al., 1997) and MAO-A (C1460T/EcoRV) (Hotamisligil and 
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Breakefield, 1991) genes.  Target genomic fragments, containing these polymorphisms, 
were amplified by means of the polymerase chain reaction (PCR) using published primer 
sequences and protocols (5HT1Dß (Hemmings et al., 2003); 5HT2A T102C (Warren et al., 
1993); DAT VNTR (Vandenbergh et al., 1992) and DRD4 VNTR (Lichter et al., 1993)).   
 
 5.2.2 Cluster analysis of the YBOCS-CL items 
Another type of cluster analysis (i.e. Ward’s method – also appropriate for use with binary 
data (Ward, 1963)) of the nine most frequently occurring OC symptoms was implemented to 
compare these findings with the LCA-data.  This particular analysis classified variables 
(current OC symptoms) compared to the previous attempt where OCD cases were classified 
(Chapter 4).  Subsequently, all of the 45 YBOCS-CL items, each representing a single 
obsessive or compulsive symptom, were included in the cluster analysis to determine 
whether one could identify clearly discernable OCD subgroups or symptom subtypes based 
on this much larger set of indicators.   
 
 5.2.3 Data analysis 
Selected YBOCS-CL items, each representing a current and single obsessive or compulsive 
symptom, were used for the cluster analyses.  Selection of items followed the example of 
previous factor analytic studies (e.g. Baer, 1994; Summerfeldt et al., 1999), where only 
ratings of current symptoms (i.e. present=1, or absent=0, with ratings of “past” symptoms=2 
converted to “absent”=0) were included in the cluster analysis, since inaccuracies or bias in 
participants’ recall of non-current symptoms may have influenced results.  The YBOCS-CL 
also contains a number of ‘other’ and ‘miscellaneous’ OCD symptoms, which were 
excluded.  (For detailed reasoning behind exclusions, please refer to Chapter 4).   
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For each respondent, cluster scores were obtained by the calculation of the mean scores for 
each cluster.  The associations of the identified clusters of OC symptoms with demographic 
variables (age, gender), clinical variables (age of onset, OC symptom severity, level of 
insight, temperament, childhood trauma, treatment response) and genotypes were 
examined.  An association study between OCD clusters and the selected polymorphisms 
was performed using the cluster scores as quantitative phenotypes.  The association 
analyses were performed using Spearman correlations, one-way analysis of variance 
(ANOVA) and Mann-Whitney U-tests, as appropriate.  Since the probability plots showed 
that the residuals were not normally distributed, and in some cases, the presence of 
heteroscedasticity, non-parametric tests were used to investigate the associations among 
the patient cluster scores and the selected variables.  The present genetic investigations 
were conducted using a Caucasian subset of the interviewed OCD patients (N=204, males: 
N=107, females: N=97).  This subset was not divided further (into e.g. Afrikaners / non-
Afrikaners) given the relatively low numbers of available DNA-samples of OCD patients for 
genetic analyses.   
 
 
5.3 Results 
 
5.3.1 Cluster analysis of the nine most prevalent OC symptoms 
At the 1.0 linkage distance level, cluster analysis of the nine most frequently occurring OC 
symptoms (YBOCS-CL items) obtained three clusters (Figure 1): 
1.) Cluster I, subsequently termed “Checking and repeating”, included mental 
compulsions, counting, re-reading / re-writing, checking for mistakes, and checking 
locks, stove, appliances, etc. 
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2.) Based on the content of the two symptoms included in Cluster II, it was subsequently 
termed “Symmetry, exactness, ordering, arranging”. 
3.) Cluster III also included two symptoms and based on their content was subsequently 
termed “Contamination and washing”.   
 
(Figure 1 follows on the next page.) 
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FIGURE 1. Cluster analysis (Ward’s method) results: Tree Diagram for nine YBOCS-CL  
items* 
Item nr 45
Item nr 42
Item nr 40
Item nr 38
Item nr 34
Item nr 43
Item nr 27
Item nr 30
Item nr 11
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
Li
nk
ag
e 
D
is
ta
nc
e
 
 
 CLUSTER I CLUSTER II CLUSTER III 
 
 
 
 
CLUSTERS YBOCS-CL 
item number 
Item description* 
45 Mental compulsions 
42 Counting compulsions 
40 Re-reading or re-writing 
38 Checking that did not make a mistake 
I 
34 Checking locks, stove, appliances, etc. 
43 Ordering / arranging compulsions II 
27 Need for symmetry or exactness not accompanied by magical thinking 
30 Excessive or ritualised hand washing III 
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5.3.2 Cluster analysis of 45 YBOCS-CL items (OC symptoms) 
Given the ease with which this programme managed to cluster the 9 indicators / items, it 
was decided to proceed with cluster analysis (Ward’s Method, using the Statistica computer 
software package) of all of the 45 selected YBOCS-CL items.  (The way in which these 
items were selected was described in detail in Chapters 3 and 4.) 
At the 1.5 linkage distance level, cluster analysis of these 45 OC symptoms included in the 
YBOCS-CL rendered 6 clusters (Figure 2): 
1.) Cluster I was termed “Contamination fears / washing”, and included items referring 
to contamination or related fears or cleaning / washing rituals. 
2.) Cluster II was termed “Hoarding / collecting”, including both hoarding / collecting 
items of the YBOCS-CL. 
3.) Cluster III included two “strands” of symptoms; firstly, symptoms related to 
obsessions with symmetry and order as well as ordering and arranging compulsions, 
and secondly, a number of “repetitive rituals”, including mental compulsions (e.g. 
reviewing conversations), counting, ‘repeating’ compulsions (e.g. opening and 
closing the door, or getting up and sitting down repeatedly), re-reading / re-writing 
and checking (doors, locks, appliances, for mistakes, etc.).  This cluster was 
subsequently termed “Symmetry / ordering / counting / arranging / repeating”. 
4.) Cluster IV was termed “Sexual” and included all of the YBOCS-CL sexually-related 
obsessive-compulsive symptoms (including ‘forbidden or perverse sexual thoughts / 
images / impulses’, and ‘sexual behaviour towards others (aggressive)’. 
5.) Cluster V was termed “Somatic, religious and diverse” given the inclusion of a 
number of body-focused as well as religion-based symptoms together with a varying, 
apparently non-related, array of other obsessive-compulsive symptoms in this 
cluster.  For example, in addition to concerns focused on bodily appearance or 
health (e.g. body dysmorphic fears, fears of illness / disease, fears of getting others 
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ill) and related (e.g. checking appearance) compulsions, other symptoms such as an 
obsessive fear of acting embarrassingly, and an obsession with symmetry and order 
accompanied by magical thinking, were also included in Cluster V. 
6.) Cluster VI included most of the aggressive or harm-related obsessions and related 
compulsions of the YBOCS-CL (e.g. ‘fear will harm self’ and ‘fear will harm others’) 
and was subsequently termed “Harm-related”. 
 
(Figure 2 follows on the next page.) 
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FIGURE 2. Cluster analysis results: Tree Diagram for 45 YBOCS-CL items 
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CLUSTERS YBOCS-CL 
item number 
Item description* 
14 Excessive concern with animals (e.g. insects) 
13 Excessive concern with household items (e.g. cleaners, solvents) 
12 Excessive concern with environmental contaminants (e.g. asbestos, radiation, toxic 
waste) 
15 Bothered by sticky substances or residues 
33 Other measures (than those in item 32) to prevent or remove contact with 
contaminants 
32 Compulsions involving cleaning of household items or other inanimate objects 
31 Excessive or ritualised showering, bathing, teeth brushing, grooming or toilet 
routine 
30 Excessive or ritualised handwashing 
11 Concern with dirt or germs 
CLUSTER I: 
Contamination fears / 
washing 
10 Concerns or disgust with bodily waste or secretion (e.g. urine, faeces and saliva) 
44 Hoarding / Collecting compulsions CLUSTER II: 
Hoarding / collecting 23 Hoarding / Saving obsessions 
43 Ordering / Arranging compulsions 
27 Obsession with need for symmetry or exactness - Not accompanied by magical 
thinking  
45 Mental compulsions (e.g. special words, prayers, images, numbers repeated 
mentally or repeated in set manner to neutralise anxiety; mental reviewing e.g. 
reviewing of conversations) 
42 Counting compulsions 
41 Need to repeat routine activities (e.g. in / out door, up / down from chair, i.e. 
repeating rituals) 
40 Re-reading or re-writing 
38 Checking that I did not make a mistake 
34 Checking locks, stove, appliances, etc. 
CLUSTER III: 
Symmetry / ordering / 
counting / arranging / 
checking / repeating 
7 Fear that I will steal things 
22 (Obsession with) sexual behaviour toward others (aggressive) 
20 Content (of obsession) involves children or incest 
21 Content (of obsession) involves homosexuality 
CLUSTER IV: 
Sexual 
19 Forbidden or perverse sexual thoughts / images / impulses 
26 Obsession with need for symmetry or exactness - Accompanied by magical 
thinking (e.g. concerned that mother will have accident unless things are in the 
right place) 
18 No concern with consequences of contamination other than how it might feel 
17 Concerned that I will get others ill by spreading contamination (aggressive) 
39 Checking tied to somatic obsessions 
28 Concern with illness or disease 
16 Concerned that I will get ill because of contaminant 
25 Excessive concern with right / wrong, morality 
24 Concerned with sacrilege and blasphemy  
29 Excessive concern with a body part or an aspect of appearance (e.g. 
dysmorphophobia) 
5 Fear of doing something else embarrassing 
CLUSTER V: 
Somatic, religious 
and diverse 
4 Fear of blurting out obscenities or insults 
37 Checking that nothing terrible did / will happen 
36 Checking that I did not / will not harm self 
9 Fear that I will be responsible for something else terrible happening (e.g. fire, 
burglary) 
8 Fear that I will harm others because of not being careful enough (e.g. hit/run MVA) 
35 Checking that I did not / will not harm others 
2 Fear that I might harm others 
6 Fear that I will act on unwanted impulses (e.g. to stab friend) 
3 Violent or horrific images 
CLUSTER VI: 
Harm-related 
1 Fear that I might harm myself 
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5.3.3 Clinical comparison data of the 6 identified clusters 
The following significant results were found: 
1.) Higher Cluster I-scores (i.e. “Contamination fears / washing”) were significantly 
associated with higher total OCD severity scores on the YBOCS-SS (r = 0.29; p < 
0.001).  An increase in Cluster I-scores was associated with comorbid specific 
phobia (Mann-Whitney U (MWU): p = 0.01), or anorexia nervosa (AN) (MWU: p = 
0.03), and trichotillomania (TTM) (MWU: p = 0.02).  Adult OCD patients (aged 18 
years or older) with comorbid obsessive-compulsive personality disorder (OCPD) (N 
= 100; p = 0.01) or borderline personality disorder (BPD) (N = 45; p = 0.01) also 
presented with higher Cluster I-scores. 
2.) Higher Cluster II-scores (i.e. “Hoarding / collecting”) were significantly associated 
with older age at the time of the interview (r = 0.22; p < 0.001).  Significantly higher 
Cluster II-scores were found in patients with dysthymia (MWU: p = 0.03), generalized 
anxiety disorder (GAD) (MWU: p = 0.01), and hypochondriasis (MWU: p = 0.01).  
Adult OCD patients with comorbid OCPD (N = 100; p < 0.001) presented with higher 
Cluster II-scores.   
3.) Higher Cluster III-scores (“Symmetry / ordering / counting / arranging / checking / 
repeating”) were significantly associated with younger age of OCD onset (r = -0.15; p 
= 0.03), and higher total OCD severity on the YBOCS-SS (r = 0.30; p < 0.001).  OCD 
patients with higher Cluster III-scores showed lower cooperativeness on the TCI (r = 
-0.23; p = 0.02).  Patients with any of the comorbid Axis I - disorders did not present 
with significantly higher Cluster III-scores or increased symmetry / ordering / 
counting / arranging / checking / repeating symptoms.  In terms of personality 
disorders, patients with OCPD (N = 100; p < 0.001) or BPD (N = 45; p = 001) 
presented with higher Cluster III-scores.  
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4.) Patients with higher Cluster IV-scores (“Sexual”) were significantly younger at the 
time of the interview (r = -0.16; p = 0.01).  Male patients had higher scores on this 
cluster (MWU: p = 0.001).  Higher scorers showed an association with good insight 
(into the excessiveness or senselessness of OC symptoms) (MWU: p = 0.04).  
Comorbidity with hypersexual disorder (MWU: p = 0.002) or tics (MWU: p = 0.002) 
was associated with higher Cluster IV-scores. 
5.) Higher Cluster V-scores (“Somatic, religious and diverse”) were associated with 
younger age at the time of the interview (r = -0.15; p = 0.01) and younger age of 
onset of OCD (r = -0.19; p = 0.004).  There was a significant association with higher 
total OCD severity scores on the YBOCS-SS (r = 0.13; p = 0.03).  OCD patients had 
significantly higher Cluster V-scores when comorbid with social anxiety disorder 
(SAD) (MWU: p = 0.02); specific phobia (MWU: p = 0.02), GAD (MWU: p = 0.003), 
body dysmorphic disorder (BDD) (MWU: p < 0.01), self-injury (MWU: p = 0.04) and 
hypersexual disorder (MWU: p = 0.02) (both ‘Impulse Control Disorders, Not 
Otherwise Specified’ (ICD NOS) in DSM-IV), respectively.  Comorbidity with BPD (N 
= 45; p < 0.01) was associated with higher Cluster V-scores.  
6.) Higher Cluster VI-scores (“Harm-related”) were associated with younger age at the 
time of the interview (r = -0.20; p = 0.001), and younger age of OCD onset (r = -0.25; 
p < 0.001).  Significantly higher Cluster VI-scores were evident in OCD patients with 
comorbid BDD (MWU: p < 0.05), IED (MWU: p < 0.01), self-injury (MWU: p < 0.01), 
hypersexual disorder (MWU: p = 0.03), or BPD (N = 45; MWU: p = 0.001).  
 
None of the identified clusters were significantly associated with either treatment 
response (medication or CBT), scores on the CTQ dimensions of emotional / physical / 
sexual abuse or emotional / physical neglect specifically, or with scores on the TCI 
temperament dimensions of novelty seeking, harm avoidance, or reward dependence.  
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Most of the cluster scores of the different identified symptom clusters were highly 
correlated with one another (Table 1); in other words, an increase in, for example, 
Cluster VI-symptoms would suggest increased presentation of symptoms included in 
Clusters I to V.  The highest correlations (i.e. r > 0.45) were found between Clusters V 
and VI (r = 0.0489) and Cluster V and I (r = 0.454).  Cluster III were moderately 
correlated with Clusters I (r = 0.291), VI (r = 0.271), and II (r = 0.261), respectively.  
Lowest correlated (although still significantly) were Clusters I and VI (r = 0.138).   
 
 
TABLE 1. Correlations (Spearman) amongst Clusters I – VI  
  CLUSTER  
I 
CLUSTER  
II 
CLUSTER 
III 
CLUSTER 
IV 
CLUSTER 
V 
CLUSTER 
VI 
Spearman r 1 0.045 0.291** -0.002 0.454** 0.138* CLUSTER I: 
Contamination 
fears / washing 
p-value --- NS 0.000 NS 0.000 0.026 
Spearman r 0.045 1 0.261** -0.016 0.159** 0.175* CLUSTER II: 
Hoarding / 
collecting 
p-value NS --- 0.000 NS 0.01 0.005 
Spearman r 0.291** 0.261** 1 -0.023 0.218** 0.271** CLUSTER III: 
Symmetry / 
ordering / 
counting / 
arranging / 
checking / 
repeating 
p-value 0.000 0.000 --- NS 0.000 0.000 
Spearman r 0.002 -0.016 -0.023 1 0.200** 0.205** CLUSTER IV: 
Sexual  p-value NS NS NS --- 0.001 0.001 
Spearman r 0.454** 0.159** 0.218** 0.200** 1 0.489** CLUSTER V: 
Somatic, 
religious and 
diverse 
p-value 0.000 0.01 0.000 0.000 --- 0.000 
Spearman r 0.138* 0.175* 0.271** 0.205** 0.489** 1 CLUSTER VI: 
Harm-related  p-value 0.026 0.005 0.000 0.001 0.000 --- 
**. Correlation is significant at the 0.01 level  
*. Correlation is significant at the 0.05 level 
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5.3.4 Molecular analyses: OC clusters with selected polymorphisms 
The significant results of the association analysis (ANOVA) performed on the seven 
(7) polymorphisms and six cluster scores distributions are summarized in Tables 2 
and 3.  One of the 7 polymorphisms that were studied showed a significant 
association with some of the symptom clusters.  In the Caucasian subset of the total 
interviewed sample, patients carrying the L/L (met/met) genotype of the COMT 
Val158Met polymorphism scored significantly higher on Cluster IV (“Sexual”) (p < 
0.001), Cluster V (”Somatic, religious and diverse”) (p = 0.004) and Cluster VI 
(“Harm-related”) (p = 0.018) than those with the H/H (val/val) or H/L (val/met) 
genotypes, respectively (Table 2).  Allelic comparisons were performed using the 
Mann-Whitney U-test (Table 3).  There were significant differences in the Cluster IV-, 
V- and VI- mean scores for the alleles of COMT for OCD patients.  Patients carrying 
the low activity L (met) alleles were found to score significantly higher on Cluster IV 
(mean: 0.14 ± 0.26), Cluster V (mean: 0.23 ± 0.20) and Cluster VI (mean: 0.29 ± 
0.29) respectively, than those carrying the high activity H (val) alleles (in Cluster IV: 
mean: 0.08 ± 0.20; Mann-Whitney U-test, Z = -2.017; p = 0.04; in Cluster V: mean: 
0.17 ± 0.16; Mann-Whitney U-test, Z = -2.731; p = 0.006; and in Cluster VI: mean: 
0.22 ± 0.26; Mann-Whitney U-test, Z = -2.151; p = 0.03). 
 
 
(Tables 2 and 3 follow on the next page.) 
  150
TABLE 2. Analysis of variance for the three COMT genotypes (Caucasians)  
Clusters Group 1: 
35 val/val 
Group 2: 
93 val/met 
Group 3: 
36 met/met 
F p value 
(I) Contamination fears / 
washing 
0.33 ± 0.34 0.29 ± 0.29 0.27 ± 0.31 0.40 NS 
(II) Hoarding / collecting 0.24 ± 0.41 0.26 ± 0.41 0.32 ± 0.45 0.33 NS 
(III) Symmetry / ordering / 
counting / arranging / 
repeating 
0.40 ± 0.28 0.44 ± 0.27 0.43 ± 0.25 0.33 NS 
(IV) Sexual* 0.11 ± 0.23 0.06 ± 0.17 0.24 ± 0.32 8.95 <0.001 
(V) Somatic, religious and 
diverse** 
0.15 ± 0.16 0.19 ± 0.17 0.29 ± 0.22 5.62 0.004 
(VI) Harm-related*** 0.21 ± 0.25 0.23 ± 0.26 0.37 ± 0.31 4.14 0.018 
* Cluster IV:  Group 1 vs 3: p = 0.032; group 2 vs group 3: p < 0.001 
** Cluster V:  Group 1 vs 3: p = 0.005; group 2 vs 3: p = 0.03 
*** Cluster VI: Group 1 vs 3: p = 0.04; group 2 vs 3: p = 0.03 
 
 
TABLE 3. Mann-Whitney U-test for alleles of the COMT Val158Met polymorphism 
Clusters H (val) 
allele 
L (met) 
allele 
Z-adjusted p-level N group H N group L 
(I) Contamination 
fears / washing 
0.31 ± 0.31 0.28 ± 0.30 -0.697 0.49 163 165 
(II) Hoarding / 
collecting 
0.25 ± 0.41 0.29 ± 0.43 -0.690 0.49 163 165 
(III) Symmetry / 
ordering / 
counting / 
arranging / 
repeating 
0.42 ± 0.27 0.44 ± 0.26 -0.474 0.64 163 165 
(IV) Sexual  0.08 ± 0.20 0.14 ± 0.26 -2.017 0.04 163 165 
(V) Somatic, 
religious and 
diverse 
0.17 ± 0.16 0.23 ± 0.20 -2.731 0.006 163 165 
(VI) Harm-related 0.22 ± 0.26 0.29 ± 0.29 -2.151 0.03 163 165 
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5.4 Discussion 
 
The cluster analysis of the nine most frequently reported OC symptoms in a sample of 261 
OCD patients rendered a 3-cluster solution.  This OCD symptom dimension solution was 
consistent with most findings from previous factor analysis (FA) studies (e.g. Leckman et al., 
1997), but differed to an extent from the OC symptom profile of the six clusters of cases that 
were identified with LCA (see Chapter 4).  This is reasonable given that in the current 
chapter, cluster analyses of current OC symptoms (i.e. variables) were done compared to 
the previous investigation where OCD cases were categorized or grouped according to their 
symptoms, i.e. the one method carved out the specific OC symptoms from one another, the 
other method rendered groups in which patients had multiple OC symptoms.   
 
The three clusters or symptom dimensions identified here comprised checking, obsessions 
with symmetry / exactness / ordering and arranging, as well as obsessive contamination 
fears and related compulsions – perhaps also a more useful or “neat” classification than the 
six cluster of cases solution rendered by the LCA of nine OC symptoms.  The comparability 
of the cluster analysis of the nine OC symptoms compared to previous classification 
attempts (and also the omission of other important OC symptoms such as hoarding) 
encouraged subsequent cluster analyses of the 45 selected items of the YBOCS-CL.   
 
Cluster analysis of the 45 selected items of the YBOCS-CL in this sample of OCD patients 
identified 6 separate clusters at the 1.5 linkage distance level.  These clusters were labelled 
as follows: 
I) “Contamination fears / washing”;  
II) “Hoarding / collecting”;  
III) “Symmetry / ordering / counting / arranging / checking / repeating”;  
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IV) “Sexual”;  
V) “Somatic, religious and diverse” and  
VI) “Harm-related”.   
A number of demographic and clinical features defined each cluster and will subsequently 
be discussed.  In terms of genetics, the L/L (met/met) genotype of the COMT Val158Met 
polymorphism was associated with increased sexual, somatic, religious and diverse, and 
harm-related symptoms of OCD.     
 
5.4.1 CLUSTER I: The CONTAMINATION FEARS / WASHING cluster 
The cluster labelled “Contamination fears and washing” has emerged as a separate 
symptom cluster in all previous factor analysis studies.  In this study, patients with increased 
Cluster I-symptomatology had significantly higher YBOCS-SS total severity scores.  
Subsequently, it may be argued that these OC symptoms (related to contamination / 
washing) reflect a more severe form or subtype of OCD.  On the other hand, given the 
relatively high number of patients presenting with this symptom profile, this association may 
have been inflated artificially given the increased statistical power.  The findings also 
suggest that OCD patients with comorbid specific phobia(-s), AN or TTM had more Cluster I 
- symptoms compared to those without these comorbid disorders.  The significant 
phenomenological overlap between the symptoms of OCD and AN, and the frequent 
comorbidity of the two conditions, have been described in many studies (e.g. Fahy et al., 
1993; Hsu et al., 1993).  Similarly, existing comorbidity data have suggested some overlap 
between TTM and OCD (Stein et al., 1995).  However, whether patients with TTM and OCD 
present with increased Cluster I-symptoms in particular needs further investigation.  The 
relationship with specific phobia, AN, TTM, OCPD, BPD and higher severity scores may 
suggest that these may all be severity related rather than related to the specific OC 
symptomatology characterizing Cluster I.  
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5.4.2 CLUSTER II: The HOARDING / COLLECTING cluster 
Similar to most of the previous factor analysis studies, this study also rendered a separate 
hoarding / collecting symptom dimension.  Hoarding may be defined as the acquisition of 
and failure to discard possessions of little use or value to others (Frost and Gross, 1993).  
Clinically significant hoarding results in living spaces being sufficiently cluttered as to 
preclude normal use and activities, and creates considerable distress or impairment in 
functioning (Frost and Hartl, 1996).  Furthermore, hoarding may represent an important 
clinical subtype with different pathophysiology or neuroanatomy in patients with OCD 
(Damecour and Charron, 1998; Fontenelle et al., 2004; Frost and Gross, 1993; Stein et al., 
1999; Winsberg et al., 1999).  Similar to previous studies, our findings suggested that 
patients with OCD who hoard obsessively are older than OCD patients who do not hoard 
(Frost et al., 2000; Saxena et al., 2002).  The finding of an association between a number of 
Axis I-conditions (including mood and anxiety disorders (such as dysthymia and GAD), as 
well as hypochondriasis is consistent with data suggesting that OCD patients with hoarding 
often present with significant anxiety and depression (Frost et al., 2000; Baer, 1994; 
Samuels et al., 2002).  Hoarding may be a symptom of both OCD and OCPD; indeed, in this 
symptom cluster there was also a significant association with OCPD, a finding 
corresponding with epidemiological and genetic reports (Clifford et al., 1984; Lensi et al., 
1996).   
 
5.4.3 CLUSTER III: The SYMMETRY / ORDERING / COUNTING / ARRANGING / 
CHECKING / REPEATING cluster 
The third symptom cluster showed increased symptoms relating to concerns with symmetry, 
ordering, counting, arranging, checking and repeating.  While knowledge of the different 
symptom subtypes of OCD has been expanding much in recent years, relatively little 
attention has been given to this set of symptoms.  Radomsky and Rachman (2004) have 
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recently commented that this neglect is surprising given epidemiological evidence that 
ordering and arranging is one of the more common OCD presentations (Rasmussen and 
Eisen, 1992; Sasson et al., 1997).  Surprisingly, the findings here did not show an 
association between increased Cluster III-symptomatology and the presence of comorbid 
Axis I-disorders.  However, increased comorbidity with OCPD and BPD was noted.   
 
5.4.4 CLUSTER IV: The SEXUAL cluster 
Cluster IV consisted of symptoms such as ‘forbidden or perverse sexual thoughts / images / 
impulses’, ‘(aggressive) sexual behaviour towards others’ and ‘sexual obsessions involving 
children / incest’.  It was found that males with OCD tend to report more of these types of 
symptoms compared to women.  In addition to the sexual symptomatology characterizing 
this cluster, an association with younger age at the time of the interview and comorbidity 
with tics, or hypersexual disorder (HD) was also suggested.  This is consistent with a 
number of studies; for example, sexual symptoms (Bogetto et al., 1999; Lensi et al., 1996) 
as well as comorbid tics (Bogetto et al., 1999; Holzer et al., 1994; Leckman et al., 1994; 
Pauls et al., 1995) have previously been found to be more common in OCD males.  Also, 
there may arguably be an association between tics, male gender, early age of onset, and 
disruptive behaviour disorders in younger OCD patients (Geller et al., 2001).  Of relevance 
here, for example, is the finding that intrusive violent or sexual images and thoughts were 
more likely to be seen in OCD patients with tics (George et al., 1993).  The question may be 
raised whether the association between increased sexual symptomatology and the 
presence of comorbid tics can be explained by the known link between male gender and 
both these factors.  In terms of comorbidity, OCD patients with comorbid HD presented with 
increased (violent) sexual obsessions and/or compulsions.  The findings also suggested that 
higher scorers on Cluster IV had good insight in the excessiveness or senselessness of 
their OC symptoms.  Although a few researchers have posited a relationship between type 
  155
of OCD symptom and level of insight (Damecour and Charron, 1998; Matsunaga et al., 
2002), the available data on the association between insight and symptom subtypes are 
relatively limited and should be investigated further. 
 
5.4.5 CLUSTER V: The SOMATIC, RELIGIOUS AND DIVERSE cluster 
Cluster V, characterized by somatic, religious and diverse symptomatology, did not occur as 
an independent factor in previous factor analysis studies.  However, most of the items 
included in this cluster had a “somatic” or “health-related” focus, which is consistent with the 
high incidence of these symptoms reported in epidemiological studies.  Indeed, it has been 
suggested that 34% of OCD patients present with obsessions concerning bodily (somatic) 
symptoms (Rasmussen and Tsuang, 1986).  As noted previously, OCD patients often have 
somatic concerns (Simeon et al., 1995), including excessive or unfounded concerns about 
body defects, imagined defects in appearance, or concerns about illness (i.e. somatic 
obsessions / related compulsions).  Increased comorbidity with BDD was therefore not 
surprising.  The present findings did not, however, suggest an association between Cluster 
V - symptomatology and hypochondriasis.  The findings did nevertheless suggest an 
association between increased somatic symptoms and GAD.  Similarly, other studies have 
found a higher prevalence of GAD among OCD patients with health concerns (Abramowitz 
et al., 1999).  This is consistent with the findings (Starcevic et al., 1992) that patients with 
GAD exhibit a high rate of hypochondriacal or illness-related symptoms.  In addition, 
patients presenting with these types of symptoms were younger at the time of the interview 
and also reported a younger age of onset of OCD.  Previous reports have suggested that 
OCD patients with early age of onset were characterized by increased severity of OC 
symptoms at baseline (Fontenelle et al., 2003).  Subsequently it may be argued that the link 
between Cluster V and increased OCD severity scores may be explained by the association 
with early onset or possibly with the specific symptomatology characteristic of Cluster V.  
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Also, the relationship with BDD, GAD, HD, self-injury, specific phobia, social anxiety 
disorder and BPD, and higher severity scores may suggest that these may all be severity 
related reather than related to the specific OC symptomatology characterizing Cluster V. 
 
5.4.6 CLUSTER VI: The HARM-RELATED cluster 
Cluster VI encompassed harm-related or aggressive fears and related compulsions.  
Patients that presented with increased harm-related fears and/or related compulsions in this 
study presented with OCD at an earlier age.  The findings also suggest an association 
between this cluster and younger age at the time of the interview.  Increased obsessional 
fear of violence or harm to the self / others with related rituals in patients with prominent 
Cluster I – symptomatology may provide explanations for the increased comorbidity of 
Cluster VI with BDD, IED and perhaps self-injury and BPD as well.  All of these conditions 
involve a degree of destructiveness, whether aimed at the self or others. 
 
5.4.7 Genetics findings 
Genetic findings suggest that Caucasian patients carrying the L/L (met/met) genotype of the 
COMT Val158Met polymorphism had more sexual (Cluster IV -), somatic, religious and 
diverse (Cluster V -), and harm-related (Cluster VI -) symptomatology than those with the 
H/H or H/L genotype, respectively.  Patients carrying the low activity L (met) alleles were 
found to score significantly higher on these clusters than those carrying the H (val) alleles.  
Here, a role for the dopaminergic system in the development of (some subtypes of) OCD 
has been suggested, given the involvement of COMT in the inactivation of catecholamines 
such as dopamine.  Some previous studies of genes involved in monoaminergic 
neurotransmitter systems have also suggested an association between OCD and 
polymorphisms of COMT (Camarena et al., 1998, 2002; Karayiorgou et al., 1997, 1999).  In 
particular, the low activity variant of the COMT gene has previously been associated with 
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OCD in males (Karayiorgou et al., 1997).  However, these findings have not been 
consistently replicated; for example, Alsobrook et al. (2002) observed a significant 
association of OCD with the COMT L allele in females, but not in males, while in a study of 
the Afrikaner population of South Africa, Niehaus et al. (2001) observed an association 
between the increased occurrence of OCD and the H/L genotype irrespective of gender.  
Whether COMT plays a role in the development of Cluster IV-symptomatology, or whether 
the link between COMT (L alleles) and increased Cluster IV-symptoms can be explained by 
the prominence of males with these symptoms, remains an important question.  Focusing 
attention on the Karayiorgou - findings on COMT (Karayiorgou et al., 1997), it may be 
hypothesized that the dominance of males in Cluster IV may explain the link that was found 
between this cluster of symptoms with the low activity variant of COMT.  Conversely, males 
and females did not differ with regards to the extent to which Cluster V-symptoms were 
presented, so that it may be argued that genetics, rather than gender, may have played a 
role in the nature of these symptoms.   
 
Clearly, the existing data on genetics and specific OC symptom subtypes are limited.  
Existing data do however include findings such as those of Alsobrook et al. (1999), the first 
researchers to use the OC symptom dimensions in a family / genetic study.  They have 
found that higher scores on their identified cluster characterized by aggressive / sexual / 
religious obsessions and related compulsions or factors characterized by symmetry / 
ordering were twice as likely to have first-degree family members with OCD compared to 
patients scoring low on these factors.  Given the relatively varying nature of the symptoms 
characteristic of the identified Clusters IV, V and VI, it may be argued that the COMT 
Val158Met polymorphism is involved in the etiology of OCD in general (or perhaps of a 
significant number of symptom subtypes) rather than just with the development of a single 
specific OC symptom subtype.  Furthermore, recent studies have shown that this functional 
  158
polymorphism may influence performance on tests of prefrontal cortex (PFC) (such as 
executive function and working memory) and prefrontal cortex physiologic activity (Callicott 
et al., 2003; Diamond et al., 2004; Egan et al., 2001; Gallinat et al., 2003; Goldberg et al., 
2003; Malhotra et al., 2002; Mattay et al., 2003).  Interestingly, it has been suggested that 
symptoms of PFC dysfunction are characteristic of many psychiatric disorders such as 
OCD; for example, neuro-imaging studies have provided strong evidence that frontal-
subcortical brain circuitry may mediate OCD symptomatology (Saxena et al., 1998).  
Arguably, these findings support the involvement of the COMT genotype in specific 
cognitive dysfunctions, which in turn, may impact on the modulation of (some) OC 
symptoms.  Clearly, the continued search for other vulnerability genes (and the possible 
interaction thereof with other factors such as cognitive load) for the development of specific 
OCD symptom subtypes should remain a priority.   
 
As in Clusters I and II, this investigation did not find a relationship between Cluster III and 
the investigated dopaminergic (and serotonergic) polymorphisms, suggesting that variants 
in other genes in these systems should rather be explored.   
 
 
5.5 Limitations and conclusions 
In summary, in this study it was attempted to find differential associations in the identified 
clusters.  However, in terms of the associations found between, for example, higher OCD 
severity scores and some of the identified symptom clusters (e.g. Clusters I), admittedly 
these may have been artefactual findings that have come up significant given the relative 
higher statistical power (due to higher N) in these clusters compared to others.  
Nevertheless, some of these associated factors may be of particular interest given existing 
or previously replicated data, e.g. early age of onset (characteristic of Clusters III, V and VI).  
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In addition, focusing on the comorbidity patterns of each of the clusters, it may be suggested 
that mood and anxiety comorbidity is lower in some clusters (e.g. Cluster III), while OCPD 
comorbidity is higher in others (e.g. Clusters I to III).  However, again the argument could be 
raised that with large enough sample size, any cluster would be associated with significantly 
increased comorbidity (which in some respects may be indicative of severity).  Furthermore, 
although there was significant phenomenological overlap between Cluster III – symptoms 
(i.e. symmetry / ordering / counting / arranging / checking / repeating) and OCPD, Clusters I, 
II and III have all shown increased comorbidity with OCPD, as was noted before.  What this 
may suggest, is that comorbid OCPD is firstly highly prevalent in OCD in general (consistent 
with existing literature), but also that OCPD may be associated with specific OC symptoms 
such as symmetry or hoarding obsessions / compulsions.  In addition, given the possible 
disability or impairment associated with the presence of OCPD, one may argue that 
comorbidity with OCPD may have played a role in the higher OCD severity scores 
associated with both Clusters I and III.  More work is needed to explore these hypotheses.  
Clearly, analysis of the overlap in findings across clusters is indicated in addition to focusing 
on findings within clusters.   
 
Briefly focusing on a cut-off or linkage distance level of 2.0 (rather than 1.5) in Figure 1 
(illustrating our original cluster analysis results), three clusters - rather than six - remain.  In 
this instance, Cluster I would remain separate, Clusters II and III, and Clusters IV, V and VI 
of the original cluster analysis would be grouped together into Cluster II and III, respectively.  
Using the 6-cluster labels (or combinations thereof), Cluster I would remain “Contamination 
fears / washing”, Cluster II would be labeled “Hoarding / symmetry / ordering / counting / 
arranging / checking / repeating” and “Sexual / somatic / religious / harm-related / diverse” 
would be an appropriate label for Cluster III.  In fact, the significant OCPD comorbidity 
associated with increased Clusters II- and III- scores, and the association found between 
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the L/L (met/met) genotype of COMT Val158Met polymorphism and Clusters IV, V and VI of 
the 6-cluster solution, supports such a 3-cluster solution for the data.  However, it may be 
argued that only three OC symptom clusters would not do justice to the heterogeneous 
phenomenology that is characteristic of OCD.   
 
The limitations of the present data need to be addressed:  Firstly, following the example of 
previous factor analysis studies, only 45 items of the YBOCS-CL were used in the cluster 
analysis.  Ideally, this type of analysis should be performed on all reported symptoms 
without the restriction of an a priori limited pool of items.  In addition, given the known and 
significant phenomenological overlap between OCD and the OC spectrum disorders 
(OCSD’s), as well as the significant comorbidity with OCSD’s in the clusters that were 
identified in this investigation, decisions about the inclusion of more of the symptoms 
characteristic of the putative OCSD’s in OC symptoms checklists (e.g. the YBOCS-CL) need 
to be revisited.  Furthermore, focus on current OC symptoms may be considered a 
limitation.  However, it may be argued that the inaccuracies or bias in patients’ recall of non-
current (past) symptoms may influence results, as such justifying use of current symptoms 
in the analyses.  In the same vein, it has been suggested that the results from data 
reduction techniques such as cluster or factor analysis using symptoms reported at a given 
time should be interpreted with caution given the fact that the majority of patients do not 
maintain their initial symptoms across time (Baer, 1994) and present with multiple types of 
symptoms (Calamari et al., 1999; Khanna et al., 1990; Leckman et al., 1997).  This was an 
exploratory study and we therefore did not correct for multiple testing.  Subsequently, some 
of the significant associations may in fact have been artefactual or the result of error 1.   
 
In conclusion, despite the limitations, the findings here have again substantiated the 
presence of clinical subtypes of OCD.  In particular, a number of OCD symptom subtypes 
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has been identified and described in terms of their associated demographic, clinical and, in 
some cases, genetic features.  These findings significantly overlap with published OCD 
subtyping data; for instance, the six clusters identified here, each with their typical OC 
symptom profile, were similar to the early factor analysis work presented by Leckman et al. 
(1997) (especially when the Clusters IV, V and VI identified here, are combined).  The 
finding that all three of these symptom clusters were associated with the L/L (met/met) 
genotype of the COMT Val158Met polymorphism supports the combination of Clusters IV, V 
and VI.  On the other hand, the associated features (e.g. comorbid disorders such as 
depression, high severity or poor insight) did not clearly or uniquely differentiate clusters 
from one another.  In fact, there were many instances of overlap amongst clusters in this 
regard.  However, some hints, e.g. lack of comorbidity in some clusters, or increased 
comorbidity with OCPD, may be worth following up in future.  Furthermore, the clusters were 
highly correlated with one another; for example, the highest correlation found between 
Cluster V and VI suggesting significant overlap and arguably supporting combining these 
OC symptoms into one cluster, whereas others were correlated to a much lesser extent 
(e.g. Clusters I and VI) suggesting that these clusters should probably remain separate 
clusters.  The high correlations amongst the different clusters nevertheless suggest that 
delineation of OCD into OC symptom clusters is not the best or only way to approach the 
heterogeneity characteristic of OCD.  Nevertheless, our findings support the idea that 
subtyping OCD based on symptom structure is a useful approach given its potential to 
assist in efforts to advance the understanding of OCD and to identify more robust 
endophenotypes.  Finally, the different possible OCD subtypes have not been fully 
delineated yet, and more work remains to be done to fully understand the complex 
heterogeneity of OCD patients – especially in larger samples.   
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CHAPTER 6 
CLUSTER ANALYSIS OF OBSESSIVE-COMPULSIVE SPECTRUM DISORDERS 
IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER 
 
 
Abstract 
While the majority of patients with obsessive-compulsive disorder (OCD) suffer from at least 
one comorbid obsessive-compulsive spectrum disorder (OCSD) in their lifetime, there has 
been relatively little systematic investigation of the structure and implications of such 
comorbidity.  Nevertheless, published data as well as Chapter 5 of this dissertation have 
suggested that OC symptom clusters may be associated with comorbidity with some of the 
OCSD’s.  Subsequently, it has been suggested that comorbidity with certain OCSD’s in 
OCD may also serve to define important OCD subtypes, characterized by differing 
phenomenology and neurobiological mechanisms.  In this chapter, existing literature on the 
comorbidity of OCD with different putative OCSD’s was reviewed.  In addition, a cluster 
analysis of OCSD’s in patients with OCD suggested that comorbid OCSD’s in OCD fall into 
three different clusters (reward dependence, impulsivity, somatic), which are defined by 
different clinical features.  None of these clusters was associated with any particular genetic 
variant.  The clusters of conditions are partially consistent with previous theoretical 
approaches taken towards classifying the OCSD’s.  In conclusion, the lack of genetic 
validation of these clusters in the present study may indicate the involvement of other, as 
yet untested, genes.  Further genetic and cluster analyses of comorbid OCSD’s in OCD may 
ultimately contribute to a better delineation of OCD endophenotypes.  
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6.1 Introduction 
 
Chapter 5 of this dissertation raised the question about the way that the putative obsessive-
compulsive spectrum disorders (OCSD’s) “fit” with the standard OC symptomatology 
outlined in the Yale-Brown Obsessive-Compulsive Symptom Checklist (YBOCS-CL).  Until 
now, this issue has not received that much attention in the literature.  It is clear, however, 
that the OCSD symptoms have significant phenomenological and neurobiological overlap 
with the features of obsessive-compulsive disorder (OCD) and should arguably therefore be 
considered for inclusion in attempts to identify a comprehensive and multidimensional model 
for OC symptom subtypes.  As was suggested before, the expansion of the OCD symptom 
checklists such as the YBOCS-CL is on the cards.  At this stage, the YBOCS-CL contains 
very few items that can be labelled as “OC spectrum symptoms”, suggesting the need for an 
incorporation of the other possible spectrum items from a different scale specifically 
assessing the OCSD’s, such as the SCID-OCSD (Du Toit et al., 2001), into the YBOCS-CL.  
On the other hand, arguably the YBOCS-CL measures one entity, and the SCID-OCSD 
another, suggesting that the items should not be combined for classification purposes.   
 
Comorbidity data (see Chapter 5) nevertheless suggest that OCSD’s in OCD cannot be 
ignored.  In fact, comorbidity of certain OCSD’s in OCD may serve to define important OCD 
subtypes, characterized by differing phenomenology and neurobiological mechanisms.  For 
example, patients with comorbid OCD and Tourette’s disorder (TD) appear to be 
characterized by specific demographic features (they are more likely to be male) and clinical 
characteristics (they are less likely to respond to SSRI’s) (McDougle et al., 1993).  While the 
majority of OCD patients suffer from at least one comorbid OCSD (Du Toit et al., 2001), 
there has been relatively little systematic investigation of the structure and implications of 
such comorbidity.  One approach may be to focus on the different dimensions of the OCD 
  164
spectrum, which perhaps correspond to differential involvement of various neurochemical 
systems and neuroanatomical circuits (McElroy et al., 1994; Van Ameringen et al., 2001).  
Indeed, while most of the literature focuses on the dimensional relationships across OCD 
and different OCSD’s, the current chapter will focus on the comorbidity of OCSD’s in OCD.  
It will be argued that a consideration of such comorbidity may well contribute to delineating 
the heterogeneity of OCD.   
 
In this study it was aimed to delineate OCD subtypes using cluster analysis of OCSD’s in 
patients with OCD.  The association of these identified clusters with demographic variables 
(age, gender), clinical variables (age of onset, obsessive-compulsive symptom severity and 
dimensions, level of insight, temperament/character, treatment response) and 
monoaminergic genotypes was investigated. 
 
 
6.2 Methods 
 
6.2.1 Subjects and interview 
This investigation made use of the SCID-OCSD (Du Toit et al., 2001) to assess putative 
OCSD’s.  Complete SCID-OCSD data were recorded for a subset of the interviewed sample 
of 261 patients; i.e. SCID-OCSD data from two hundred and ten adult patients with OCD 
(N=210: 102 male; 108 female), with ages ranging between 18 and 75 years (35.7 ± 13.3) 
were included in the analyses.  For a detailed description of the recruitment and interviewing 
procedures, please refer to Chapter 2. 
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6.2.2 Genotyping 
DNA was extracted from venous blood (10-30 ml) in a Caucasian subset of OCD patients 
(N=171) and controls (N=168), including patients (N=77) and controls (N=144) from the 
genetically homogeneous Afrikaner population, and was genotyped for polymorphisms in 
genes involved in monoamine function, which had previously been hypothesized to be 
relevant to OCD (Hemmings et al., 2003).  (Please refer to Chapter 2 for more information 
on the the genotyping protocols and the polymorphisms that were investigated.)   
 
6.2.3 Data analysis 
Firstly, as the items of the SCID-OCSD were binary (present / absent), a cluster analysis 
(Ward’s method), appropriate for use with binary data (Ward, 1963), was performed on the 
items (lifetime) of the SCID-OCSD for all OCD patients.  OCSD’s were selected on the basis 
of previous literature and comprised TD, pathological gambling, hypersexual disorder, 
kleptomania, compulsive shopping, trichotillomania (TTM), intermittent explosive disorder 
(IED), eating disorders (including bulimia and anorexia nervosa), self-injury (i.e. impulse 
control disorder not otherwise specified), body dysmorphic disorder (BDD) and 
hypochondriasis.  For each respondent cluster scores were obtained by calculation of the 
mean score for each cluster.  The associations of cluster scores with demographic variables 
(age, gender), clinical variables (age of onset, obsessive-compulsive symptom severity and 
dimensions, level of insight, temperament, treatment response) and genotypes were then 
examined, using Pearson correlation coefficients and one-way analysis of variance 
(ANOVA), where appropriate.  Since the normal probability plots showed that the residuals 
were not normally distributed, a non-parametric bootstrap ANOVA for multiple comparisons 
was used (Efron and Tibshirani, 1993).    
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6.3 Results 
 
6.3.1 Cluster analysis 
At the 1.1 linkage distance level, three clusters were obtained (Figure 1). 
1.) Cluster I, subsequently named “Reward deficiency”, included TTM, pathological  
gambling, hypersexual disorder and TD. 
2.) Cluster II, subsequently named “Impulsivity”, included compulsive shopping,  
kleptomania, eating disorders (including anorexia and bulimia nervosa), self-
injury and IED disorder. 
3.) Cluster III, subsequently named “Somatic”, included BDD and hypochondriasis.  
 
6.3.2 Comparison data 
The following significant results were found: 
1.) Cluster I scores (i.e. “reward deficiency”) were significantly associated with earlier 
onset of OCD (r = - 0.17; p = 0.02), and the presence of tics (t = -3.26; p = 0.001).  
Cluster I scores were also significantly associated with harm-related (r = 0.18; p = 
0.01) and sexual / religious obsessions and compulsions (r = 0.21, p = 0.004). 
2.) Cluster II scores (i.e. “impulsivity”) were significantly associated with female gender 
(t = -2.45, p = 0.02), increased severity of OCD on the YBOCS (r = 0.18, p = 0.01), a 
history of childhood emotional abuse (r = 0.22, p = 0.03) and increased scores on 
the temperament trait of novelty seeking (r = 0.35, p < 0.001).   
3.) Cluster III scores (i.e. “somatic”) were significantly associated with deficits in insight 
into the excessiveness or senselessness of obsessive-compulsive symptoms (r = 
.22; p = 0.02) and with somatic obsessions and compulsions (r = 0.22; p = 0.002).    
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The three identified clusters did not show significant associations with the other 
demographic and clinical variables (including treatment response) and there were no 
significant associations with the different genotypes. 
 
(Figure 1 follows on the next page.) 
. 
FIGURE 1. Cluster analysis (Ward’s method) results: Tree diagram 
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6.4 Discussion 
 
Cluster analysis of the OCSD’s in this sample of OCD patients identified 3 separate 
clusters at the 1.1 linkage distance level.  These clusters were labelled: 
1) “Reward deficiency” (including TTM, pathological gambling, hypersexual disorder 
and TD),  
2.) “Impulsivity” (including compulsive shopping, kleptomania, eating disorders, self-
injury and IED) and  
3.) “Somatic” (including BDD and hypochondriasis).   
Each cluster was defined by different clinical features; none of these clusters were 
associated with any particular genetic variant. 
 
6.4.1 The REWARD DEFICIENCY cluster 
A substantial literature has documented the comorbidity between OCD and TD, and the 
finding that TTM, pathological gambling, and hypersexual disorder clustered together 
with TD is consistent with some previous evidence of comorbidity between these 
disorders.  A number of authors have emphasized the involvement of the dopaminergic 
system in OCD patients with comorbid tics (McDougle et al., 1994a; 1994b) and TD 
(Singer et al., 1991).  There is some evidence that pathological gambling (Hollander et 
al., 2000), hypersexual disorder (Bergh et al., 1997; Hollander et al., 2000; Seedat et al., 
2000) and TTM (Stein and Hollander, 1992) (all clustered together with TD in Cluster I) 
may also be mediated by a dysfunctional dopaminergic system.  Indeed Blum and 
colleagues (2000) have argued that a number of OCSD’s is characterized by reward 
deficiency, pleasure seeking behaviour, and dopaminergic deficits – hence the use of 
the term “reward deficiency” to describe the cluster.   
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6.4.1.i Phenomenology 
TD is characterized by motor and one or more verbal tics (described as sudden rapid 
repetitive non-rhythmic movements, gestures or utterances) beginning before the age of 
18 years (APA, 1994), the performance of which is associated with a reduction in tension 
or relief.  Similarly, the symptoms of TTM, hypersexual disorder (e.g. the excessive 
preoccupation with non-paraphilic sexually arousing fantasies, urges, or excessive 
sexual behaviours over time) and pathological gambling may also be seen as involving 
attempts at achieving gratification or reward.   
 
Furthermore, the incidence of tics and tic disorders in OCD is high (37 – 59%) (Leonard 
et al., 1992; Pitman et al., 1987).  Patients with a primary diagnosis of TD also often 
report OCD and OC symptoms (12 – 90%) (Como, 1995; Leckman et al., 1994).  
Interestingly, tics share some phenomenological similarities with the compulsions of 
OCD (Como, 1995; Leckman et al., 1994).  On the other hand, tics may be distinguished 
from compulsions:  In general, compulsions are typically quite complex and performed in 
response to an obsession or according to some rigidly applied rules.  In contrast, 
although they may also be complex, tics are typically less complex than compulsions 
and not aimed at neutralizing the anxiety associated with the obsessions (APA, 1994).   
 
There is a large body of evidence suggesting that OCD patients with tics and OCD 
patients without tics differ in a number of ways, with differences observed in the 
phenomenology, symptom profile, age of onset and gender ratio, and pharmacological 
treatment response (also see Chapter 1: Background) (Holzer et al., 1994; Leckman et 
al., 1994; McDougle et al., 1993; Zohar et al., 1997).  For example, in a comparison of 
patients with OCD alone and patients with both OCD and TD (George et al., 1993), the 
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former group (OCD alone) was more likely to have: 
(1) contamination obsessions and compulsions,  
(2) fear of not saying the right thing, and  
(3) BDD,  
while the latter group (OCD with TD) was more likely to have: 
(1) an obsession with the need for symmetry accompanied by magical thinking,  
(2) fear of doing something embarrassing or of blurting out an obscenity,  
(3) intrusive violent or sexual images and thoughts,  
(4) touching compulsions,  
(5) blinking or staring rituals,  
(6) self-injurious compulsions,  
(7) hoarding, and  
(8) counting.   
Several other studies have found similar findings, e.g. adolescents with OCD and 
comorbid tics were more prone to aggressive and sexual images and obsessions than 
were adolescents without tics (Zohar et al., 1997).  In another study comparing adult 
OCD patients with those who had comorbid OCD and TD, findings differed somewhat 
from the previous, with obsessions involving non-violent images being significantly more 
common in the OCD/TD group; however, the rest of the findings of this study by Petter et 
al. (1998) overlaps significantly with others, i.e. excessive concern with appearance, 
need for symmetry, touching, blinking or staring, and counting compulsions in patients 
with OCD/TD. 
 
Sensory phenomena may be another important phenotypic measure for grouping 
patients into an OCD-TD/tics subtype.  Sensory phenomena include both bodily and 
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mental sensations:  Bodily sensations refer to focal or generalized body sensations 
(usually tactile, muscular-skeletal/visceral, or both) occurring either before, or during, the 
patient's performance of the repetitive behaviours.  Mental sensations on the other hand 
include urge only, energy release (i.e. mental energy build-up that needs to be 
discharged), incompleteness, and just-right perceptions.  Evidence suggests that these 
bodily and mental sensations are more frequently found in patients with OCD and TD 
than in patients with OCD alone (Miguel et al., 2000).   
 
OCD patients with and without tics may also differ in terms of other clinical features.  An 
OCD family study found that younger age of onset of OCD symptoms and possibly male 
gender in probands were associated with increased tic disorders in relatives (Leckman et 
al., 2003).  Similarly, an association of Cluster I scores was found with earlier onset 
OCD, as well as with harm-related and sexual / religious obsessions and compulsions, 
and these findings are consistent with previous data indicating that OCD with tics is 
characterized by early age of onset and by these symptom subtypes (Do Rosario-
Campos et al., 2001; Eichstedt and Arnold, 2001; Geller et al., 1998; George et al., 
1993). 
 
6.4.1.ii Neurobiology 
Tic disorders tend to occur in a specific subgroup of OCD families, suggesting that 
presence of tic disorders is more likely to indicate a more familial OCD phenotype (Pauls 
et al., 1995).  Consistent with this hypothesis, family studies of OCD probands have 
revealed tics in at least 17% of adult patients and increased rates of tics in their first-
degree relatives (Holzer et al., 1994; Pauls et al., 1995).  Interestingly, it was suggested 
that tics are more useful than obsessions or compulsions in distinguishing relatives of 
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patients with OCD from relatives of control subjects.   
 
In addition to genetic or familial transmission, OCD with comorbid tics may also both be 
seen after neuroimmunological insult.  Regional cerebral blood flow patterns in 
individuals with OC behaviour in TD families are comparable to their relatives with TD, 
and differ from individuals with primary OCD, but with no family history of tic disorders 
(Moriarty et al., 1997).  This finding further supports the hypothesis that at least some 
forms of OCD are genetically related to TD.  
 
Additional data supporting the existence of an OCD-TD/tic subtype focus on treatment 
response.  However, despite evidence that treatment response differs between OCD 
patients with tics versus OCD patients without tics, there are inconsistencies in treatment 
data.  A retrospective, case-controlled analysis by McDougle et al. (1993) found that the 
SSRI, fluvoxamine, alone was less effective in OCD patients with tics than in patients 
without tics.  In a continuation of this study, the researchers (McDougle et al., 1994a) 
found that treatment-refractory OCD patients with comorbid tic disorders (including TD) 
responded to haloperidol (a dopamine blocker) augmentation of fluvoxamine, whereas 
this strategy was of little benefit for patients without tics.  Other studies have also 
suggested that augmentation of SRI’s with dopamine blockers may be useful in 
treatment-refractory OCD (Mohr et al., 2002).   
 
The release of dopamine in the ventral striatum (nucleus accumbens) plays a crucial role 
in reward processing (Blum et al., 2000), and dysfunction in such reward processing may 
be characteristic of the conditions included in this cluster of comorbid OCSD’s.  It can be 
speculated that the gratification / release symptoms that characterize this cluster of 
  174
 
 
disorders are mediated by dopaminergic dysfunction in ventral striatal circuits.    
 
6.4.2 The IMPULSIVITY cluster 
The second identified cluster included compulsive shopping, kleptomania, eating 
disorders, self-injury and IED, and as these conditions are associated with impaired 
impulse control, Cluster II was termed “impulsivity”.  Comorbidity of impulse control 
disorders in OCD is consistent with previous work noting that many patients with OCD 
manifest impulsive behaviour or comorbid impulse control disorders (Hollander et al., 
1996; Hollander and Rosen, 2000; Manchanda et al., 1979; McElroy et al., 1994; Millar, 
1983; Stein and Hollander, 1993a, 1993b; Stein et al., 1994; Thornton and Russell, 
1997; Winchel and Stanley, 1991).   
 
The findings indicated that Cluster II was associated with increased novelty seeking, a 
temperament trait that is characterized by impulsivity and risk taking behaviour 
(Cloninger et al., 1993).  Indeed, although OCD has been associated with increased 
harm or risk avoidance, the role of impulsivity in OCD has received substantial 
theoretical and clinical interest (Oldham et al., 1996).  Much of this work has used 
aggressive and auto-aggressive (suicidal) behaviours as an index of impulsivity.  For 
example, it has been suggested that at least a subset of OCD patients has difficulties 
controlling their anger (Hoehn-Saric and Barksdale, 1983; Manchanda et al., 1979; 
Millar, 1983).  Similarly, consistent with the hypothesis of significant impulsivity in OCD, 
an epidemiological study showed increased incidence of conduct problems in the 
childhood history of OCD patients (Hollander et al., 1996).   
 
Impulsivity is a characteristic feature of the OCSD’s in this cluster of conditions.  For 
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example, kleptomania is classified in the DSM-IV as one of the impulse control 
disorders, and is characterized by repeated failure to resist impulses to steal objects not 
for personal use or financial gain.  Compulsive shopping is also characterized by the 
presence of repetitive impulsive and excessive buying that leads to personal and familial 
distress, with impulsivity singled out as one of the main clinical features of this condition 
(Lejoyeux et al., 1996).  Furthermore, the literature has consistently found that OCD 
patients often present with comorbid eating disorders (Nagata et al., 2000) as well as 
with self-injurious behaviours (Winchel and Stanley, 1991).  Indeed eating disorders, 
essentially characterized by a severe disturbance in the person’s perception of body 
shape and weight, may also have impulsive symptoms or ‘multi-impulsivity’ (Eddy and 
Walbroehl, 1998; Fessler, 2002; Nagata et al., 2000).  In addition, as previously 
discussed, in their comparison of OCD patients with and without comorbid putative 
OCSD’s, Du Toit et al. (2001) found that one of the OCSD’s with the highest prevalence 
rates was self-injury (i.e. impulse control disorder not otherwise specified).  The 
compulsive self-injurious behaviours seen in these patients with OCD included 
pathological skin picking, trichotillomania, and onychophagia (nail biting).  
 
Also included in this cluster is IED, a condition that is characterized by discrete episodes 
of aggressive impulses that result in serious assaultive acts towards other people and/or 
destruction of property (DSM-IV).  Rather little research has been done on IED as 
defined by these DSM-IV criteria, or on the comorbidity between IED and OCD.  The 
association between OCD and IED-type of behaviour is supported by early analyses that 
revealed that patients with obsessive-compulsive “neurosis” have impulsive “other-
directed” symptoms, such as acting-out hostility (Manchanda et al., 1979; Millar, 1983), 
arguably resembling aspects of IED. 
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The finding of an association between Cluster II scores and increased severity of OCD is 
consistent with previous data indicating a link between impulsivity and OCD severity 
(Stein et al., 1994).  In addition, the association of Cluster II scores with female gender 
and with emotional abuse is consistent with previous studies linking a subset of OCD 
patients, as well as eating disorders and self-injurious behaviours in women, to early 
traumatic experiences (Bogetto et al., 1999; De Silva and Marks, 1999; Fallon et al., 
2000; Paul et al., 2002; Yates, 2004).   
 
6.4.2.i Phenomenology 
In summary, OCD patients with any of the OCSD’s included in Cluster II may present 
with significant impulsiveness or impulse control problems.  Indeed, increasing data from 
comorbidity studies support the existence of an OCD-Impulsivity subtype.  For example, 
an earlier analysis of this data set (Du Toit et al., 2001) compared OCD patients with and 
without comorbid OCSD’s, and found evidence for significant comorbidity between OCD 
and impulse control disorders, e.g. 10.6% of patients also presented with comorbid 
compulsive shopping and IED.  The cluster analysis findings also positioned some of 
these impulse control disorders (including compulsive shopping, kleptomania and IED) in 
one cluster, supporting a common feature of impulsivity in these comorbid OCSD’s in 
OCD patients.   
 
It has been suggested that obsessive-compulsive and impulsive symptoms are 
qualitatively similar in that both involve difficulties delaying or inhibiting repetitive 
behaviours (Hollander and Wong, 1995).  Indeed, there are significant similarities in the 
phenomenology between OCD and disorders of impulse control.  For example, both 
OCD and the impulse control disorders are characterized by intrusive, irresistible urges 
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to commit an act that may or may not be seen as senseless.  Also, many patients with 
either of these conditions frequently experience an increasing sense of tension 
associated with attempts to resist the behaviour, and temporary relief from anxiety 
following their engagement in the behaviour.   
 
In addition, the cluster analysis findings suggest an association between the conditions 
included in this “impulsivity” cluster with female gender and with emotional abuse.  This 
is consistent with previous work linking a subset of OCD patients, as well as eating 
disorders and self-injurious behaviours in women, to early traumatic experiences 
(Bogetto et al., 1999; De Silva and Marks, 1999; Fallon et al., 2000; Paul et al., 2002).   
 
 6.4.2.ii Neurobiology 
In addition to the phenomenological similarities, there are also some similarities in the 
neurobiology and treatment response between OCD and disorders of impulse control, 
suggesting that patients with the OCD-Impulsivity subtype may require treatment with 
medications proven useful for these conditions (e.g. SRI’s).  Interestingly, abnormalities 
in central serotonergic system function are reported in patients with impulsive aggressive 
behaviour as well as in patients with OCD, with many of the medications that are useful 
in the treatment of impulsivity and OCD respectively, acting on the serotonergic system.  
There are now several controlled studies of serotonergic medications in different impulse 
control disorders, including borderline personality disorder.  Similarly, reductions in 
impulsivity and hostility have been noted after successful treatment of OCD symptoms 
with SRI’s (Lopez-Ibor Jr, 1990).   
 
In addition, medications that do not act on the serotonergic system may also prove to be 
  178
 
 
useful in disorders characterized by impulsivity.  Arguably, the anticonvulsants, which 
are effective for controlling impulsivity in a number of these conditions, may also be 
useful in OCD patients with comorbid impulsivity.  For example, Khanna has written 
about the use of carbamazepine in the treatment of OCD (Khanna, 1988).  There has 
also been some interest in the use of valproate, gabapentin, lamotrigine and the mood-
stabilizer lithium.  Some studies have shown that antipsychotics have been effective in 
reducing hostility and suicidality in patients with a personality disorder (Klein, 1968; 
Montgomery and Montgomery, 1982; Soloff et al., 1986).  Similarly, antipsychotics have 
proven beneficial when added to an SRI in the treatment of OCD patients with symptoms 
of (amongst others) cluster B personality disorders (these may include impulsivity).  No 
data on the effect of antipsychotics on specifically impulsivity in OCD patients could be 
found however.    
 
6.4.3 The SOMATIC cluster 
BDD, characterized by a preoccupation with imagined defects in appearance (APA, 
1994), and hypochondriasis, a disorder characterized by repeated concerns about 
illness, were included in Cluster III which was termed “somatic”.  Ruminations and rituals 
that concern health or appearance are the hallmark of somatic-related disorders included 
in this cluster, and may include a number of OCSD’s, e.g. BDD, hypochondriasis and 
perhaps olfactory reference syndrome (ORS) (ORS was not included in this cluster 
analysis however).  There are other obsessive-compulsive related symptoms that can 
also be conceptualized as revolving around the body, the body functions or appearance, 
for example eating disorders, TTM, and self-injury; however, these conditions were 
included in other clusters. 
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The finding of an association between Cluster III and somatic obsessions and 
compulsions was therefore not surprising.  Indeed, consistent with a somatic subtype of 
OCD, many OCD patients report somatic or body-focused concerns and rituals (Simeon 
et al., 1995).  In addition, somatic OCD symptoms are often seen in non-psychiatric 
healthcare settings, e.g. Dermatology clinics.  For example, brief psychiatric screening of 
92 patients attending a Dermatology clinic revealed that approximately one fifth scored 
positive either for OCD or for a clinically relevant spectrum disorder such as BDD 
(Fineberg and Roberts, 2001).   
 
Somatic concerns in patients with BDD manifest as obsessive preoccupations with an 
imagined or minimal defect in physical appearance despite an objectively normal 
appearance (also described as “imagined ugliness”) (DSM-IV).  BDD patients suffer from 
repetitive, persistent ideas or thoughts about these defects, with consequent compulsive, 
mostly body-focused, behaviours, including constant checking in mirrors, applying make-
up to cover-up the “flaw”, excessive grooming (e.g. hair), and repeated reassurance 
seeking from others about their “defect” (Phillips, 1991).  Body parts often involved in 
BDD concerns are the head or facial features (including nose, mouth, skin and hair), 
body size or symmetry and the sexual organs (penis, breasts) (Hollander et al., 1993b). 
 
Hypochondriasis is similarly characterized by excessive somatic concerns.  In particular, 
patients with hypochondriasis have a preoccupation or excessive concern with the fear 
of having, or a belief that they have an illness (in the absence of objective proof), with 
subsequent reassurance seeking, compulsive checking behaviours and a relentless 
pursuit of medical care (DSM-IV).  Again, patients with hypochondriacal concerns may 
present widely to general medical settings seeking medical assistance for their somatic 
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symptoms. 
 
ORS is another putative OCD-related condition characterized by persistent 
preoccupations about body odour accompanied by shame, embarrassment, significant 
distress, avoidance behaviour and social isolation.  Although ORS was not included in 
the cluster analysis described here, this condition may arguably be positioned together 
with other disorders with somatic concerns.  ORS is not included in the DSM-IV or the 
International Classification of Diseases 10th Edition (ICD-10) as a separate category.  
Nevertheless, it has been argued that ORS represents a unique cluster of symptoms that 
can be delineated as a separate diagnostic entity (Lochner and Stein, 2003b).  Patients 
with ORS describe excessive concerns with personal or body odour, a preoccupation 
with fear of causing offence to others, leading to excessive cleaning of the body or body 
parts, reassurance seeking and consequent significant functional impairment (Pryse-
Phillips, 1971).  
 
6.4.3.i Phenomenology    
Similarities between OCD and BDD have been described in terms of clinical 
presentation, comorbidity rates, treatment response profiles, and other features.  In 
particular, the two disorders have similar sex ratios, demographic characteristics, and 
illness severity (McKay et al., 1997; Phillips et al., 1998; Saxena et al., 2001).  In 
addition, the repetitive and intrusive nature of their body-focused concerns, together with 
rituals such as checking, also suggest significant overlap between OCD and BDD 
(Phillips, 1992; Saxena et al., 2001).  Some authors have suggested that “obsessive-
compulsiveness” or obsessive or compulsive personality traits are a hallmark of BDD.  
BDD appears to be relatively common among patients with OCD, with rates of BDD 
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ranging from 8% to 38% among patients with OCD (Hollander and Phillips, 1993; 
Phillips, 1991; Phillips et al., 1998; Pigott et al., 1994; Simeon et al., 1995).  That BDD is 
related to OCD may also be supported by the finding of an elevated rate of BDD in family 
members of OCD patients compared to those of controls (Bienvenu et al., 2000).  
Moreover, patients with body dysmorphic concerns frequently have poor insight; 
previous data have also suggested an association between health concerns and poor 
insight (Abramowitz et al., 1999).  Similarly, the data also suggest an association 
between the somatic cluster of conditions and poor insight.   
   
In addition, some of the somatic symptoms presented by patients with OCD or BDD 
overlap with the somatic and health related concerns characteristic of hypochondriasis.  
Similar to OCD and BDD, patients with hypochondriasis may also have elaborate 
“checking” rituals involving their body resulting in at least temporary reduction in their 
anxiety levels.  Consistent with the finding that hypochondriasis in included in the 
somatic cluster of conditions, it has been suggested that there is much overlap and 
relatively high prevalence of hypochondriasis in OCD (Bienvenu et al., 2000; Jaisoorya 
et al., 2003).  Relatively few studies have systematically assessed the prevalence of 
comorbid hypochondriasis in OCD patients; nevertheless, Pigott et al. (1994) have found 
a lifetime prevalence rate of 23% for hypochondriasis in a sample of OCD patients.  
Recent work has also suggested that hypochondriasis occurred more frequently in OCD 
compared to controls (Bienvenu et al., 2000; Jaisoorya et al., 2003).  
  
ORS symptoms meet DSM-IV criteria for obsessions and compulsions insofar as these 
are repetitive intrusive thoughts (about body odour and the offence that their body/body 
odour may cause to others), followed by ritualistic attempts to decrease anxiety (e.g. 
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excessive washing, asking for reassurance etc.).  Also similar to some OCD and BDD 
patients, patients with ORS tend to change their clothes with more than the usual 
frequency, and often restrict their social and domestic excursions to an extent because 
of their obsessions and fears (Pryse-Phillips, 1971).  In addition, in OCD, BDD, 
hypochondriasis and ORS, the fixity of and the resistance to the pathological thoughts 
vary to a large extent, and insight into the excessiveness or irrationality thereof may 
waver over time.  The prevalence of comorbid ORS in OCD patients is unknown.  
Nevertheless, given the significant overlap between the somatic symptoms that are often 
characteristic of both disorders, it may be suggested that ORS may in some contexts 
even be considered as a variant of OCD or BDD.  As such, one may argue that ORS 
symptoms should be considered for inclusion in OCD checklists such as the YBOCS-CL.   
 
6.4.3.ii Neurobiology 
A somatic subtype of OCD is validated by this cluster analysis, and there is evidence 
that both OCD and somatic OCD spectrum disorders respond to similar medications 
(Phillips and Najjar, 2003).  In particular, in all of these disorders, a preferential response 
to treatment with anti-obsessional drugs, particularly SRI’s and other agents that act by 
inhibiting the reuptake of serotonin, e.g. clomipramine, has been suggested.  Until 
recently, approaches to treatment-resistant BDD in particular have received little 
investigation, but available data indicate that switching to another SRI and several SRI-
augmentation strategies may be helpful (Phillips, 2002).  In a family study conducted by 
Bienvenu et al. (2000), it was suggested that BDD may be co-transmitted with OCD, 
providing further evidence for a significant neurobiological overlap between these 
disorders.   
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For now, there is no evidence that OCD patients of the comorbid somatic subtype have a 
different or unique neurobiological profile or treatment response compared to other OCD 
subtypes.  Nevertheless, it has been suggested that the group of OCD patients with poor 
insight may have a different treatment response than patients with better insight 
(Attiullah et al., 2000), but the relationship between the degree of insight and outcome of 
therapy remains unclear (Kozak and Foa, 1994).  Additional research is needed in order 
to address this issue. 
 
6.4.4 Clusters and genetics 
As noted previously, a relationship between any of the identified clusters and the 
investigated dopaminergic and serotonergic polymorphisms was not found, suggesting 
that variants in other genes in these systems should rather be explored.  
 
 
6.5 Conclusion 
 
In conclusion, although aspects of the links discussed here have previously been 
described, to our knowledge this is the first cluster analysis based on a prospective 
comprehensive interview investigating a range of OCSD’s.  The data support the 
existence of OCD subtypes, partially similar to existing literature on possible OCD 
subtypes, based on comorbidity between OCD and OCSD’s.  The significant 
associations found between cluster scores and clinical variables suggest the value of 
delineating the dimensions in which OCSD’s fall when comorbid with OCD: The TS/tics 
subtype of OCD (part of the reward deficiency cluster) has received particular attention.  
Nevertheless, the present data also suggest the existence of other subtypes including an 
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impulsivity subtype, and a somatic subtype.  Several significant associations consistent 
with previous data were found between these subtypes and other clinical and 
demographic variables.  A relationship between any of the identified clusters and the 
investigated dopaminergic and serotonergic polymorphisms was not found, suggesting 
that variants in other genes in these systems should rather be explored.  
 
Mood and anxiety disorders are also highly comorbid with OCD, suggesting that future 
work on the structure of comorbid disorders in OCD should address the inclusion of 
these conditions.  In addition, future work with larger samples, and additional variants in 
other genes, may ultimately show that examining comorbidity in OCD is helpful in 
delineating the endophenotypes that mediate the pathogenesis of this condition.     
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CHAPTER 7 
GENERAL DISCUSSION AND CONCLUSION  
 
 
The clinical presentation of obsessive-compulsive disorder (OCD) is remarkably diverse 
indeed.  The variability in phenomenology has previously lead to the hypothesis that 
OCD is a heterogeneous type of psychiatric disorder and that the inconsistencies in 
clinical, natural history, treatment response and genetic study findings may be ascribed 
to this heterogeneity.  Subsequently, it was suggested that OCD may be categorized into 
a number of subtypes, each associated with specific clinical and neurobiological 
features.  Identification of consistent OCD phenotypes has the potential to further the 
understanding of OCD and may contribute to the identification of more robust 
endophenotypes.     
 
The overall objective of the present study was to assemble, analyze and interpret 
original data in order to better previous efforts delineating valid and reliable OCD 
subtypes or dimensions and their associated features, with appropriate data 
classification and association study methods, in a large sample of South African OCD 
patients.  The research reported here examined OCD from both a clinical and genetic 
perspective.   
 
The analyses presented in this dissertation were based upon a comprehensive review of 
literature focused on the heterogeneity of OCD.  The literature review provided an 
overview of the ways in which this neuropsychiatric disorder has been subtyped in an 
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attempt to integrate data on its symptomatology, psychobiology, genetics and treatment 
response to facilitate predictions about etiology and disease outcome.  Until now, 
methods focused on OCD symptomatology and/or comorbidity (especially with 
obsessive-compulsive (OC) spectrum conditions) as classifying variables have been 
some of the most popular strategies for identifying OCD subtypes, and these foci have 
been receiving increased attention in recent years.     
 
Presentation of the findings obtained with the Yale-Brown Obsessive-Compulsive 
Symptom Checklist (YBOCS-CL) established an important introduction to subsequent 
analyses of OC symptomatology and its associated features.  Indeed, following the 
literature review of the heterogeneity of OCD, a review of available descriptive data on 
the YBOCS-CL was provided, with a discussion of the rationale for using this scale in the 
present investigations, and then, finally, provision of a profile of the OCD sample used 
based on their YBOCS-CL responses.  This profile included for example, the frequencies 
in which the major OC symptom categories were reported, the mean number of 
symptoms reported by the patients and the frequency with which each individual item of 
the YBOCS-CL (i.e. symptom) was reported, as well as the association of each of these 
items / symptoms with specific demographic (gender, age, population) and clinical 
variables (total OCD severity and disability).  The findings suggest that the present 
sample was not dissimilar to OCD samples used in other investigations.  Thus, analyses 
and findings using this patient population and checklist arguably rendered information 
comparable and applicable to other OCD patients in similar contexts.  This chapter also 
included comments on the content and comprehensiveness of the YBOCS-CL as an 
assessment tool of OC symptomatology.   
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The first subtyping attempt made use of latent class analysis (LCA), a special “type” of 
factor analysis appropriate for the categorical nature of the data rendered by the 
YBOCS-CL.  The “best fit” comprised six (6) clusters of cases or OCD patient subtypes 
when the nine most frequently occurring obsessive-compulsive symptoms were included 
in the analysis.  When additional indicators were used in LCA, the potential for 
computational instability increased.  To gain insight into the cluster structure, the way in 
which clusters differ with respect to specific demographic variables (age, gender) and 
clinical variables (OC symptoms, total OCD severity, treatment response, childhood 
trauma history) was investigated.  In summary, the LCA-findings support the existence of 
six clusters of OCD cases classified according to their OC symptomatology.  Clusters I to 
VI were labelled ‘Mental compulsions’, ‘Maximal disorder’, ‘Minimal disorder’, ‘No 
checking compulsions, ‘Checking compulsions’, and ‘Pure contamination compulsions / 
washing’, respectively.  In contrast to factor analysis, in LCA or cluster analysis, patients 
are unambiguously assigned to groups that are created by maximizing between-group 
differences and minimizing within-group variability on the chosen set of measures.  Here, 
each patient falls into only one class or cluster.  Conversely, as noted before, in factor 
analysis, a subject may have loadings on all of the identified factors.  Use of cluster 
analysis has gained ground in recent years, with some investigators suggesting that 
cluster analysis may be a superior method for identifying OCD subtypes.  In a way, 
categorization of OCD patients into different groups and investigating their respective 
features go beyond the literature and thus add another dimension to the increasing 
efforts to fully delineate OCD subtypes.  Some of the clusters identified with LCA broadly 
resembled some of the current sub-classifications of OCD suggested in the literature.  It 
has previously been argued that pure symptoms are of key importance in defining 
groups of OCD patients.  To an extent, the findings here similarly suggest that some 
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groups or classes are characterized by “pure” symptoms (e.g. ‘Pure contamination 
compulsions / washing’).  On the other hand, it was argued that classes very often rather 
are characterized by mixed symptoms, e.g. Cluster II (‘Maximal disorder’ including a 
wide variety of OC symptoms).  Indeed, there is some clinical evidence in support of the 
latter argument; in fact, it is well known that OCD patients mostly present with multiple 
symptoms that often change over time.  It was concluded, based upon both the existing 
OCD literature and the findings here, that not only does one need to investigate OCD 
phenotypes characterized by pure symptoms or predominantly one type of OC symptom, 
but also those classes characterized by mixed or a wide array of different OC symptoms.  
As noted before, relatively few items were included in the LCA given the fact that, when 
using additional indicators in LCA, the potential for computational instability increased.  
Subsequently, given the importance of accurate and comprehensive representation of 
OCD symptoms when subtyping OCD based on patients’ reported symptomatology, it 
was attempted to remedy this situation with implementation of another clustering 
method.  Cluster analysis (Ward’s method) of the same few items (the nine most 
frequently reported OC symptoms) in a sample of 261 OCD patients rendered a 3-cluster 
solution.  This OCD symptom dimension solution was consistent with most findings from 
previous factor analysis studies, but differed to an extent from the six clusters of cases 
identified with LCA.  This is reasonable given that these two methods actually render 
different types of data; the one cutting across symptoms and rendering groups in which 
patients had multiple OC symptoms (LCA), the other cutting up symptoms or carving out 
the specific OC symptoms from one another (cluster analysis).  Importantly, each may 
be useful for different purposes.  In particular, the three identified clusters or symptom 
dimensions comprised checking and repeating (i.e. pure compulsions), obsessions with 
symmetry / exactness / ordering and arranging, as well as obsessive contamination fears 
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and related compulsions (washing).  The consistency of the cluster analysis of the nine 
OC symptoms compared to previous factor analyses encouraged subsequent cluster 
analyses of the 45 selected items of the YBOCS-CL.  Cluster analysis of the 45 selected 
items of the YBOCS-CL in this sample of OCD patients identified 6 separate clusters; 
these clusters were labelled “Contamination fears / washing”, “Hoarding / collecting”,  
“Symmetry / ordering / counting / arranging / repeating”, “Sexual”, “Somatic, religious 
and diverse” and “Harm-related”.  Each of the clusters was associated with specific 
demographic, clinical and, in some cases, genetic characteristics, which supported the 
presence of clinical subtypes of OCD.  Notably, the genetics findings indicated the L/L 
(met/met) genotype of COMT Val158Met polymorphism plays a major role in the 
manifestation of sexual / somatic, religious and diverse / harm-related symptoms of 
OCD.  This finding contributes to the relatively limited data on OC symptom subtypes 
and genetics.  However, given the relatively varying nature of the symptoms 
characteristic of our three identified symptom clusters, it was argued that the COMT 
Val158Met polymorphism is involved in the etiology of OCD in general (or perhaps of a 
significant number of symptom subtypes) rather than just with the development of a 
single specific OC symptom subtype.  Although each of the subtypes had a number of 
associated features, these associations did not clearly or uniquely differentiate clusters 
given the substantial overlap in this regard.  Furthermore, the clusters were highly 
correlated with one another, suggesting that delineation of the OCD complex into 
symptom clusters is not the only or best way to approach the heterogeneity 
characteristic of OCD.  The significant comorbidity with obsessive-compulsive spectrum 
disorders (OCSD’s) in each of the identified clusters highlighted the significant 
relationship of OCD with the OCSD’s.  Indeed, although most efforts to subtype OCD 
thusfar gave prominence to classification built upon OC symptomatology, it was argued 
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that another important approach to subtyping would be to consider issues of comorbidity, 
especially with the OCSD’s.  A question was also raised about the way that the OCSD’s 
“fit” with the standard OC symptomatology outlined in the YBOCS-CL.  OCSD symptoms 
have significant phenomenological and neurobiological overlap with the features of OCD 
and should arguably therefore be considered for inclusion in attempts to identify a 
comprehensive and multidimensional model for OC symptom subtypes.  At this stage, 
the YBOCS-CL contains very few items that can be labelled as “OC spectrum 
symptoms”, suggesting the need for an incorporation of the other possible spectrum 
items from a different scale specifically assessing the OCSD’s, such as the Structured 
Clinical Interview for the Diagnosis of putative OCSD’s (SCID-OCSD), into the YBOCS-
CL.  Development of another version of the YBOCS-CL, the so-called Dimensional 
YBOCS (Personal communication with J.F. Leckman, Child Study Center, Yale 
University School of Medicine, New Haven, Connecticut, USA, Unpublished script), 
which incorporates a number of other symptoms characteristic of the OC spectrum, 
could be considered as an attempt to fill this void and thus may be an important 
contribution to the field of OCD research.   
 
A description of the cluster analysis of comorbid OCSD’s in patients with OCD followed, 
with findings suggesting that comorbidity of certain OCSD’s in OCD may serve to define 
important OCD subtypes.  This is the first cluster analysis based on a prospective 
comprehensive interview (the SCID-OCSD) investigating a range of OCSD’s.  The 
significant associations found between cluster scores and clinical variables suggest the 
value of delineating the dimensions in which OCSD’s fall when comorbid with OCD.  For 
example, the TS/tics subtype of OCD (part of the so-called “reward deficiency” cluster) 
has received particular attention.  Nevertheless, the data also suggest the existence of 
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other subtypes including an impulsivity subtype, and a somatic subtype.  Several 
significant associations consistent with previous data were found between these 
subtypes and other clinical and demographic variables.  A significant relationship 
between the identified clusters and the investigated dopaminergic and serotonergic 
polymorphisms was not found, suggesting that variants in other genes in these systems 
should rather be explored.  Given that mood and anxiety disorders often are comorbid 
with OCD, it was suggested that future work on the structure of comorbid disorders in 
OCD should address the inclusion of these conditions.  In addition, future work with 
larger samples, and additional variants in other genes, may ultimately show that 
examining comorbidity in OCD is helpful in delineating the endophenotypes that mediate 
the pathogenesis of this condition.  
 
In conclusion, the main finding of this study was that OCD is indeed a heterogeneous 
disorder that may be categorized into different symptom dimensions or subtypes.  The 
identified OCD subtypes with their associated features were to a large extent consistent 
with previously published data.  However, the findings here also suggested that there 
may be different ways of approaching the heterogeneity of OCD (e.g. focusing on OCD 
symptoms, as well as the spectrum of OCD-related disorders).  In addition, in contrast to 
factor analysis, LCA provided a novel, appropriate and advantageous data analysis 
strategy for the data.  Furthermore, to the candidate’s knowledge, the attempt to classifiy 
OCD according to comorbid OCSD’s was the first cluster analysis based on a 
prospective comprehensive interview investigating a range of OCSD’s.  As such, 
although the dimensional structure of OCD is still not entirely understood, the 
categorization of our OCD patients into different groups and the investigation of their 
respective clinical features and neurobiological underpinnings have gone beyond the 
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literature and thus add another dimension to the increasing efforts to fully delineate OCD 
subtypes.   
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